KR102611207B1 - Condensed-cyclic compound and organic light emitting device comprising the same - Google Patents
Condensed-cyclic compound and organic light emitting device comprising the same Download PDFInfo
- Publication number
- KR102611207B1 KR102611207B1 KR1020160006995A KR20160006995A KR102611207B1 KR 102611207 B1 KR102611207 B1 KR 102611207B1 KR 1020160006995 A KR1020160006995 A KR 1020160006995A KR 20160006995 A KR20160006995 A KR 20160006995A KR 102611207 B1 KR102611207 B1 KR 102611207B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- formula
- substituted
- unsubstituted
- layer
- Prior art date
Links
- 150000001923 cyclic compounds Chemical class 0.000 claims abstract description 7
- -1 pentalenyl group Chemical group 0.000 claims description 267
- 239000010410 layer Substances 0.000 claims description 210
- 150000001875 compounds Chemical class 0.000 claims description 140
- 125000003118 aryl group Chemical group 0.000 claims description 103
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 78
- 239000012044 organic layer Substances 0.000 claims description 74
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 claims description 68
- 125000003367 polycyclic group Chemical group 0.000 claims description 64
- 125000001624 naphthyl group Chemical group 0.000 claims description 63
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 56
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 56
- 229910052805 deuterium Inorganic materials 0.000 claims description 56
- 125000006267 biphenyl group Chemical group 0.000 claims description 55
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims description 53
- 125000005638 hydrazono group Chemical group 0.000 claims description 53
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 53
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 53
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 51
- 125000006749 (C6-C60) aryl group Chemical group 0.000 claims description 45
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 44
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 38
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 37
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 claims description 36
- 238000002347 injection Methods 0.000 claims description 35
- 239000007924 injection Substances 0.000 claims description 35
- 125000006753 (C1-C60) heteroaryl group Chemical group 0.000 claims description 34
- 125000005509 dibenzothiophenyl group Chemical group 0.000 claims description 34
- 125000004076 pyridyl group Chemical group 0.000 claims description 34
- 230000005525 hole transport Effects 0.000 claims description 33
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 32
- 125000005299 dibenzofluorenyl group Chemical group C1(=CC=CC2=C3C(=C4C=5C=CC=CC5CC4=C21)C=CC=C3)* 0.000 claims description 31
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims description 31
- 125000006717 (C3-C10) cycloalkenyl group Chemical group 0.000 claims description 30
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 30
- 125000003860 C1-C20 alkoxy group Chemical group 0.000 claims description 30
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 claims description 30
- 125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 claims description 30
- 125000004585 polycyclic heterocycle group Chemical group 0.000 claims description 30
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 29
- 125000001725 pyrenyl group Chemical group 0.000 claims description 27
- 125000006743 (C1-C60) alkyl group Chemical group 0.000 claims description 26
- 239000002019 doping agent Substances 0.000 claims description 26
- 229910052739 hydrogen Inorganic materials 0.000 claims description 26
- 239000001257 hydrogen Substances 0.000 claims description 26
- JQQSUOJIMKJQHS-UHFFFAOYSA-N pentaphenyl group Chemical group C1=CC=CC2=CC3=CC=C4C=C5C=CC=CC5=CC4=C3C=C12 JQQSUOJIMKJQHS-UHFFFAOYSA-N 0.000 claims description 26
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 25
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 25
- 125000003914 fluoranthenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC=C4C1=C23)* 0.000 claims description 25
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 25
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 25
- 125000004306 triazinyl group Chemical group 0.000 claims description 25
- 150000002431 hydrogen Chemical class 0.000 claims description 24
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 24
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims description 24
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 24
- 125000006751 (C6-C60) aryloxy group Chemical group 0.000 claims description 23
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 23
- 125000002541 furyl group Chemical group 0.000 claims description 23
- 125000001544 thienyl group Chemical group 0.000 claims description 23
- 125000006752 (C6-C60) arylthio group Chemical group 0.000 claims description 21
- 125000001633 hexacenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC5=CC6=CC=CC=C6C=C5C=C4C=C3C=C12)* 0.000 claims description 21
- 125000003933 pentacenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C12)* 0.000 claims description 21
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 claims description 21
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 21
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims description 20
- 125000006744 (C2-C60) alkenyl group Chemical group 0.000 claims description 20
- 125000006745 (C2-C60) alkynyl group Chemical group 0.000 claims description 20
- 125000004429 atom Chemical group 0.000 claims description 20
- 229910052760 oxygen Inorganic materials 0.000 claims description 20
- 125000006746 (C1-C60) alkoxy group Chemical group 0.000 claims description 19
- 229910052717 sulfur Inorganic materials 0.000 claims description 19
- 229910052799 carbon Inorganic materials 0.000 claims description 18
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 18
- 125000001935 tetracenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 claims description 18
- 125000003960 triphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C3=CC=CC=C3C12)* 0.000 claims description 18
- 125000002883 imidazolyl group Chemical group 0.000 claims description 17
- 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 claims description 17
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 17
- 125000002971 oxazolyl group Chemical group 0.000 claims description 17
- 125000001388 picenyl group Chemical group C1(=CC=CC2=CC=C3C4=CC=C5C=CC=CC5=C4C=CC3=C21)* 0.000 claims description 17
- 125000001828 phenalenyl group Chemical group C1(C=CC2=CC=CC3=CC=CC1=C23)* 0.000 claims description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 15
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 claims description 15
- 230000000903 blocking effect Effects 0.000 claims description 14
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 14
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 14
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims description 14
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 14
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 14
- 125000000335 thiazolyl group Chemical group 0.000 claims description 14
- 125000003828 azulenyl group Chemical group 0.000 claims description 13
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 13
- 125000003336 coronenyl group Chemical group C1(=CC2=CC=C3C=CC4=CC=C5C=CC6=CC=C1C1=C6C5=C4C3=C21)* 0.000 claims description 13
- 125000003427 indacenyl group Chemical group 0.000 claims description 13
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 claims description 12
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 claims description 12
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 12
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 claims description 11
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 10
- 125000004653 anthracenylene group Chemical group 0.000 claims description 10
- 125000005584 chrysenylene group Chemical group 0.000 claims description 10
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 10
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims description 10
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 claims description 10
- 125000005567 fluorenylene group Chemical group 0.000 claims description 10
- 125000001072 heteroaryl group Chemical group 0.000 claims description 10
- 125000004957 naphthylene group Chemical group 0.000 claims description 10
- MHAUGLFOVCQYNR-UHFFFAOYSA-N pentaphenylene Chemical group C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C3=CC=CC=C3C3=CC=CC=C3C2=C1 MHAUGLFOVCQYNR-UHFFFAOYSA-N 0.000 claims description 10
- 125000005560 phenanthrenylene group Chemical group 0.000 claims description 10
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 claims description 10
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 10
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 claims description 10
- 125000005548 pyrenylene group Chemical group 0.000 claims description 10
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 10
- 125000001425 triazolyl group Chemical group 0.000 claims description 9
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 8
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims description 8
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims description 8
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 7
- 125000005563 perylenylene group Chemical group 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 4
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 4
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 4
- 125000004054 acenaphthylenyl group Chemical group C1(=CC2=CC=CC3=CC=CC1=C23)* 0.000 claims description 3
- 125000002192 heptalenyl group Chemical group 0.000 claims description 3
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004305 biphenyl Substances 0.000 claims description 2
- 235000010290 biphenyl Nutrition 0.000 claims description 2
- HXGDTGSAIMULJN-UHFFFAOYSA-N acetnaphthylene Natural products C1=CC(C=C2)=C3C2=CC=CC3=C1 HXGDTGSAIMULJN-UHFFFAOYSA-N 0.000 claims 1
- GBXQPDCOMJJCMJ-UHFFFAOYSA-M trimethyl-[6-(trimethylazaniumyl)hexyl]azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCCCCC[N+](C)(C)C GBXQPDCOMJJCMJ-UHFFFAOYSA-M 0.000 claims 1
- 239000000243 solution Substances 0.000 description 111
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 105
- 238000003786 synthesis reaction Methods 0.000 description 96
- 230000015572 biosynthetic process Effects 0.000 description 95
- 238000006243 chemical reaction Methods 0.000 description 50
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 46
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 32
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- 239000000463 material Substances 0.000 description 28
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 26
- 239000012300 argon atmosphere Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 238000000034 method Methods 0.000 description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- 238000001816 cooling Methods 0.000 description 18
- 238000010898 silica gel chromatography Methods 0.000 description 17
- 239000002356 single layer Substances 0.000 description 17
- 229910052783 alkali metal Inorganic materials 0.000 description 16
- 150000001340 alkali metals Chemical class 0.000 description 16
- 229910000029 sodium carbonate Inorganic materials 0.000 description 16
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 15
- 150000001342 alkaline earth metals Chemical class 0.000 description 15
- 125000001041 indolyl group Chemical group 0.000 description 15
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 14
- 125000002837 carbocyclic group Chemical group 0.000 description 13
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 12
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 11
- 239000012535 impurity Substances 0.000 description 11
- 229910052761 rare earth metal Inorganic materials 0.000 description 11
- 150000002910 rare earth metals Chemical class 0.000 description 11
- 125000006762 (C1-C60) heteroarylene group Chemical group 0.000 description 10
- 125000006761 (C6-C60) arylene group Chemical group 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 125000002993 cycloalkylene group Chemical group 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 125000006588 heterocycloalkylene group Chemical group 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 239000011777 magnesium Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 8
- 125000005724 cycloalkenylene group Chemical group 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 125000005551 pyridylene group Chemical group 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- 125000005730 thiophenylene group Chemical group 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 7
- 150000001341 alkaline earth metal compounds Chemical class 0.000 description 7
- 125000005842 heteroatom Chemical group 0.000 description 7
- 229910052698 phosphorus Inorganic materials 0.000 description 7
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 7
- IPWBFGUBXWMIPR-UHFFFAOYSA-N 1-bromo-2-fluorobenzene Chemical compound FC1=CC=CC=C1Br IPWBFGUBXWMIPR-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 6
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 6
- 150000001339 alkali metal compounds Chemical class 0.000 description 6
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229940125904 compound 1 Drugs 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 6
- 239000012046 mixed solvent Substances 0.000 description 6
- 229920000767 polyaniline Polymers 0.000 description 6
- 150000002909 rare earth metal compounds Chemical class 0.000 description 6
- 229910052710 silicon Inorganic materials 0.000 description 6
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 6
- ICPSWZFVWAPUKF-UHFFFAOYSA-N 1,1'-spirobi[fluorene] Chemical group C1=CC=C2C=C3C4(C=5C(C6=CC=CC=C6C=5)=CC=C4)C=CC=C3C2=C1 ICPSWZFVWAPUKF-UHFFFAOYSA-N 0.000 description 5
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 5
- JNETZJWWXCLUKM-UHFFFAOYSA-N 4-bromo-1-fluoro-2-iodobenzene Chemical compound FC1=CC=C(Br)C=C1I JNETZJWWXCLUKM-UHFFFAOYSA-N 0.000 description 5
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 5
- 125000005577 anthracene group Chemical group 0.000 description 5
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical group C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- XNKVIGSNRYAOQZ-UHFFFAOYSA-N dibenzofluorene Chemical group C12=CC=CC=C2C2=CC=CC=C2C2=C1CC1=CC=CC=C12 XNKVIGSNRYAOQZ-UHFFFAOYSA-N 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 125000002950 monocyclic group Chemical group 0.000 description 5
- 239000011368 organic material Substances 0.000 description 5
- 235000015320 potassium carbonate Nutrition 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 150000003852 triazoles Chemical class 0.000 description 5
- 125000005580 triphenylene group Chemical group 0.000 description 5
- RVPCPPWNSMAZKR-UHFFFAOYSA-N (10-phenylanthracen-9-yl)boronic acid Chemical compound C12=CC=CC=C2C(B(O)O)=C2C=CC=CC2=C1C1=CC=CC=C1 RVPCPPWNSMAZKR-UHFFFAOYSA-N 0.000 description 4
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 4
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 4
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical group C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 4
- KXZQISAMEOLCJR-UHFFFAOYSA-N 7H-indeno[2,1-a]anthracene Chemical group C1=CC=C2C=C3C4=CC5=CC=CC=C5CC4=CC=C3C2=C1 KXZQISAMEOLCJR-UHFFFAOYSA-N 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- HKMTVMBEALTRRR-UHFFFAOYSA-N Benzo[a]fluorene Chemical group C1=CC=CC2=C3CC4=CC=CC=C4C3=CC=C21 HKMTVMBEALTRRR-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 4
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 4
- 125000005578 chrysene group Chemical group 0.000 description 4
- 229940125782 compound 2 Drugs 0.000 description 4
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 125000003518 norbornenyl group Chemical group C12(C=CC(CC1)C2)* 0.000 description 4
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 4
- 125000005565 oxadiazolylene group Chemical group 0.000 description 4
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 4
- 125000005550 pyrazinylene group Chemical group 0.000 description 4
- 125000005581 pyrene group Chemical group 0.000 description 4
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000005558 triazinylene group Chemical group 0.000 description 4
- YGVDBZMVEURVOW-UHFFFAOYSA-N (10-naphthalen-2-ylanthracen-9-yl)boronic acid Chemical compound C12=CC=CC=C2C(B(O)O)=C(C=CC=C2)C2=C1C1=CC=C(C=CC=C2)C2=C1 YGVDBZMVEURVOW-UHFFFAOYSA-N 0.000 description 3
- 125000000355 1,3-benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 3
- UCCUXODGPMAHRL-UHFFFAOYSA-N 1-bromo-4-iodobenzene Chemical compound BrC1=CC=C(I)C=C1 UCCUXODGPMAHRL-UHFFFAOYSA-N 0.000 description 3
- IXHWGNYCZPISET-UHFFFAOYSA-N 2-[4-(dicyanomethylidene)-2,3,5,6-tetrafluorocyclohexa-2,5-dien-1-ylidene]propanedinitrile Chemical compound FC1=C(F)C(=C(C#N)C#N)C(F)=C(F)C1=C(C#N)C#N IXHWGNYCZPISET-UHFFFAOYSA-N 0.000 description 3
- BPMFPOGUJAAYHL-UHFFFAOYSA-N 9H-Pyrido[2,3-b]indole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=N1 BPMFPOGUJAAYHL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229910015845 BBr3 Inorganic materials 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 3
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 229910052771 Terbium Inorganic materials 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 229910052792 caesium Inorganic materials 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 3
- IYYZUPMFVPLQIF-ALWQSETLSA-N dibenzothiophene Chemical group C1=CC=CC=2[34S]C3=C(C=21)C=CC=C3 IYYZUPMFVPLQIF-ALWQSETLSA-N 0.000 description 3
- 239000007772 electrode material Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 125000005576 pyrimidinylene group Chemical group 0.000 description 3
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 238000001771 vacuum deposition Methods 0.000 description 3
- 125000006758 (C2-C60) alkyl group Chemical group 0.000 description 2
- 125000006736 (C6-C20) aryl group Chemical group 0.000 description 2
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 2
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical group C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 2
- UIWLITBBFICQKW-UHFFFAOYSA-N 1h-benzo[h]quinolin-2-one Chemical compound C1=CC=C2C3=NC(O)=CC=C3C=CC2=C1 UIWLITBBFICQKW-UHFFFAOYSA-N 0.000 description 2
- YQAPKRUPKSVPLI-UHFFFAOYSA-N 2-(5-phenylthiadiazol-4-yl)phenol Chemical compound OC1=CC=CC=C1C1=C(C=2C=CC=CC=2)SN=N1 YQAPKRUPKSVPLI-UHFFFAOYSA-N 0.000 description 2
- JVYZLBBNUCRSNR-UHFFFAOYSA-N 2-phenyl-1,3-benzothiazol-4-ol Chemical compound N=1C=2C(O)=CC=CC=2SC=1C1=CC=CC=C1 JVYZLBBNUCRSNR-UHFFFAOYSA-N 0.000 description 2
- CCMLIFHRMDXEBM-UHFFFAOYSA-N 2-phenyl-1,3-thiazol-4-ol Chemical compound OC1=CSC(C=2C=CC=CC=2)=N1 CCMLIFHRMDXEBM-UHFFFAOYSA-N 0.000 description 2
- HJJXCBIOYBUVBH-UHFFFAOYSA-N 2-phenyl-1h-benzimidazol-4-ol Chemical compound N1C=2C(O)=CC=CC=2N=C1C1=CC=CC=C1 HJJXCBIOYBUVBH-UHFFFAOYSA-N 0.000 description 2
- VHRHRMPFHJXSNR-UHFFFAOYSA-N 2-phenylpyridin-3-ol Chemical compound OC1=CC=CN=C1C1=CC=CC=C1 VHRHRMPFHJXSNR-UHFFFAOYSA-N 0.000 description 2
- ZVFQEOPUXVPSLB-UHFFFAOYSA-N 3-(4-tert-butylphenyl)-4-phenyl-5-(4-phenylphenyl)-1,2,4-triazole Chemical compound C1=CC(C(C)(C)C)=CC=C1C(N1C=2C=CC=CC=2)=NN=C1C1=CC=C(C=2C=CC=CC=2)C=C1 ZVFQEOPUXVPSLB-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 229910001148 Al-Li alloy Inorganic materials 0.000 description 2
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229910018068 Li 2 O Inorganic materials 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- JHYLKGDXMUDNEO-UHFFFAOYSA-N [Mg].[In] Chemical compound [Mg].[In] JHYLKGDXMUDNEO-UHFFFAOYSA-N 0.000 description 2
- XIVOUNPJCNJBPR-UHFFFAOYSA-N acridin-1-ol Chemical compound C1=CC=C2C=C3C(O)=CC=CC3=NC2=C1 XIVOUNPJCNJBPR-UHFFFAOYSA-N 0.000 description 2
- 125000004450 alkenylene group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 150000001717 carbocyclic compounds Chemical class 0.000 description 2
- WDECIBYCCFPHNR-UHFFFAOYSA-N chrysene Chemical compound C1=CC=CC2=CC=C3C4=CC=CC=C4C=CC3=C21 WDECIBYCCFPHNR-UHFFFAOYSA-N 0.000 description 2
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 2
- DKHNGUNXLDCATP-UHFFFAOYSA-N dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile Chemical compound C12=NC(C#N)=C(C#N)N=C2C2=NC(C#N)=C(C#N)N=C2C2=C1N=C(C#N)C(C#N)=N2 DKHNGUNXLDCATP-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical compound C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 2
- SJCKRGFTWFGHGZ-UHFFFAOYSA-N magnesium silver Chemical compound [Mg].[Ag] SJCKRGFTWFGHGZ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 239000013110 organic ligand Substances 0.000 description 2
- XDJOIMJURHQYDW-UHFFFAOYSA-N phenalene Chemical compound C1=CC(CC=C2)=C3C2=CC=CC3=C1 XDJOIMJURHQYDW-UHFFFAOYSA-N 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- KELCFVWDYYCEOQ-UHFFFAOYSA-N phenanthridin-1-ol Chemical compound C1=CC=CC2=C3C(O)=CC=CC3=NC=C21 KELCFVWDYYCEOQ-UHFFFAOYSA-N 0.000 description 2
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical class N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 2
- GBROPGWFBFCKAG-UHFFFAOYSA-N picene Chemical compound C1=CC2=C3C=CC=CC3=CC=C2C2=C1C1=CC=CC=C1C=C2 GBROPGWFBFCKAG-UHFFFAOYSA-N 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 2
- 150000004059 quinone derivatives Chemical class 0.000 description 2
- 239000010948 rhodium Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- PCCVSPMFGIFTHU-UHFFFAOYSA-N tetracyanoquinodimethane Chemical compound N#CC(C#N)=C1C=CC(=C(C#N)C#N)C=C1 PCCVSPMFGIFTHU-UHFFFAOYSA-N 0.000 description 2
- 150000003536 tetrazoles Chemical class 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- VPBMVFVMYGLPNN-UHFFFAOYSA-N (2,3-dimethoxynaphthalen-1-yl)boronic acid Chemical compound C1=CC=C2C(B(O)O)=C(OC)C(OC)=CC2=C1 VPBMVFVMYGLPNN-UHFFFAOYSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- 125000006759 (C2-C60) alkenylene group Chemical group 0.000 description 1
- 125000006760 (C2-C60) alkynylene group Chemical group 0.000 description 1
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 1
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical group C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 1
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical group C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 1
- HQHHKYXPFKHLBF-UHFFFAOYSA-N 1-bromo-4-iodonaphthalene Chemical compound C1=CC=C2C(Br)=CC=C(I)C2=C1 HQHHKYXPFKHLBF-UHFFFAOYSA-N 0.000 description 1
- IYZMXHQDXZKNCY-UHFFFAOYSA-N 1-n,1-n-diphenyl-4-n,4-n-bis[4-(n-phenylanilino)phenyl]benzene-1,4-diamine Chemical compound C1=CC=CC=C1N(C=1C=CC(=CC=1)N(C=1C=CC(=CC=1)N(C=1C=CC=CC=1)C=1C=CC=CC=1)C=1C=CC(=CC=1)N(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 IYZMXHQDXZKNCY-UHFFFAOYSA-N 0.000 description 1
- MYKQKWIPLZEVOW-UHFFFAOYSA-N 11h-benzo[a]carbazole Chemical compound C1=CC2=CC=CC=C2C2=C1C1=CC=CC=C1N2 MYKQKWIPLZEVOW-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- STTGYIUESPWXOW-UHFFFAOYSA-N 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline Chemical compound C=12C=CC3=C(C=4C=CC=CC=4)C=C(C)N=C3C2=NC(C)=CC=1C1=CC=CC=C1 STTGYIUESPWXOW-UHFFFAOYSA-N 0.000 description 1
- LRKMFFQTCGUHNO-UHFFFAOYSA-N 2-(5-phenyloxadiazol-4-yl)phenol Chemical compound Oc1ccccc1-c1nnoc1-c1ccccc1 LRKMFFQTCGUHNO-UHFFFAOYSA-N 0.000 description 1
- LYTMVABTDYMBQK-UHFFFAOYSA-N 2-benzothiophene Chemical group C1=CC=CC2=CSC=C21 LYTMVABTDYMBQK-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- QZTQQBIGSZWRGI-UHFFFAOYSA-N 2-n',7-n'-bis(3-methylphenyl)-2-n',7-n'-diphenyl-9,9'-spirobi[fluorene]-2',7'-diamine Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=C3C4(C5=CC=CC=C5C5=CC=CC=C54)C4=CC(=CC=C4C3=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 QZTQQBIGSZWRGI-UHFFFAOYSA-N 0.000 description 1
- ZDAWFMCVTXSZTC-UHFFFAOYSA-N 2-n',7-n'-dinaphthalen-1-yl-2-n',7-n'-diphenyl-9,9'-spirobi[fluorene]-2',7'-diamine Chemical compound C1=CC=CC=C1N(C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C=2C(=CC(=CC=2)N(C=2C=CC=CC=2)C=2C3=CC=CC=C3C=CC=2)C23C4=CC=CC=C4C4=CC=CC=C43)C2=C1 ZDAWFMCVTXSZTC-UHFFFAOYSA-N 0.000 description 1
- FZTBAQBBLSYHJZ-UHFFFAOYSA-N 2-phenyl-1,3-oxazol-4-ol Chemical compound OC1=COC(C=2C=CC=CC=2)=N1 FZTBAQBBLSYHJZ-UHFFFAOYSA-N 0.000 description 1
- DHDHJYNTEFLIHY-UHFFFAOYSA-N 4,7-diphenyl-1,10-phenanthroline Chemical compound C1=CC=CC=C1C1=CC=NC2=C1C=CC1=C(C=3C=CC=CC=3)C=CN=C21 DHDHJYNTEFLIHY-UHFFFAOYSA-N 0.000 description 1
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 1
- AWXGSYPUMWKTBR-UHFFFAOYSA-N 4-carbazol-9-yl-n,n-bis(4-carbazol-9-ylphenyl)aniline Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(N(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 AWXGSYPUMWKTBR-UHFFFAOYSA-N 0.000 description 1
- ZOKIJILZFXPFTO-UHFFFAOYSA-N 4-methyl-n-[4-[1-[4-(4-methyl-n-(4-methylphenyl)anilino)phenyl]cyclohexyl]phenyl]-n-(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1N(C=1C=CC(=CC=1)C1(CCCCC1)C=1C=CC(=CC=1)N(C=1C=CC(C)=CC=1)C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 ZOKIJILZFXPFTO-UHFFFAOYSA-N 0.000 description 1
- DIVZFUBWFAOMCW-UHFFFAOYSA-N 4-n-(3-methylphenyl)-1-n,1-n-bis[4-(n-(3-methylphenyl)anilino)phenyl]-4-n-phenylbenzene-1,4-diamine Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)N(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 DIVZFUBWFAOMCW-UHFFFAOYSA-N 0.000 description 1
- AOQKGYRILLEVJV-UHFFFAOYSA-N 4-naphthalen-1-yl-3,5-diphenyl-1,2,4-triazole Chemical compound C1=CC=CC=C1C(N1C=2C3=CC=CC=C3C=CC=2)=NN=C1C1=CC=CC=C1 AOQKGYRILLEVJV-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- NWDPNIXKLZDOBU-UHFFFAOYSA-N COC1=C(C=CC2=CC(=CC=C12)OC)B(O)O Chemical compound COC1=C(C=CC2=CC(=CC=C12)OC)B(O)O NWDPNIXKLZDOBU-UHFFFAOYSA-N 0.000 description 1
- XZNUFLYCXMFEFD-UHFFFAOYSA-N COC=1C(=CC2=CC=CC(=C2C=1)OC)B(O)O Chemical compound COC=1C(=CC2=CC=CC(=C2C=1)OC)B(O)O XZNUFLYCXMFEFD-UHFFFAOYSA-N 0.000 description 1
- XURPGVPTINLVPE-UHFFFAOYSA-N CSC1=C(C2=CC=CC=C2C=C1SC)B(O)O Chemical compound CSC1=C(C2=CC=CC=C2C=C1SC)B(O)O XURPGVPTINLVPE-UHFFFAOYSA-N 0.000 description 1
- JNFKGGUWARFGHQ-UHFFFAOYSA-N CSC1=C(C=CC2=CC(=CC=C12)SC)B(O)O Chemical compound CSC1=C(C=CC2=CC(=CC=C12)SC)B(O)O JNFKGGUWARFGHQ-UHFFFAOYSA-N 0.000 description 1
- DZOHBSJMMNYANZ-UHFFFAOYSA-N CSC=1C(=CC2=CC=CC(=C2C=1)SC)B(O)O Chemical compound CSC=1C(=CC2=CC=CC(=C2C=1)SC)B(O)O DZOHBSJMMNYANZ-UHFFFAOYSA-N 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- OUXLLHACECEJAF-UHFFFAOYSA-N FC1=C(C=CC=C1)C1=C(C(=C(C2=CC=CC=C12)B(O)O)SC)SC Chemical compound FC1=C(C=CC=C1)C1=C(C(=C(C2=CC=CC=C12)B(O)O)SC)SC OUXLLHACECEJAF-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- 229910005690 GdF 3 Inorganic materials 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 101000837344 Homo sapiens T-cell leukemia translocation-altered gene protein Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- 102100028692 T-cell leukemia translocation-altered gene protein Human genes 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- 229910052775 Thulium Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- SLGBZMMZGDRARJ-UHFFFAOYSA-N Triphenylene Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- VHHPDZDTKZOHTB-UHFFFAOYSA-M [Br-].[Mg+]C.C1CCOC1 Chemical compound [Br-].[Mg+]C.C1CCOC1 VHHPDZDTKZOHTB-UHFFFAOYSA-M 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 150000008045 alkali metal halides Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 229910052789 astatine Inorganic materials 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- 229910001422 barium ion Inorganic materials 0.000 description 1
- LPTWEDZIPSKWDG-UHFFFAOYSA-N benzenesulfonic acid;dodecane Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCCCCCCCCCCC LPTWEDZIPSKWDG-UHFFFAOYSA-N 0.000 description 1
- 229910001423 beryllium ion Inorganic materials 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 229910001417 caesium ion Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 125000005566 carbazolylene group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical compound N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- WCVXAYSKMJJPLO-UHFFFAOYSA-N furan Chemical group C=1C=COC=1.C=1C=COC=1 WCVXAYSKMJJPLO-UHFFFAOYSA-N 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- DDTGNKBZWQHIEH-UHFFFAOYSA-N heptalene Chemical compound C1=CC=CC=C2C=CC=CC=C21 DDTGNKBZWQHIEH-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical group [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 150000002527 isonitriles Chemical class 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 238000007648 laser printing Methods 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- IMKMFBIYHXBKRX-UHFFFAOYSA-M lithium;quinoline-2-carboxylate Chemical compound [Li+].C1=CC=CC2=NC(C(=O)[O-])=CC=C21 IMKMFBIYHXBKRX-UHFFFAOYSA-M 0.000 description 1
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000476 molybdenum oxide Inorganic materials 0.000 description 1
- BLFVVZKSHYCRDR-UHFFFAOYSA-N n-[4-[4-(n-naphthalen-2-ylanilino)phenyl]phenyl]-n-phenylnaphthalen-2-amine Chemical compound C1=CC=CC=C1N(C=1C=C2C=CC=CC2=CC=1)C1=CC=C(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C3C=CC=CC3=CC=2)C=C1 BLFVVZKSHYCRDR-UHFFFAOYSA-N 0.000 description 1
- LKKPNUDVOYAOBB-UHFFFAOYSA-N naphthalocyanine Chemical class N1C(N=C2C3=CC4=CC=CC=C4C=C3C(N=C3C4=CC5=CC=CC=C5C=C4C(=N4)N3)=N2)=C(C=C2C(C=CC=C2)=C2)C2=C1N=C1C2=CC3=CC=CC=C3C=C2C4=N1 LKKPNUDVOYAOBB-UHFFFAOYSA-N 0.000 description 1
- QGLKJKCYBOYXKC-UHFFFAOYSA-N nonaoxidotritungsten Chemical compound O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 QGLKJKCYBOYXKC-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 125000005564 oxazolylene group Chemical group 0.000 description 1
- PQQKPALAQIIWST-UHFFFAOYSA-N oxomolybdenum Chemical compound [Mo]=O PQQKPALAQIIWST-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- JZRYQZJSTWVBBD-UHFFFAOYSA-N pentaporphyrin i Chemical class N1C(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JZRYQZJSTWVBBD-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-M picolinate Chemical compound [O-]C(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-M 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- 229910001419 rubidium ion Inorganic materials 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 229910052706 scandium Inorganic materials 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- VSZWPYCFIRKVQL-UHFFFAOYSA-N selanylidenegallium;selenium Chemical compound [Se].[Se]=[Ga].[Se]=[Ga] VSZWPYCFIRKVQL-UHFFFAOYSA-N 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 229910001427 strontium ion Inorganic materials 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- IFLREYGFSNHWGE-UHFFFAOYSA-N tetracene Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C21 IFLREYGFSNHWGE-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003507 tetrahydrothiofenyl group Chemical group 0.000 description 1
- 238000001931 thermography Methods 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 125000005557 thiazolylene group Chemical group 0.000 description 1
- FRNOGLGSGLTDKL-UHFFFAOYSA-N thulium atom Chemical compound [Tm] FRNOGLGSGLTDKL-UHFFFAOYSA-N 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000005559 triazolylene group Chemical group 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical group NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
- 229910001930 tungsten oxide Inorganic materials 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
- C07C15/20—Polycyclic condensed hydrocarbons
- C07C15/27—Polycyclic condensed hydrocarbons containing three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
Abstract
축합환 화합물 및 이를 포함한 유기 발광 소자가 개시된다.Condensed cyclic compounds and organic light-emitting devices containing the same are disclosed.
Description
축합환 화합물 및 이를 포함한 유기 발광 소자에 관한 것이다. It relates to condensed cyclic compounds and organic light-emitting devices containing them.
유기 발광 소자(organic light emitting device)는 자발광형 소자로서 시야각이 넓고 콘트라스트가 우수할 뿐만 아니라, 응답시간이 빠르며, 휘도, 구동전압 및 응답속도 특성이 우수하고 다색화가 가능하다는 장점을 가지고 있다.Organic light emitting devices (organic light emitting devices) are self-emitting devices that not only have a wide viewing angle and excellent contrast, but also have the advantages of fast response time, excellent brightness, driving voltage, and response speed characteristics, and the ability to be multicolored.
상기 유기 발광 소자는 기판 상부에 제1전극이 배치되어 있고, 상기 제1전극 상부에 정공 수송 영역(hole transport region), 발광층, 전자 수송 영역(electron transport region) 및 제2전극이 순차적으로 형성되어 있는 구조를 가질 수 있다. 상기 제1전극으로부터 주입된 정공은 정공 수송 영역을 경유하여 발광층으로 이동하고, 제2전극으로부터 주입된 전자는 전자 수송 영역을 경유하여 발광층으로 이동한다. 상기 정공 및 전자와 같은 캐리어들은 발광층 영역에서 재결합하여 엑시톤(exciton)을 생성한다. 이 엑시톤이 여기 상태에서 기저상태로 변하면서 광이 생성된다.The organic light-emitting device has a first electrode disposed on an upper part of a substrate, and a hole transport region, a light-emitting layer, an electron transport region, and a second electrode are sequentially formed on the first electrode. It can have a structure. Holes injected from the first electrode move to the light-emitting layer via the hole transport region, and electrons injected from the second electrode move to the light-emitting layer via the electron transport region. Carriers such as holes and electrons recombine in the light emitting layer region to generate excitons. Light is generated as this exciton changes from the excited state to the ground state.
신규 축합환 화합물 및 이를 포함한 유기 발광 소자를 제공하는 것이다.The aim is to provide novel condensed cyclic compounds and organic light-emitting devices containing them.
일 측면에 따르면, 하기 화학식 1로 표시되는 축합환 화합물이 제공된다:According to one aspect, a condensed ring compound represented by the following formula (1) is provided:
<화학식 1><Formula 1>
<화학식 2A><Formula 2A>
<화학식 2B><Formula 2B>
<화학식 2C><Formula 2C>
<화학식 10><Formula 10>
상기 화학식 1, 2A 내지 2C 및 10 중,In formulas 1, 2A to 2C and 10,
A1은 상기 화학식 2A 내지 2C로 표시되는 그룹 중에서 선택되고, n1은 1 내지 3의 정수 중에서 선택되고,A 1 is selected from the group represented by Formulas 2A to 2C, n1 is selected from the integer of 1 to 3,
X1은 N-[(L11)a11-(Ar11)b11], O, S 및 C(R14)(R15) 중에서 선택되고, and _ _ _ _ _ _
B2 고리, B3 고리 및 B4 고리는 서로 축합되어 있고,The B 2 ring, B 3 ring and B 4 ring are condensed with each other,
B1 고리 및 B4 고리는 서로 독립적으로, C6-C60 방향족 고리 및 C1-C60헤테로방향족 고리 중에서 선택되고,B 1 ring and B 4 ring are independently selected from C 6 -C 60 aromatic ring and C 1 -C 60 heteroaromatic ring,
B2 고리는 C7-C60방향족 고리 및 C1-C60 헤테로방향족 고리 중에서 선택되고,B 2 ring is selected from C 7 -C 60 aromatic ring and C 1 -C 60 heteroaromatic ring,
B3 고리는 상기 화학식 10로 표시되되, X2는 N-[(L12)a12-(Ar12)b12], O, S 및 C(R16)(R17) 중에서 선택되고, The B 3 ring is represented by the above formula ( 10 ) , where
L1, L2, L11 및 L12는 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬렌기, 치환 또는 비치환된 C1-C10헤테로시클로알킬렌기, 치환 또는 비치환된 C3-C10시클로알케닐렌기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐렌기, 치환 또는 비치환된 C6-C60아릴렌기, 치환 또는 비치환된 C1-C60헤테로아릴렌기, 치환 또는 비치환된 2가 비-방향족 축합다환 그룹(substituted or unsubstituted divalent non-aromatic condensed polycyclic group) 및 치환 또는 비치환된 2가 비-방향족 헤테로축합다환 그룹(substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group) 중에서 선택되고,L 1 , L 2 , L 11 and L 12 are each independently a substituted or unsubstituted C 3 -C 10 cycloalkylene group, a substituted or unsubstituted C 1 -C 10 heterocycloalkylene group, or a substituted or unsubstituted C 1 -C 10 heterocycloalkylene group. C 3 -C 10 Cycloalkenylene group, substituted or unsubstituted C 1 -C 10 heterocycloalkenylene group, substituted or unsubstituted C 6 -C 60 Arylene group, substituted or unsubstituted C 1 -C 60 hetero Arylene group, substituted or unsubstituted divalent non-aromatic condensed polycyclic group and substituted or unsubstituted divalent non-aromatic heterocondensed polycyclic group (substituted or unsubstituted divalent non-aromatic condensed polycyclic group) aromatic condensed heteropolycyclic group),
a1, a2, a11 및 a12는 서로 독립적으로, 0 내지 3의 정수 중에서 선택되고,a1, a2, a11 and a12 are independently selected from integers from 0 to 3,
Ar1, Ar11 및 Ar12은 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹 중에서 선택되고,Ar 1 , Ar 11 and Ar 12 are each independently selected from a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, or a substituted or unsubstituted C 3 -C 10 Cycloalkenyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted selected from monovalent non-aromatic condensed polycyclic groups and substituted or unsubstituted monovalent non-aromatic heterocondensed polycyclic groups,
b1, b11 및 b12는 서로 독립적으로, 1 내지 5의 정수 중에서 선택되고,b1, b11 and b12 are independently selected from integers from 1 to 5,
R1 내지 R8 및 R14 내지 R17는 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, 치환 또는 비치환된 C1-C60알킬기, 치환 또는 비치환된 C2-C60알케닐기, 치환 또는 비치환된 C2-C60알키닐기, 치환 또는 비치환된 C1-C60알콕시기, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C6-C60아릴옥시기, 치환 또는 비치환된 C6-C60아릴티오기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹, 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹, -Si(Q1)(Q2)(Q3), -N(Q1)(Q2), -B(Q1)(Q2), -C(=O)(Q1), -S(=O)2(Q1) 및 -P(=O)(Q1)(Q2) 중에서 선택되고,R 1 to R 8 and R 14 to R 17 are each independently selected from hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, Hydrazono group, substituted or unsubstituted C 1 -C 60 alkyl group, substituted or unsubstituted C 2 -C 60 alkenyl group, substituted or unsubstituted C 2 -C 60 alkynyl group, substituted or unsubstituted C 1 - C 60 alkoxy group, substituted or unsubstituted C 3 -C 10 cycloalkyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, substituted or unsubstituted C 3 -C 10 cycloalkenyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 6 -C 60 aryloxy group, substituted or unsubstituted C 6 -C 60 aryl group Group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, -Si(Q 1 )(Q 2 )(Q 3 ), -N(Q 1 )(Q 2 ), -B(Q 1 )(Q 2 ), -C(=O)(Q 1 ), -S(=O) 2 (Q 1 ) and -P(=O)(Q 1 )(Q 2 ),
R11 내지 R13은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, 치환 또는 비치환된 C1-C60알킬기, 치환 또는 비치환된 C2-C60알케닐기, 치환 또는 비치환된 C2-C60알키닐기, 치환 또는 비치환된 C1-C60알콕시기, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴옥시기, 치환 또는 비치환된 C6-C60아릴티오기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹, 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹, -Si(Q1)(Q2)(Q3), -N(Q1)(Q2), -B(Q1)(Q2), -C(=O)(Q1), -S(=O)2(Q1) 및 -P(=O)(Q1)(Q2) 중에서 선택되고,R 11 to R 13 are independently of each other hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, substituted or Unsubstituted C 1 -C 60 alkyl group, substituted or unsubstituted C 2 -C 60 alkenyl group, substituted or unsubstituted C 2 -C 60 alkynyl group, substituted or unsubstituted C 1 -C 60 alkoxy group, substituted or unsubstituted C 3 -C 10 cycloalkyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, substituted or unsubstituted C 3 -C 10 cycloalkenyl group, substituted or unsubstituted C 1 -C 10 Heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryloxy group, substituted or unsubstituted C 6 -C 60 arylthio group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted Substituted monovalent non-aromatic condensed polycyclic group, substituted or unsubstituted monovalent non-aromatic heterocondensed polycyclic group, -Si(Q 1 )(Q 2 )(Q 3 ), -N(Q 1 )(Q 2 ), -B(Q 1 )(Q 2 ), -C(=O)(Q 1 ), -S(=O) 2 (Q 1 ), and -P(=O)(Q 1 )(Q 2 ). is selected from,
c11 내지 c13은 서로 독립적으로, 0 내지 4의 정수 중에서 선택되고, c11 to c13 are independently selected from integers from 0 to 4,
*는 이웃한 원자와의 결합 사이트이고,* is the binding site with the neighboring atom,
상기 치환된 C3-C10시클로알킬렌기, 치환된 C1-C10헤테로시클로알킬렌기, 치환된 C3-C10시클로알케닐렌기, 치환된 C1-C10헤테로시클로알케닐렌기, 치환된 C6-C60아릴렌기, 치환된 C1-C60헤테로아릴렌기, 치환된 2가 비-방향족 축합다환 그룹, 치환된 2가 비-방향족 헤테로축합다환 그룹, 치환된 C1-C60알킬기, 치환된 C2-C60알케닐기, 치환된 C2-C60알키닐기, 치환된 C1-C60알콕시기, 치환된 C3-C10시클로알킬기, 치환된 C1-C10헤테로시클로알킬기, 치환된 C3-C10시클로알케닐기, 치환된 C1-C10헤테로시클로알케닐기, 치환된 C6-C60아릴기, 치환된 C6-C60아릴옥시기, 치환된 C6-C60아릴티오기, 치환된 C1-C60헤테로아릴기, 치환된 1가 비-방향족 축합다환 그룹 및 치환된 1가 비-방향족 헤테로축합다환 그룹의 치환기 중에서 선택된 적어도 하나는, The substituted C 3 -C 10 cycloalkylene group, substituted C 1 -C 10 heterocycloalkylene group, substituted C 3 -C 10 cycloalkenylene group, substituted C 1 -C 10 heterocycloalkenylene group, substituted C 6 -C 60 arylene group, substituted C 1 -C 60 heteroarylene group, substituted divalent non-aromatic condensed polycyclic group, substituted divalent non-aromatic condensed heteropolycyclic group, substituted C 1 -C 60 Alkyl group, substituted C 2 -C 60 alkenyl group, substituted C 2 -C 60 alkynyl group, substituted C 1 -C 60 alkoxy group, substituted C 3 -C 10 cycloalkyl group, substituted C 1 -C 10 hetero Cycloalkyl group, substituted C 3 -C 10 cycloalkenyl group, substituted C 1 -C 10 heterocycloalkenyl group, substituted C 6 -C 60 aryl group, substituted C 6 -C 60 aryloxy group, substituted C At least one selected from the group consisting of a 6 -C 60 arylthio group, a substituted C 1 -C 60 heteroaryl group, a substituted monovalent non-aromatic condensed polycyclic group, and a substituent of a substituted monovalent non-aromatic condensed heteropolycyclic group,
중수소(-D), -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기 및 C1-C60알콕시기; Deuterium (-D), -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 - C 60 alkenyl group, C 2 -C 60 alkynyl group and C 1 -C 60 alkoxy group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹, 1가 비-방향족 헤테로축합다환 그룹, -Si(Q11)(Q12)(Q13), -N(Q11)(Q12), -B(Q11)(Q12), -C(=O)(Q11), -S(=O)2(Q11) 및 -P(=O)(Q11)(Q12) 중에서 선택된 적어도 하나로 치환된, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기 및 C1-C60알콕시기; Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 3 -C 10 cycloalkyl group, C 1 -C 10 hetero Cycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group, monovalent non-aromatic condensed heteropolycyclic group, -Si(Q 11 )(Q 12 )(Q 13 ), -N(Q 11 )(Q 12 ), -B(Q 11 )(Q 12 ), -C(=O)(Q 11 ), -S(=O) 2 (Q 11 ), and -P(=O)(Q 11 )(Q 12 ). C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group, C 2 -C 60 alkynyl group and C 1 -C 60 alkoxy group substituted with at least one selected from among;
C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹 및 1가 비-방향족 헤테로축합다환 그룹;C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryl Oxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group and monovalent non-aromatic condensed heteropolycyclic group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기, C1-C60알콕시기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹, 1가 비-방향족 헤테로축합다환 그룹, -Si(Q21)(Q22)(Q23), -N(Q21)(Q22), -B(Q21)(Q22), -C(=O)(Q21), -S(=O)2(Q21) 및 -P(=O)(Q21)(Q22) 중에서 선택된 적어도 하나로 치환된, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹 및 1가 비-방향족 헤테로축합다환 그룹; 및Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group , C 2 -C 60 alkynyl group, C 1 -C 60 alkoxy group, C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocyclo Alkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group, monovalent non-aromatic group -aromatic heterocondensed polycyclic group, -Si(Q 21 )(Q 22 )(Q 23 ), -N(Q 21 )(Q 22 ), -B(Q 21 )(Q 22 ), -C(=O) (Q 21 ), -S(=O) 2 (Q 21 ) and -P(=O)(Q 21 )(Q 22 ), C 3 -C 10 cycloalkyl group, C 1 -C substituted with at least one selected from 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group and monovalent non-aromatic condensed heteropolycyclic group; and
-Si(Q31)(Q32)(Q33), -N(Q31)(Q32), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31) 및 -P(=O)(Q31)(Q32); -Si(Q 31 )(Q 32 )(Q 33 ), -N(Q 31 )(Q 32 ), -B(Q 31 )(Q 32 ), -C(=O)(Q 31 ), -S (=O) 2 (Q 31 ) and -P(=O)(Q 31 )(Q 32 );
중에서 선택되고,is selected from,
상기 Q1 내지 Q3, Q11 내지 Q13, Q21 내지 Q23 및 Q31 내지 Q33은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기, C1-C60알콕시기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C1-C60알킬기로 치환된 C6-C60아릴기, C6-C60아릴기로 치환된 C6-C60아릴기, 터페닐기, C1-C60헤테로아릴기, C1-C60알킬기로 치환된 C1-C60헤테로아릴기, C6-C60아릴기로 치환된 C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹 및 1가 비-방향족 헤테로축합다환 그룹 중에서 선택된다. Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 and Q 31 to Q 33 are each independently selected from hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, No group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group, C 2 -C 60 alkynyl group, C 1 -C 60 alkoxy group, C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 1 -C 60 substituted with alkyl group C 6 -C 60 aryl group, C 6 -C 60 aryl group substituted with C 6 -C 60 aryl group, terphenyl group, C 1 -C 60 heteroaryl group, C 1 - substituted with C 1 -C 60 alkyl group. It is selected from a C 60 heteroaryl group, a C 1 -C 60 heteroaryl group substituted with a C 6 -C 60 aryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group.
다른 측면에 따르면, 제1전극; 상기 제1전극에 대향된 제2전극; 및 상기 제1전극과 상기 제2전극 사이에 개재되고 발광층을 포함한 유기층;을 포함하고, 상기 유기층이 상술한 바와 같은 축합환 화합물을 1종 이상 포함한, 유기 발광 소자가 제공된다. According to another aspect, a first electrode; a second electrode opposite the first electrode; and an organic layer interposed between the first electrode and the second electrode and including a light-emitting layer, wherein the organic layer includes one or more types of condensed ring compounds as described above.
상기 축합환 화합물을 포함한 유기 발광 소자는 고효율 및 장수명을 가질 수 있다.Organic light-emitting devices containing the condensed cyclic compound can have high efficiency and long lifespan.
도 1 내지 4는 일 구현예를 따르는 유기 발광 소자의 구조를 각각 개략적으로 나타낸 도면이다. 1 to 4 are diagrams schematically showing the structure of an organic light-emitting device according to an embodiment.
상기 축합환 화합물은 하기 화학식 1로 표시된다:The condensed ring compound is represented by the following formula (1):
<화학식 1><Formula 1>
<화학식 2A><Formula 2A>
<화학식 2B><Formula 2B>
<화학식 2C><Formula 2C>
<화학식 10><Formula 10>
상기 화학식 1 중 X1은 N-[(L11)a11-(Ar11)b11], O, S 및 C(R14)(R15) 중에서 선택된다. 여기서, L11, a11, Ar11, b11, R14 및 R15에 대한 설명은 본 명세서에 기재된 바를 참조한다. 예를 들어, X1은 O, S 및 C(R14)(R15) 중에서 선택될 수 있다. 일 구현예에 따르면, X1은 O 또는 S일 수 있다. In Formula 1 , _ _ _ Here, descriptions of L 11 , a11, Ar 11 , b11, R 14 and R 15 refer to what is described herein. For example, X 1 may be selected from O, S and C(R 14 )(R 15 ). According to one embodiment, X 1 may be O or S.
상기 화학식 1 중 A1은 상기 화학식 2A 내지 2C로 표시되는 그룹 중에서 선택되고, n1은 1 내지 3의 정수 중에서 선택된다. n1은 A1의 개수를 나타낸 것으로서 n1이 2 이상일 경우 2 이상의 A1은 서로 동일하거나 상이하다. 일 구현예에 따르면, n1은 1 또는 2이거나, 1일 수 있으나, 이에 한정되는 것은 아니다.In Formula 1, A 1 is selected from the group represented by Formulas 2A to 2C, and n1 is selected from an integer of 1 to 3. n1 represents the number of A 1s , and when n1 is 2 or more, 2 or more A 1s are the same or different from each other. According to one embodiment, n1 is 1 or 2, or may be 1, but is not limited thereto.
상기 화학식 2A 내지 2C 중 B2 고리, B3 고리 및 B4 고리는 서로 축합되어 있다. In Formulas 2A to 2C, the B 2 ring, B 3 ring, and B 4 ring are condensed with each other.
상기 화학식 2A 내지 2C 중 B1 고리 및 B4 고리는 서로 독립적으로, C6-C60 방향족 고리 및 C1-C60헤테로방향족 고리 중에서 선택된다. In Formulas 2A to 2C, the B 1 ring and the B 4 ring are independently selected from a C 6 -C 60 aromatic ring and a C 1 -C 60 heteroaromatic ring.
예를 들어, 상기 B1 고리 및 B4 고리는 서로 독립적으로, 서로 독립적으로, 벤젠, 나프탈렌, 피리딘, 피리미딘, 피라진, 퀴놀린, 이소퀴놀린, 퀴녹살린, 퀴나졸린 및 시놀린 중에서 선택될 수 있다. 예를 들어, 상기 A1 고리 및 A2 고리는 서로 독립적으로, 벤젠 및 나프탈렌 중에서 선택될 수 있다. 일 구현예에 따르면, 상기 B1 고리 및 B4 고리는 벤젠일 수 있으나, 이에 한정되는 것은 아니다.For example, the B 1 ring and the B 4 ring may be independently selected from benzene, naphthalene, pyridine, pyrimidine, pyrazine, quinoline, isoquinoline, quinoxaline, quinazoline, and cynoline. . For example, the A 1 ring and the A 2 ring may be independently selected from benzene and naphthalene. According to one embodiment, the B 1 ring and the B 4 ring may be benzene, but are not limited thereto.
상기 화학식 2A 내지 2C 중 B2 고리는 C7-C60 방향족 고리 및 C1-C60 헤테로방향족 고리 중에서 선택된다.In Formulas 2A to 2C, the B 2 ring is selected from a C 7 -C 60 aromatic ring and a C 1 -C 60 heteroaromatic ring.
예를 들어, 상기 B2 고리는 나프탈렌(naphthalene), 헵탈렌(heptalene), 페날렌(phenalene), 페난트렌(phenanthrene), 안트라센(anthracene), 트리페닐렌(triphenylene), 파이렌(pyrene), 크라이센(chrysene), 나프타센(naphthacene), 피센(picene), 페릴렌(perylene), 펜타펜(pentaphene), 퀴놀린, 이소퀴놀린, 퀴녹살린, 퀴나졸린, 시놀린, 나프티리딘, 아크리딘 및 페난트롤린 중에서 선택될 수 있다. 예를 들어, 상기 B2 고리는 나프탈렌일 수 있으나, 이에 한정되는 것은 아니다.For example, the B 2 ring is naphthalene, heptalene, phenalene, phenanthrene, anthracene, triphenylene, pyrene, chrysene, naphthacene, picene, perylene, pentaphene, quinoline, isoquinoline, quinoxaline, quinazoline, cinnoline, naphthyridine, acridine and It may be selected from phenanthroline. For example, the B 2 ring may be naphthalene, but is not limited thereto.
상기 화학식 2A 내지 2C 중 B3 고리는 상기 화학식 10로 표시되되, X2는 N-[(L12)a12-(Ar12)b12], O, S 및 C(R16)(R17) 중에서 선택된다. 여기서, L12, a12, Ar12, b12, R16 및 R17에 대한 설명은 본 명세서에 기재된 바를 참조한다. 일 구현예에 따르면, X2는 O 또는 S일 수 있다. In Formulas 2A to 2C, the B 3 ring is represented by Formula 10 , and is selected. Here, descriptions of L 12 , a12, Ar 12 , b12, R 16 and R 17 refer to those described herein. According to one embodiment, X 2 may be O or S.
L1, L2, L11 및 L12는 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬렌기, 치환 또는 비치환된 C1-C10헤테로시클로알킬렌기, 치환 또는 비치환된 C3-C10시클로알케닐렌기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐렌기, 치환 또는 비치환된 C6-C60아릴렌기, 치환 또는 비치환된 C1-C60헤테로아릴렌기, 치환 또는 비치환된 2가 비-방향족 축합다환 그룹(substituted or unsubstituted divalent non-aromatic condensed polycyclic group) 및 치환 또는 비치환된 2가 비-방향족 헤테로축합다환 그룹(substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group) 중에서 선택된다.L 1 , L 2 , L 11 and L 12 are each independently a substituted or unsubstituted C 3 -C 10 cycloalkylene group, a substituted or unsubstituted C 1 -C 10 heterocycloalkylene group, or a substituted or unsubstituted C 1 -C 10 heterocycloalkylene group. C 3 -C 10 Cycloalkenylene group, substituted or unsubstituted C 1 -C 10 heterocycloalkenylene group, substituted or unsubstituted C 6 -C 60 Arylene group, substituted or unsubstituted C 1 -C 60 hetero Arylene group, substituted or unsubstituted divalent non-aromatic condensed polycyclic group and substituted or unsubstituted divalent non-aromatic heterocondensed polycyclic group (substituted or unsubstituted divalent non-aromatic condensed polycyclic group) aromatic condensed heteropolycyclic group).
예를 들어, 상기 L1, L2, L11 및 L12는 서로 독립적으로, For example, L 1 , L 2 , L 11 and L 12 are independently of each other,
페닐렌기(phenylene), 펜탈레닐렌기(pentalenylene), 인데닐렌기(indenylene), 나프틸렌기(naphthylene), 아줄레닐렌기(azulenylene), 헵탈레닐렌기(heptalenylene), 인다세닐렌기(indacenylene), 아세나프틸렌기(acenaphthylene), 플루오레닐렌기(fluorenylene), 스파이로-플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페날레닐렌기(phenalenylene), 페난트레닐렌기(phenanthrenylene), 안트라세닐렌기(anthracenylene), 플루오란테닐렌기(fluoranthenylene), 트리페닐레닐렌기(triphenylenylene), 파이레닐렌기(pyrenylene), 크라이세닐렌기(chrysenylene), 나프타세닐렌기(naphthacenylene), 피세닐렌기(picenylene), 페릴레닐렌기(perylenylene), 펜타페닐렌기(pentaphenylene), 헥사세닐렌기(hexacenylene), 펜타세닐렌기(pentacenylene), 루비세닐렌기(rubicenylene), 코로네닐렌기(coronenylene), 오발레닐기렌기(ovalenylene), 피롤일렌기(pyrrolylene), 티오페닐렌기(thiophenylene), 퓨라닐렌기(furanylene), 이미다졸일렌기(imidazolylene), 피라졸일렌기(pyrazolylene), 티아졸일렌기(thiazolylene), 이소티아졸일렌기(isothiazolylene), 옥사졸일렌기(oxazolylene), 이속사졸일렌기(isooxazolylene), 피리디닐렌기(pyridinylene), 피라지닐렌기(pyrazinylene), 피리미디닐렌기(pyrimidinylene), 피리다지닐렌기(pyridazinylene), 이소인돌일렌기(isoindolylene), 인돌일렌기(indolylene), 인다졸일렌기(indazolylene), 푸리닐렌기(purinylene), 퀴놀리닐렌기(quinolinylene), 이소퀴놀리닐렌기(isoquinolinylene), 벤조퀴놀리닐렌기(benzoquinolinylene), 프탈라지닐렌기(phthalazinylene), 나프티리디닐렌기(naphthyridinylene), 퀴녹살리닐렌기(quinoxalinylene), 퀴나졸리닐렌기(quinazolinylene), 시놀리닐렌기(cinnolinylene), 카바졸일렌기(carbazolylene), 페난트리디닐렌기(phenanthridinylene), 아크리디닐렌기(acridinylene), 페난트롤리닐렌기(phenanthrolinylene), 페나지닐렌기(phenazinylene), 벤조이미다졸일렌기(benzoimidazolylene), 벤조퓨라닐렌기(benzofuranylene), 벤조티오페닐렌기(benzothiophenylene), 이소벤조티아졸일렌기(isobenzothiazolylene), 벤조옥사졸일렌기(benzooxazolylene), 이소벤조옥사졸일렌기(isobenzooxazolylene), 트리아졸일렌기(triazolylene), 테트라졸일렌기(tetrazolylene), 옥사디아졸일렌기(oxadiazolylene), 트리아지닐렌기(triazinylene), 디벤조퓨라닐렌기(dibenzofuranylene), 디벤조티오페닐렌기(dibenzothiophenylene), 벤조카바졸일렌기, 디벤조카바졸일렌기, 티아디아졸일렌기, 이미다조피리디닐렌기 및 이미다조피리미디닐렌기; 및Phenylene, pentalenylene, indenylene, naphthylene, azulenylene, heptalenylene, indacenylene, acetate Acenaphthylene, fluorenylene, spiro-fluorenylene, benzofluorenylene, dibenzofluorenylene, phenalenylene, phenanthrenylene , anthracenylene, fluoranthenylene, triphenylenylene, pyrenylene, chrysenylene, naphthacenylene, picenylene. ), perylenylene, pentaphenylene, hexacenylene, pentacenylene, rubicenylene, coronenylene, ovalenylgylene ovalenylene, pyrrolylene, thiophenylene, furanylene, imidazolylene, pyrazolylene, thiazolylene, isothia isothiazolylene, oxazolylene, isoxazolylene, pyridinylene, pyrazinylene, pyrimidinylene, pyridazinylene , isoindolylene, indolylene, indazolylene, purinylene, quinolinylene, isoquinolinylene, benzoquinoli Benzoquinolinylene, phthalazinylene, naphthyridinylene, quinoxalinylene, quinazolinylene, cinnolinylene, carbazolinylene ( carbazolylene, phenanthridinylene, acridinylene, phenanthrolinylene, phenazinylene, benzoimidazolylene, benzofuranylene , benzothiophenylene, isobenzothiazolylene, benzoxazolylene, isobenzooxazolylene, triazolylene, tetrazolylene, oxa Oxadiazolylene group, triazinylene group, dibenzofuranylene group, dibenzothiophenylene group, benzocarbazolylene group, dibenzocarbazolylene group, thiadiazolylene group, imida Zopyridinylene group and imidazopyrimidinylene group; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴기레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 이소인돌일기, 인돌일기, 인다졸일기, 푸리닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 카바졸일기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 트리아졸일기, 테트라졸일기, 옥사디아졸일기, 트리아지닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 티아디아졸일기, 이미다조피리디닐기, 이미다조피리미디닐기 및 -Si(Q31)(Q32)(Q33) 중에서 선택된 적어도 하나로 치환된, 페닐렌기, 펜탈레닐렌기, 인데닐렌기, 나프틸렌기, 아줄레닐렌기, 헵탈레닐렌기, 인다세닐렌기, 아세나프틸렌기, 플루오레닐렌기, 스파이로-플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페날레닐렌기, 페난트레닐렌기, 안트라세닐렌기, 플루오란테닐렌기, 트리페닐레닐렌기, 파이레닐렌기, 크라이세닐렌기, 나프타세닐렌기, 피세닐렌기, 페릴레닐렌기, 펜타페닐렌기, 헥사세닐렌기, 펜타세닐렌기, 루비세닐렌기, 코로네닐렌기, 오발레닐렌기, 피롤일렌기, 티오페닐렌기, 퓨라닐렌기, 이미다졸일렌기, 피라졸일렌기, 티아졸일렌기, 이소티아졸일렌기, 옥사졸일렌기, 이속사졸일렌기, 피리디닐렌기, 피라지닐렌기, 피리미디닐렌기, 피리다지닐렌기, 이소인돌일렌기, 인돌일렌기, 인다졸일렌기, 푸리닐렌기, 퀴놀리닐렌기, 이소퀴놀리닐렌기, 벤조퀴놀리닐렌기, 프탈라지닐렌기, 나프티리디닐렌기, 퀴녹살리닐렌기, 퀴나졸리닐렌기, 시놀리닐렌기, 카바졸일렌기, 페난트리디닐렌기, 아크리디닐렌기, 페난트롤리닐렌기, 페나지닐렌기, 벤조이미다졸일렌기, 벤조퓨라닐렌기, 벤조티오페닐렌기, 이소벤조티아졸일렌기, 벤조옥사졸일렌기, 이소벤조옥사졸일렌기, 트리아졸일렌기, 테트라졸일렌기, 옥사디아졸일렌기, 트리아지닐렌기, 디벤조퓨라닐렌기, 디벤조티오페닐렌기, 벤조카바졸일렌기, 디벤조카바졸일렌기, 티아디아졸일렌기, 이미다조피리디닐렌기 및 이미다조피리미디닐렌기; 중에서 선택되고,Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, pentalenyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group. group, acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group , pyrenyl group, chrysenyl group, naphthacenyl group, picenyl group, perylgyrenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group, ovalenyl group, pyrrolyl group, thiophenyl group, Furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindoleyl group, indole Diary group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group, naphthyridinyl group, quinoxalinyl group, quinazolinyl group, cynolinyl group, carbazolyl group, phenanthri Dinyl group, acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzooxazolyl group, triazolyl group, tetra Zolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, thiadiazolyl group, imidazopyridinyl group, imidazopyrimidinyl group, and -Si(Q 31 )(Q 32 )(Q 33 ) Substituted with at least one selected from phenylene group, pentalenylene group, indenylene group, naphthylene group, azulenylene group, hepthalenylene group, indacenylene group, acetate Naphthylene group, fluorenylene group, spiro-fluorenylene group, benzofluorenylene group, dibenzofluorenylene group, phenalenylene group, phenanthrenylene group, anthracenylene group, fluoranthenylene group, triphenyl Lenylene group, pyrenylene group, chrysenylene group, naphthacenylene group, picenylene group, perylenylene group, pentaphenylene group, hexasenylene group, pentacenylene group, rubycenylene group, coronenylene group, ovalenylene group, Pyrroylene group, thiophenylene group, furanylene group, imidazolylene group, pyrazoylene group, thiazonylene group, isothiazolylene group, oxazonylene group, isoxazonylene group, pyridinylene group, pyrazinylene group, pyrimidinyl Len group, pyridazinylene group, isoindolylene group, indolylene group, indazolylene group, purinylene group, quinolinylene group, isoquinolinylene group, benzoquinollinylene group, phthalazinylene group, naphthyridinylene group , quinoxalinylene group, quinazolinylene group, cinolinylene group, carbazonylene group, phenanthridinylene group, acridinylene group, phenanthrolinylene group, phenazynylene group, benzoimidazolylene group, benzofuranylene group, Benzothiophenylene group, isobenzothiazonylene group, benzooxazonylene group, isobenzooxazonylene group, triazonylene group, tetrazolylene group, oxadiazolylene group, triazinylene group, dibenzofuranylene group, dibenzothiophenylene group , benzocarbazolylene group, dibenzocarbazolylene group, thiadiazolylene group, imidazopyridinylene group and imidazopyrimidinylene group; is selected from,
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택될 수 있다Q 31 to Q 33 may be independently selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.
또 다른 예로서, 상기 L1, L2, L11 및 L12는 서로 독립적으로, 하기 화학식 3-1 내지 화학식 3-41로 표시되는 그룹 중에서 선택될 수 있다: As another example, L 1 , L 2 , L 11 and L 12 may be independently selected from the group represented by Formulas 3-1 to 3-41 below:
상기 화학식 3-1 내지 3-41 중,In Formulas 3-1 to 3-41,
Y1은 O, S, C(Z3)(Z4), N(Z5) 또는 Si(Z6)(Z7)이고;Y 1 is O, S, C(Z 3 )(Z 4 ), N(Z 5 ) or Si(Z 6 )(Z 7 );
Z1 내지 Z7은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 파이레닐기, 크라이세닐기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 디벤조퓨라닐기, 디벤조티오페닐기, 트리아지닐기, 벤조이미다졸일기, 페난트롤리닐기 및 -Si(Q31)(Q32)(Q33) 중에서 선택되고, Z 1 to Z 7 are independently of each other hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group, phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group , anthracenyl group, pyrenyl group, chrysenyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, quinolinyl group, isoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group , dibenzofuranyl group, dibenzothiophenyl group, triazinyl group, benzoimidazolyl group, phenanthrolinyl group and -Si (Q 31 ) (Q 32 ) (Q 33 ),
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택되고,Q 31 to Q 33 are independently selected from C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group, phenyl group, biphenyl group, terphenyl group and naphthyl group,
d2는 1 또는 2이고,d2 is 1 or 2,
d3는 1 내지 3의 정수 중에서 선택되고, d3 is selected from an integer of 1 to 3,
d4는 1 내지 4의 정수 중에서 선택되고, d4 is selected from an integer of 1 to 4,
d5는 1 내지 5의 정수 중에서 선택되고, d5 is selected from an integer of 1 to 5,
d6은 1 내지 6의 정수 중에서 선택되고, d6 is selected from integers from 1 to 6,
d8은 1 내지 8의 정수 중에서 선택되고, d8 is selected from integers from 1 to 8,
* 및 *'은 이웃한 원자와의 결합 사이트이다.* and *' are binding sites with neighboring atoms.
일 구현예에 따르면, 상기 L1, L2, L11 및 L12는 서로 독립적으로, 하기 화학식 4-1 내지 화학식 4-35로 표시되는 그룹 중에서 선택될 수 있다:According to one embodiment, L 1 , L 2 , L 11 and L 12 may be independently selected from the group represented by the following Formulas 4-1 to 4-35:
상기 화학식 4-1 내지 4-35 중 * 및 *'은 이웃한 원자와의 결합 사이트이다.In Formulas 4-1 to 4-35, * and *' are bonding sites with neighboring atoms.
상기 화학식 1 및 10 중 a1, a2, a11 및 a12는 서로 독립적으로, 0 내지 3의 정수 중에서 선택된다. a1은 L1의 개수를 나타낸 것으로서, a1이 2 이상일 경우 2 이상의 L1은 서로 동일하거나 상이하다. a2, a11 및 a12에 대한 설명은 상기 a1에 대한 설명 및 화학식 1 및 10의 구조를 참조하여 이해될 수 있다. In Formulas 1 and 10, a1, a2, a11, and a12 are independently selected from integers of 0 to 3. a1 represents the number of L 1 , and when a1 is 2 or more, 2 or more L 1 are the same or different from each other. The description of a2, a11 and a12 can be understood by referring to the description of a1 and the structures of Formulas 1 and 10.
일 구현예에 따르면, 상기 화학식 1 중 a1, a2, a11 및 a12는 서로 독립적으로, 0 또는 1이거나, 1일 수 있으나, 이에 한정되지 않는다. According to one embodiment, a1, a2, a11, and a12 in Formula 1 may be independently 0, 1, or 1, but are not limited thereto.
상기 화학식 1 및 10 중 Ar1, Ar11 및 Ar12은 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹 중에서 선택된다.In Formulas 1 and 10, Ar 1 , Ar 11 and Ar 12 are each independently selected from a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, or a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group. C 3 -C 10 cycloalkenyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group.
예를 들어, 상기 Ar1, Ar11 및 Ar12은 서로 독립적으로,For example, Ar 1 , Ar 11 and Ar 12 are independently of each other,
페닐기(phenyl), 비페닐기(biphenyl), 터페닐기(terphenyl), 펜탈레닐기(pentalenyl), 인데닐기(indenyl), 나프틸기(naphthyl), 아줄레닐기(azulenyl), 헵탈레닐기(heptalenyl), 인다세닐기(indacenyl), 아세나프틸기(acenaphthyl), 플루오레닐기(fluorenyl), 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기(phenalenyl), 페난트레닐기(phenanthrenyl), 안트라세닐기(anthracenyl), 플루오란테닐기(fluoranthenyl), 트리페닐레닐기, 파이레닐기(pyrenyl), 크라이세닐기(chrysenyl), 나프타세닐기(naphthacenyl), 피세닐기(picenyl), 페릴레닐기(perylenyl), 펜타페닐기(pentaphenyl), 헥사세닐기(hexacenyl), 펜타세닐기(pentacenyl), 루비세닐기(rubicenyl), 코로네닐기(coronenyl), 오발레닐기(ovalenyl), 피롤일기(pyrrolyl), 티오페닐기(thiophenyl), 퓨라닐기(furanyl), 이미다졸일기(imidazolyl), 피라졸일기(pyrazolyl), 티아졸일기(thiazolyl), 이소티아졸일기(isothiazolyl), 옥사졸일기(oxazolyl), 이속사졸일기(isooxazolyl), 피리디닐기(pyridinyl), 피라지닐기(pyrazinyl), 피리미디닐기(pyrimidinyl), 피리다지닐기(pyridazinyl), 이소인돌일기(isoindolyl), 인돌일기(indolyl), 인다졸일기(indazolyl), 푸리닐기(purinyl), 퀴놀리닐기(quinolinyl), 이소퀴놀리닐기(isoquinolinyl), 벤조퀴놀리닐기(benzoquinolinyl), 프탈라지닐기(phthalazinyl), 나프티리디닐기(naphthyridinyl), 퀴녹살리닐기(quinoxalinyl), 퀴나졸리닐기(quinazolinyl), 시놀리닐기(cinnolinyl), 카바졸일기(carbazolyl), 페난트리디닐기(phenanthridinyl), 아크리디닐기(acridinyl), 페난트롤리닐기(phenanthrolinyl), 페나지닐기(phenazinyl), 벤조이미다졸일기(benzoimidazolyl), 벤조퓨라닐기(benzofuranyl), 벤조티오페닐기(benzothiophenyl), 벤조티아졸일기(benzothiazolyl), 이소벤조티아졸일기(isobenzothiazolyl), 벤즈옥사졸일기(benzoxazolyl), 이소벤즈옥사졸일기(isobenzoxazolyl), 트리아졸일기(triazolyl), 테트라졸일기(tetrazolyl), 옥사디아졸일기(oxadiazolyl), 트리아지닐기(triazinyl), 벤조카바졸일기(benzocarbazolyl), 디벤조카바졸일기(dibenzocarbazolyl), 티아디아졸일기(thiadiazolyl), 이미다조피리디닐기(imidazopyridinyl) 및 이미다조피리미디닐기(imidazopyrimidinyl); 및Phenyl, biphenyl, terphenyl, pentalenyl, indenyl, naphthyl, azulenyl, heptalenyl, Indacenyl, acenaphthyl, fluorenyl, spiro-fluorenyl, benzofluorenyl, dibenzofluorenyl, phenalenyl, phenanthrenyl ( phenanthrenyl, anthracenyl, fluoranthenyl, triphenylenyl, pyrenyl, chrysenyl, naphthacenyl, picenyl , perylenyl, pentaphenyl, hexacenyl, pentacenyl, rubicenyl, coronenyl, ovalenyl, pyrrole pyrrolyl, thiophenyl, furanyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl ( oxazolyl, isoxazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, isoindolyl, indolyl ), indazolyl, purinyl, quinolinyl, isoquinolinyl, benzoquinolinyl, phthalazinyl, naphthyridinyl ( naphthyridinyl, quinoxalinyl, quinazolinyl, cinnolinyl, carbazolyl, phenanthridinyl, acridinyl, phenanthrolinyl ( phenanthrolinyl, phenazinyl, benzoimidazolyl, benzofuranyl, benzothiophenyl, benzothiazolyl, isobenzothiazolyl, benz Benzoxazolyl, isobenzoxazolyl, triazolyl, tetrazolyl, oxadiazolyl, triazinyl, benzocarbazolyl ( benzocarbazolyl), dibenzocarbazolyl, thiadiazolyl, imidazopyridinyl and imidazopyrimidinyl; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴기레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 이소인돌일기, 인돌일기, 인다졸일기, 푸리닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 카바졸일기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 트리아졸일기, 테트라졸일기, 옥사디아졸일기, 트리아지닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 티아디아졸일기, 이미다조피리디닐기, 이미다조피리미디닐기 및 -Si(Q31)(Q32)(Q33) 중에서 선택된 적어도 하나로 치환된, 페닐기, 비페닐기, 터페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 이소인돌일기, 인돌일기, 인다졸일기, 푸리닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 카바졸일기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 벤조티아졸일기, 이소벤조티아졸일기, 벤즈옥사졸일기, 이소벤즈옥사졸일기, 트리아졸일기, 테트라졸일기, 옥사디아졸일기, 트리아지닐기, 벤조카바졸일기, 디벤조카바졸일기, 티아디아졸일기, 이미다조피리디닐기 및 이미다조피리미디닐기; 중에서 선택되고,Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, pentalenyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group. group, acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group , pyrenyl group, chrysenyl group, naphthacenyl group, picenyl group, perylgyrenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group, ovalenyl group, pyrrolyl group, thiophenyl group, Furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindoleyl group, indole Diary group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group, naphthyridinyl group, quinoxalinyl group, quinazolinyl group, cynolinyl group, carbazolyl group, phenanthri Dinyl group, acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzooxazolyl group, triazolyl group, tetra Zolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, thiadiazolyl group, imidazopyridinyl group, imidazopyrimidinyl group, and -Si(Q 31 )(Q 32 )(Q 33 ) Substituted with at least one selected from phenyl group, biphenyl group, terphenyl group, pentalenyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group , acenaphthyl group, fluorenyl group, spiro-fluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pi Renyl group, chrysenyl group, naphthacenyl group, picenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group, ovalenyl group, pyrrolyl group, thiophenyl group, furanyl group , imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindoleyl group, indolyl group, Indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group, naphthyridinyl group, quinoxalinyl group, quinazolinyl group, cynolinyl group, carbazolyl group, phenanthridinyl group , acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group, benzothiazolyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzoxazolyl group, triazole diyl group, tetrazolyl group, oxadiazolyl group, triazinyl group, benzocarbazolyl group, dibenzocarbazolyl group, thiadiazolyl group, imidazopyridinyl group and imidazopyrimidinyl group; is selected from,
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택될 수 있다.Q 31 to Q 33 may be independently selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.
또 다른 예로서, 상기 Ar1, Ar11 및 Ar12은 서로 독립적으로, 하기 화학식 5-1 내지 화학식 5-79로 표시되는 그룹 중에서 선택될 수 있다:As another example, Ar 1 , Ar 11 and Ar 12 may be independently selected from the group represented by Formulas 5-1 to 5-79 below:
상기 화학식 5-1 내지 5-79 중,In formulas 5-1 to 5-79,
Y31 및 Y32는 서로 독립적으로, O, S, C(Z33)(Z34), N(Z35) 또는 Si(Z36)(Z37)이고;Y 31 and Y 32 are, independently of each other, O, S, C(Z 33 )(Z 34 ), N(Z 35 ) or Si(Z 36 )(Z 37 );
Z31 내지 Z37은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 파이레닐기, 크라이세닐기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 디벤조푸라닐기, 디벤조티오페닐기, 벤조이미다졸일기, 페난트롤리닐기, 트리아지닐기 및 -Si(Q31)(Q32)(Q33) 중에서 선택되고, Z 31 to Z 37 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group, phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group , anthracenyl group, pyrenyl group, chrysenyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, quinolinyl group, isoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group , dibenzofuranyl group, dibenzothiophenyl group, benzoimidazolyl group, phenanthrolinyl group, triazinyl group and -Si (Q 31 ) (Q 32 ) (Q 33 ),
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택되고, Q 31 to Q 33 are independently selected from C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group, phenyl group, biphenyl group, terphenyl group and naphthyl group,
e2는 1 또는 2이고,e2 is 1 or 2,
e3는 1 내지 3의 정수 중에서 선택되고, e3 is selected from an integer of 1 to 3,
e4는 1 내지 4의 정수 중에서 선택되고, e4 is selected from integers 1 to 4,
e5는 1 내지 5의 정수 중에서 선택되고, e5 is selected from integers 1 to 5,
e6은 1 내지 6의 정수 중에서 선택되고, e6 is selected from integers from 1 to 6,
e8은 1 내지 8의 정수 중에서 선택되고, e8 is selected from integers from 1 to 8,
*은 이웃한 원자와의 결합 사이트이다.* is a bonding site with a neighboring atom.
일 구현예에 따르면, 상기 Ar1, Ar11 및 Ar12은 서로 독립적으로, 하기 화학식 6-1 내지 화학식 6-44로 표시되는 그룹 중에서 선택될 수 있다:According to one embodiment, Ar 1 , Ar 11 and Ar 12 may be independently selected from the group represented by Formulas 6-1 to 6-44 below:
상기 화학식 6-1 내지 6-44 중 *는 이웃한 원자와의 결합 사이트이다.In Formulas 6-1 to 6-44, * is a bonding site with a neighboring atom.
상기 화학식 1 및 10 중 b1, b11 및 b12는 서로 독립적으로, 1 내지 5의 정수 중에서 선택될 수 있다. b1은 Ar1의 개수를 나타낸 것으로서 b1이 2 이상일 경우 2 이상의 Ar1은 서로 동일하거나 상이하다. b11 및 b12에 대한 설명은 상기 b1에 대한 설명 및 화학식 1 및 10의 구조를 참조하여 이해될 수 있다.In Formulas 1 and 10, b1, b11, and b12 may be independently selected from integers of 1 to 5. b1 represents the number of Ar 1s , and when b1 is 2 or more, 2 or more Ar 1s are the same or different from each other. The description of b11 and b12 can be understood by referring to the description of b1 and the structures of Formulas 1 and 10.
일 구현예에 따르면, b1, b11 및 b12는 서로 독립적으로, 1 또는 2이거나, 1일 수 있으나, 이에 한정되는 것은 아니다.According to one embodiment, b1, b11, and b12 may be independently 1 or 2, or may be 1, but are not limited thereto.
상기 화학식들 중 R1 내지 R8 및 R14 내지 R17는 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, 치환 또는 비치환된 C1-C60알킬기, 치환 또는 비치환된 C2-C60알케닐기, 치환 또는 비치환된 C2-C60알키닐기, 치환 또는 비치환된 C1-C60알콕시기, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C6-C60아릴옥시기, 치환 또는 비치환된 C6-C60아릴티오기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹, 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹, -Si(Q1)(Q2)(Q3), -N(Q1)(Q2), -B(Q1)(Q2), -C(=O)(Q1), -S(=O)2(Q1) 및 -P(=O)(Q1)(Q2) 중에서 선택되고,In the above formulas, R 1 to R 8 and R 14 to R 17 are each independently selected from hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, Hydrazino group, hydrazono group, substituted or unsubstituted C 1 -C 60 alkyl group, substituted or unsubstituted C 2 -C 60 alkenyl group, substituted or unsubstituted C 2 -C 60 alkynyl group, substituted or unsubstituted C 1 -C 60 alkoxy group, substituted or unsubstituted C 3 -C 10 cycloalkyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, substituted or unsubstituted C 3 -C 10 cycloalkenyl group, Substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 6 -C 60 aryloxy group, substituted or unsubstituted C 6 - C 60 arylthio group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, - Si(Q 1 )(Q 2 )(Q 3 ), -N(Q 1 )(Q 2 ), -B(Q 1 )(Q 2 ), -C(=O)(Q 1 ), -S( =O) 2 (Q 1 ) and -P(=O)(Q 1 )(Q 2 ),
R11 내지 R13은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, 치환 또는 비치환된 C1-C60알킬기, 치환 또는 비치환된 C2-C60알케닐기, 치환 또는 비치환된 C2-C60알키닐기, 치환 또는 비치환된 C1-C60알콕시기, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴옥시기, 치환 또는 비치환된 C6-C60아릴티오기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹, 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹, -Si(Q1)(Q2)(Q3), -N(Q1)(Q2), -B(Q1)(Q2), -C(=O)(Q1), -S(=O)2(Q1) 및 -P(=O)(Q1)(Q2) 중에서 선택될 수 있다.R 11 to R 13 are independently of each other hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, substituted or Unsubstituted C 1 -C 60 alkyl group, substituted or unsubstituted C 2 -C 60 alkenyl group, substituted or unsubstituted C 2 -C 60 alkynyl group, substituted or unsubstituted C 1 -C 60 alkoxy group, substituted or unsubstituted C 3 -C 10 cycloalkyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, substituted or unsubstituted C 3 -C 10 cycloalkenyl group, substituted or unsubstituted C 1 -C 10 Heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryloxy group, substituted or unsubstituted C 6 -C 60 arylthio group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted Substituted monovalent non-aromatic condensed polycyclic group, substituted or unsubstituted monovalent non-aromatic heterocondensed polycyclic group, -Si(Q 1 )(Q 2 )(Q 3 ), -N(Q 1 )(Q 2 ), -B(Q 1 )(Q 2 ), -C(=O)(Q 1 ), -S(=O) 2 (Q 1 ), and -P(=O)(Q 1 )(Q 2 ). can be selected from among.
예를 들어, 상기 화학식들 중 R1 내지 R8 및 R14 내지 R17는 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, 치환 또는 비치환된 C1-C20알킬기, 치환 또는 비치환된 C1-C20알콕시기, 치환 또는 비치환된 C6-C20아릴기, 치환 또는 비치환된 C1-C20헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹, 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹, 및 -Si(Q1)(Q2)(Q3) 중에서 선택되고, For example, in the above formulas, R 1 to R 8 and R 14 to R 17 are each independently selected from hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, Amidino group, hydrazino group, hydrazono group, substituted or unsubstituted C 1 -C 20 alkyl group, substituted or unsubstituted C 1 -C 20 alkoxy group, substituted or unsubstituted C 6 -C 20 aryl group, A substituted or unsubstituted C 1 -C 20 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and -Si(Q 1 ) (Q 2 ) is selected from (Q 3 ),
R11 내지 R13은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, 치환 또는 비치환된 C1-C20알킬기, 치환 또는 비치환된 C1-C20알콕시기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹, 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹, 및 -Si(Q1)(Q2)(Q3) 중에서 선택될 수 있다.R 11 to R 13 are independently of each other hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, substituted or Unsubstituted C 1 -C 20 alkyl group, substituted or unsubstituted C 1 -C 20 alkoxy group, substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, substituted or unsubstituted monovalent non-aromatic condensed polycyclic group. group, and -Si(Q 1 )(Q 2 )(Q 3 ).
또 다른 예로서, 상기 R1 내지 R8 및 R14 내지 R17는 서로 독립적으로, As another example, R 1 to R 8 and R 14 to R 17 are independently of each other,
수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기 및 C1-C20알콕시기;Hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group and C 1 -C 20 Alkoxy group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기 및 히드라조노기 중 적어도 하나로 치환된, C1-C20알킬기 및 C1-C20알콕시기;C 1 -C 20 alkyl group and C 1 substituted with at least one of deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group and hydrazono group -C 20 alkoxy group;
페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 옥사디아졸일기, 트리아지닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 이미다조피리디닐기 및 이미다조피리미디닐기; Phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-fluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, triphenylenyl group, pyrenyl group, Chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, Pyridazinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzooxazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, imidazopyridinyl group and imidazopyrimidinyl group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C10알킬기, C1-C10알콕시기, 페닐기, 나프틸기, 플루오레닐기, 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 옥사디아졸일기, 트리아지닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 이미다조피리디닐기, 이미다조피리미디닐기 및 -Si(Q31)(Q32)(Q33) 중 적어도 하나로 치환된, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 옥사디아졸일기, 트리아지닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 이미다조피리디닐기 및 이미다조피리미디닐기; 및 Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group , phenyl group, naphthyl group, fluorenyl group, spiro-fluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrole Diary group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, Quinolinyl group, isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, Isobenzooxazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, imidazopyridinyl group, imidazopyrimidinyl group and -Si(Q 31 )(Q 32 )(Q 33 ) Substituted with at least one of: phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-fluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, triphenyl Renyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazolyl group Zinyl group, pyrimidinyl group, pyridazinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group , isobenzothiazolyl group, benzoxazolyl group, isobenzooxazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, imidazopyridinyl group and imidazopyrimidinyl group; and
-Si(Q1)(Q2)(Q3); 중에서 선택되고, -Si(Q 1 )(Q 2 )(Q 3 ); is selected from,
R11 내지 R13은 서로 독립적으로,R 11 to R 13 are independently of each other,
수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기 및 C1-C20알콕시기;Hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group and C 1 -C 20 Alkoxy group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기 및 히드라조노기 중 적어도 하나로 치환된, C1-C20알킬기 및 C1-C20알콕시기;C 1 -C 20 alkyl group and C 1 substituted with at least one of deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group and hydrazono group -C 20 alkoxy group;
플루오레닐기, 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 디벤조퓨라닐기, 및 디벤조티오페닐기; fluorenyl group, spiro-fluorenyl group, benzofluorenyl group, dibenzofluorenyl group, dibenzofuranyl group, and dibenzothiophenyl group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C10알킬기, C1-C10알콕시기, 페닐기, 나프틸기, 플루오레닐기, 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 옥사디아졸일기, 트리아지닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 이미다조피리디닐기, 이미다조피리미디닐기 및 -Si(Q31)(Q32)(Q33) 중 적어도 하나로 치환된, 플루오레닐기, 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 디벤조퓨라닐기, 및 디벤조티오페닐기; 및 Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group , phenyl group, naphthyl group, fluorenyl group, spiro-fluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrole Diary group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, Quinolinyl group, isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, Isobenzooxazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, imidazopyridinyl group, imidazopyrimidinyl group and -Si(Q 31 )(Q 32 )(Q 33 ) substituted with at least one of a fluorenyl group, a spiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; and
-Si(Q1)(Q2)(Q3); 중에서 선택되고,-Si(Q 1 )(Q 2 )(Q 3 ); is selected from,
상기 Q1 내지 Q3 및 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택될 수 있다. Q 1 to Q 3 and Q 31 to Q 33 may be independently selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.
일 구현예에 따르면, 상기 R1 내지 R8 및 R14 내지 R17는 서로 독립적으로, According to one embodiment, R 1 to R 8 and R 14 to R 17 are independently of each other,
수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C10알킬기 및 C1-C10알콕시기;Hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 10 alkyl group and C 1 -C 10 Alkoxy group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기 및 히드라조노기 중 적어도 하나로 치환된, C1-C10알킬기 및 C1-C10알콕시기;C 1 -C 10 alkyl group and C 1 substituted with at least one of deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group and hydrazono group -C 10 alkoxy group;
페닐기, 비페닐기, 터페닐기, 나프틸기, 피리디닐기, 피리미디닐기 및 트리아지닐기; phenyl group, biphenyl group, terphenyl group, naphthyl group, pyridinyl group, pyrimidinyl group and triazinyl group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 피리디닐기, 피리미디닐기 및 트리아지닐기 중 적어도 하나로 치환된, 페닐기, 나프틸기, 피리디닐기, 피리미디닐기 및 트리아지닐기 중에서 선택되고, Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group , phenyl group, biphenyl group, terphenyl group, naphthyl group, pyridinyl group, pyrimidinyl group and triazinyl group, substituted with at least one of phenyl group, naphthyl group, pyridinyl group, pyrimidinyl group and triazinyl group,
R11 내지 R13은 서로 독립적으로,R 11 to R 13 are independently of each other,
수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C10알킬기 및 C1-C10알콕시기; 중에서 선택될 수 있다.Hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 10 alkyl group and C 1 -C 10 Alkoxy group; can be selected from among.
다른 구현예에 따르면, R1 내지 R8 및 R11 내지 R13은 수소이고, R14 내지 R17는 서로 독립적으로, 수소 또는 메틸기일 수 있다.According to another embodiment, R 1 to R 8 and R 11 to R 13 may be hydrogen, and R 14 to R 17 may independently be hydrogen or a methyl group.
상기 화학식 2A 내지 2C 중 c11 내지 c13은 서로 독립적으로, 0 내지 4의 정수 중에서 선택된다. c11은 R11의 개수를 나타낸 것으로서, c1이 2 이상일 경우 2 이상의 R11은 서로 동일하거나 상이하다. c12 및 c13에 대한 설명은 상기 c11에 대한 설명 및 화학식 2A 내지 2C의 구조를 참조하여 이해될 수 있다. In Formulas 2A to 2C, c11 to c13 are independently selected from integers of 0 to 4. c11 represents the number of R 11 , and when c1 is 2 or more, 2 or more R 11 are the same or different from each other. The description of c12 and c13 can be understood by referring to the description of c11 and the structures of Formulas 2A to 2C.
일 구현예에 따르면, c11 내지 c13은 서로 독립적으로, 0 또는 1일 수 있다.According to one embodiment, c11 to c13 may be independently 0 or 1.
일 구현예에 따르면, 상기 축합환 화합물은 하기 화학식 1-1 내지 1-42 중 하나로 표시될 수 있다:According to one embodiment, the condensed ring compound may be represented by one of the following formulas 1-1 to 1-42:
<화학식 1-1><Formula 1-1>
<화학식 1-2><Formula 1-2>
<화학식 1-3><Formula 1-3>
<화학식 1-4><Formula 1-4>
<화학식 1-5><Formula 1-5>
<화학식 1-6><Formula 1-6>
<화학식 1-7><Formula 1-7>
<화학식 1-8><Formula 1-8>
<화학식 1-9><Formula 1-9>
<화학식 1-10><Formula 1-10>
<화학식 1-11><Formula 1-11>
<화학식 1-12><Formula 1-12>
<화학식 1-13><Formula 1-13>
<화학식 1-14><Formula 1-14>
<화학식 1-15><Formula 1-15>
<화학식 1-16><Formula 1-16>
<화학식 1-17><Formula 1-17>
<화학식 1-18><Formula 1-18>
<화학식 1-19><Formula 1-19>
<화학식 1-20><Formula 1-20>
<화학식 1-21><Formula 1-21>
<화학식 1-22><Formula 1-22>
<화학식 1-23><Formula 1-23>
<화학식 1-24><Formula 1-24>
<화학식 1-25><Formula 1-25>
<화학식 1-26><Formula 1-26>
<화학식 1-27><Formula 1-27>
<화학식 1-28><Formula 1-28>
<화학식 1-29><Formula 1-29>
<화학식 1-30><Formula 1-30>
<화학식 1-31><Formula 1-31>
<화학식 1-32><Formula 1-32>
<화학식 1-33><Formula 1-33>
<화학식 1-34><Formula 1-34>
<화학식 1-35><Formula 1-35>
<화학식 1-36><Formula 1-36>
<화학식 1-37><Formula 1-37>
<화학식 1-38><Formula 1-38>
<화학식 1-39><Formula 1-39>
<화학식 1-40><Formula 1-40>
<화학식 1-41><Formula 1-41>
<화학식 1-42><Formula 1-42>
상기 화학식 1-1 내지 1-42 중, X1, X2, L1, L2, a1, a2, Ar1, b1, R1 내지 R8, R11 내지 R13 및 c11 내지 c13에 대한 설명은 본 명세서에 기재된 바를 참조한다.In Formulas 1-1 to 1-42 , description of X 1 , Refer to what is described herein.
다른 구현예에 따르면, 상기 축합환 화합물은 하기 화학식 1-1(1) 내지 1-42(1) 중 하나로 표시될 수 있다:According to another embodiment, the condensed ring compound may be represented by one of the following formulas 1-1(1) to 1-42(1):
<화학식 1-1(1)><Formula 1-1(1)>
<화학식 1-2(1)><Formula 1-2(1)>
<화학식 1-3(1)><Formula 1-3(1)>
<화학식 1-4(1)><Formula 1-4(1)>
<화학식 1-5(1)><Formula 1-5(1)>
<화학식 1-6(1)><Formula 1-6(1)>
<화학식 1-7(1)><Formula 1-7(1)>
<화학식 1-8(1)><Formula 1-8(1)>
<화학식 1-9(1)><Formula 1-9(1)>
<화학식 1-10(1)><Formula 1-10(1)>
<화학식 1-11(1)><Formula 1-11(1)>
<화학식 1-12(1)><Formula 1-12(1)>
<화학식 1-13(1)><Formula 1-13(1)>
<화학식 1-14(1)><Formula 1-14(1)>
<화학식 1-15(1)><Formula 1-15(1)>
<화학식 1-16(1)><Formula 1-16(1)>
<화학식 1-17(1)><Formula 1-17(1)>
<화학식 1-18(1)><Formula 1-18(1)>
<화학식 1-18(1)><Formula 1-18(1)>
<화학식 1-19(1)><Formula 1-19(1)>
<화학식 1-20(1)><Formula 1-20(1)>
<화학식 1-21(1)><Formula 1-21(1)>
<화학식 1-22(1)><Formula 1-22(1)>
<화학식 1-23(1)><Formula 1-23(1)>
<화학식 1-24(1)><Formula 1-24(1)>
<화학식 1-25(1)><Formula 1-25(1)>
<화학식 1-26(1)><Formula 1-26(1)>
<화학식 1-27(1)><Formula 1-27(1)>
<화학식 1-28(1)><Formula 1-28(1)>
<화학식 1-29(1)><Formula 1-29(1)>
<화학식 1-30(1)><Formula 1-30(1)>
<화학식 1-31(1)><Formula 1-31(1)>
<화학식 1-32(1)><Formula 1-32(1)>
<화학식 1-33(1)><Formula 1-33(1)>
<화학식 1-34(1)><Formula 1-34(1)>
<화학식 1-35(1)><Formula 1-35(1)>
<화학식 1-36(1)><Formula 1-36(1)>
<화학식 1-37(1)><Formula 1-37(1)>
<화학식 1-38(1)><Formula 1-38(1)>
<화학식 1-39(1)><Formula 1-39(1)>
<화학식 1-40(1)>
<Formula 1-40(1)>
<화학식 1-41(1)><Formula 1-41(1)>
<화학식 1-42(1)><Formula 1-42(1)>
상기 화학식 1-1(1) 내지 1-42(1) 중 X1, X2, L1, L2, a1, a2, Ar1 및 b1에 대한 설명은 본 명세서에 기재된 바를 참조한다. For descriptions of X 1 ,
예를 들어, X1은 O, S 및 C(R14)(R15) 중에서 선택되고,For example, X 1 is selected from O, S and C(R 14 )(R 15 );
X2는 O 및 S 중에서 선택되고,X 2 is selected from O and S,
L1 및 L2은 서로 독립적으로, 상기 화학식 4-1 내지 화학식 4-35로 표시되는 그룹 중에서 선택되고,L 1 and L 2 are independently selected from the group represented by Formulas 4-1 to 4-35,
a1 및 a2는 서로 독립적으로, 0 또는 1이고,a1 and a2 are independently 0 or 1,
상기 Ar1은 상기 화학식 6-1 내지 화학식 6-44로 표시되는 그룹 중에서 선택되고,Ar 1 is selected from the group represented by Formulas 6-1 to 6-44,
b1은 1 또는 2일 수 있다.b1 can be 1 or 2.
상기 축합환 화합물은 하기 화합물들 중 하나일 수 있다:The condensed ring compound may be one of the following compounds:
상기 화학식 1로 표시되는 축합환 화합물 중 B2 고리는 C7-C60방향족 고리 및 C1-C60 헤테로방향족 고리 중에서 선택되므로, 분자 구조 전체의 크기가 증가하여 헤테로 원자 (예를 들어, O 또는 S) 상의 전자가 분산되기 쉬워지고, 이에 따라 분자 구조 전체가 안정화될 수 있다. 따라서, 상기 축합환 화합물을 포함한 유기 발광 소자는 고효율 및 장수명을 달성할 수 있다.Among the condensed ring compounds represented by Formula 1, the B 2 ring is selected from a C 7 -C 60 aromatic ring and a C 1 -C 60 heteroaromatic ring, so the size of the entire molecular structure increases to form heteroatoms (for example, O Alternatively, electrons on S) become easily dispersed, and thus the entire molecular structure can be stabilized. Therefore, an organic light emitting device containing the condensed ring compound can achieve high efficiency and long lifespan.
또한, 상기 축합환 화합물은 하기 화학식 1-1'로 표시되는 바와 같이, 특정 위치에 화학식 2A 내지 2C로 표시되는 그룹 중 하나가 결합되어 있으므로, 발광층의 호스트로서 사용하기에 적합하고, 이에 따라 상기 축합환 화합물을 포함한 유기 발광 소자는 고효율 및 장수명을 달성할 수 있다.In addition, the condensed ring compound is suitable for use as a host of a light-emitting layer because one of the groups represented by formulas 2A to 2C is bonded to a specific position, as represented by the following formula 1-1', and accordingly, the Organic light-emitting devices containing condensed cyclic compounds can achieve high efficiency and long lifespan.
<화학식 1-1'><Formula 1-1'>
상기 화학식 1로 표시되는 축합환 화합물은 공지의 유기 합성 방법을 이용하여 합성될 수 있다. 상기 축합환 화합물의 합성 방법은 후술하는 실시예를 참조하여 당업자가 인식할 수 있다. The condensed ring compound represented by Formula 1 can be synthesized using known organic synthesis methods. The method for synthesizing the condensed ring compound can be recognized by those skilled in the art by referring to the examples described below.
따라서, 제1전극; 상기 제1전극에 대향된 제2전극; 및 상기 제1전극과 상기 제2전극 사이에 개재되고 발광층을 포함한 유기층;을 포함하고, 상기 유기층은 상기 화학식 1로 표시되는 축합환 화합물을 1종 이상 포함한, 유기 발광 소자가 제공된다. Therefore, the first electrode; a second electrode opposite the first electrode; and an organic layer interposed between the first electrode and the second electrode and including a light-emitting layer, wherein the organic layer includes at least one condensed ring compound represented by Formula 1.
본 명세서 중 "(유기층이) 축합환 화합물을 1종 이상 포함한다"란, "(유기층이) 상기 화학식 1의 범주에 속하는 1종의 축합환 화합물 또는 상기 화학식 1의 범주에 속하는 서로 다른 2종 이상의 축합환 화합물을 포함할 수 있다"로 해석될 수 있다.In this specification, “(the organic layer) includes one or more types of condensed ring compounds” means “(the organic layer) includes one type of condensed ring compound belonging to the category of Formula 1 above or two different types of compounds belonging to the category of Formula 1 above. It can be interpreted as “may include one or more condensed ring compounds.”
예를 들어, 상기 유기층은, 상기 축합환 화합물로서, 상기 화합물 1만을 포함할 수 있다. 이 때, 상기 화합물 1은 상기 유기 발광 소자의 발광층에 존재할 수 있다. 또는, 상기 유기층은 상기 축합환 화합물로서, 상기 화합물 1과 화합물 2를 포함할 수 있다. 이 때, 상기 화합물 1과 화합물 2는 동일한 층에 존재(예를 들면, 상기 화합물 1과 화합물 2는 모두 발광층에 존재할 수 있음)하거나, 서로 다른 층에 존재(예를 들면, 상기 화합물 1은 정공 수송층에 존재하고 상기 화합물 2는 발광층에 존재할 수 있음)할 수 있다.For example, the organic layer may include only Compound 1 as the condensed ring compound. At this time, Compound 1 may be present in the light-emitting layer of the organic light-emitting device. Alternatively, the organic layer may include Compound 1 and Compound 2 as the condensed ring compound. At this time, Compound 1 and Compound 2 may exist in the same layer (for example, Compound 1 and Compound 2 may both exist in the light-emitting layer) or in different layers (for example, Compound 1 may exist in a hole present in the transport layer and Compound 2 may be present in the light-emitting layer).
상기 유기층은, i) 상기 제1전극(애노드)과 상기 발광층 사이에 개재되며, 정공 주입층, 정공 수송층, 버퍼층 및 전자 저지층 중 적어도 하나를 포함한, 정공 수송 영역을 포함하고, ii) 상기 발광층과 상기 제2전극(캐소드) 사이에 개재되며, 정공 저지층, 전자 수송층 및 전자 주입층 중 적어도 하나를 포함한, 전자 수송 영역을 포함할 수 있다. 상기 정공 수송 영역 및 발광층 중 적어도 하나에 상기 화학식 1로 표시되는 축합환 화합물 중 적어도 하나가 포함될 수 있다. 예를 들어, 상기 유기 발광 소자의 발광층은 상기 화학식 1로 표시되는 축합환 화합물 중 적어도 하나를 포함할 수 있다. 상기 발광층에 포함된 화학식 1로 표시되는 축합환 화합물은 호스트의 역할을 할 수 있으며, 이 때, 상기 발광층은 도펀트를 더 포함할 수 있다. 상기 도펀트는 인광 도펀트 또는 형광 도펀트일 수 있다. 일 구현예에 따르면, 상기 도펀트는 형광 도펀트일 수 있다. The organic layer includes i) a hole transport region interposed between the first electrode (anode) and the light-emitting layer and including at least one of a hole injection layer, a hole transport layer, a buffer layer, and an electron blocking layer, and ii) the light-emitting layer and the second electrode (cathode), and may include an electron transport region including at least one of a hole blocking layer, an electron transport layer, and an electron injection layer. At least one of the condensed ring compounds represented by Formula 1 may be included in at least one of the hole transport region and the light emitting layer. For example, the light emitting layer of the organic light emitting device may include at least one of the condensed ring compounds represented by Formula 1 above. The condensed cyclic compound represented by Formula 1 included in the light-emitting layer may serve as a host, and in this case, the light-emitting layer may further include a dopant. The dopant may be a phosphorescent dopant or a fluorescent dopant. According to one embodiment, the dopant may be a fluorescent dopant.
본 명세서 중 "유기층"은 상기 유기 발광 소자 중 제1전극과 제2전극 사이에 개재된 단일 및/또는 복수의 모든 층을 가리키는 용어이다. 상기 "유기층"의 층에 포함된 물질이 유기물로 한정되는 것은 아니다. In this specification, “organic layer” is a term referring to all single and/or multiple layers interposed between the first electrode and the second electrode of the organic light emitting device. Materials included in the “organic layer” layer are not limited to organic materials.
[도 1에 대한 설명][Description of Figure 1]
도 1은 본 발명의 일 구현예를 따르는 유기 발광 소자(10)의 단면도를 개략적으로 도시한 것이다. 상기 유기 발광 소자(10)는 제1전극(110), 유기층(150) 및 제2전극(190)을 포함한다. Figure 1 schematically shows a cross-sectional view of an organic light-emitting device 10 according to an embodiment of the present invention. The organic light emitting device 10 includes a first electrode 110, an organic layer 150, and a second electrode 190.
이하, 도 1을 참조하여 본 발명의 일 구현예를 따르는 유기 발광 소자(10)의 구조 및 제조 방법을 설명하면 다음과 같다. Hereinafter, the structure and manufacturing method of the organic light-emitting device 10 according to an embodiment of the present invention will be described with reference to FIG. 1.
[제1전극(110)][First electrode (110)]
도 1의 제1전극(110)의 하부 또는 제2전극(190)의 상부에는 기판이 추가로 배치될 수 있다. 상기 기판으로는, 기계적 강도, 열안정성, 투명성, 표면 평활성, 취급 용이성 및 방수성이 우수한 유리 기판 또는 플라스틱 기판을 사용할 수 있다.A substrate may be additionally disposed below the first electrode 110 or above the second electrode 190 in FIG. 1 . As the substrate, a glass substrate or a plastic substrate excellent in mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and waterproofness can be used.
상기 제1전극(110)은, 예를 들면, 기판 상부에, 제1전극용 물질을 증착법 또는 스퍼터링법 등을 이용하여 제공함으로써 형성될 수 있다. 상기 제1전극(110)이 애노드일 경우, 정공 주입이 용이하도록, 제1전극용 물질은, 높은 일함수를 갖는 물질 중에서 선택될 수 있다. The first electrode 110 may be formed, for example, by providing a first electrode material on the upper part of the substrate using a deposition method or sputtering method. When the first electrode 110 is an anode, the material for the first electrode may be selected from materials with a high work function to facilitate hole injection.
상기 제1전극(110)은 반사형 전극, 반투과형 전극 또는 투과형 전극일 수 있다. 투과형 전극인 제1전극(110)을 형성하기 위하여, 제1전극용 물질은, 산화인듐주석(ITO), 산화인듐아연(IZO), 산화주석(SnO2), 산화아연(ZnO) 및 이의 임의의 조합 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다. 또는, 반투과형 전극 또는 반사형 전극인 제1전극(110)을 형성하기 위하여, 제1전극용 물질은, 마그네슘(Mg), 은(Ag), 알루미늄(Al), 알루미늄-리튬(Al-Li), 칼슘(Ca), 마그네슘-인듐(Mg-In), 마그네슘-은(Mg-Ag) 및 이의 임의의 조합 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다. The first electrode 110 may be a reflective electrode, a transflective electrode, or a transmissive electrode. In order to form the first electrode 110, which is a transmissive electrode, the first electrode material is indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO 2 ), zinc oxide (ZnO), and any of them. It may be selected from a combination of, but is not limited to this. Alternatively, to form the first electrode 110, which is a transflective electrode or a reflective electrode, the first electrode material is magnesium (Mg), silver (Ag), aluminum (Al), or aluminum-lithium (Al-Li). ), calcium (Ca), magnesium-indium (Mg-In), magnesium-silver (Mg-Ag), and any combination thereof, but is not limited thereto.
상기 제1전극(110)은 단일층인 단층 구조 또는 복수의 층을 갖는 다층 구조를 가질 수 있다. 예를 들어, 상기 제1전극(110)은 ITO/Ag/ITO의 3층 구조를 가질 수 있으나, 이에 한정되는 것은 아니다.The first electrode 110 may have a single-layer structure or a multi-layer structure having a plurality of layers. For example, the first electrode 110 may have a three-layer structure of ITO/Ag/ITO, but is not limited to this.
[유기층(150)][Organic layer (150)]
상기 제1전극(110) 상부에는 유기층(150)이 배치되어 있다. 상기 유기층(150)은 발광층을 포함한다. An organic layer 150 is disposed on the first electrode 110. The organic layer 150 includes a light emitting layer.
상기 유기층(150)은, 상기 제1전극(110)과 상기 발광층 사이에 개재된 정공 수송 영역(hole transport region) 및 상기 발광층과 상기 제2전극(190) 사이에 개재된 전자 수송 영역(electron transport region)을 더 포함할 수 있다.The organic layer 150 includes a hole transport region between the first electrode 110 and the light-emitting layer and an electron transport region between the light-emitting layer and the second electrode 190. region) may be further included.
[유기층(150) 중 정공 수송 영역][Hole transport area in organic layer 150]
상기 정공 수송 영역은, i) 단일 물질로 이루어진 단일층으로 이루어진 단층 구조, ii) 복수의 서로 다른 물질로 이루어진 단일층으로 이루어진 단층 구조 또는 iii) 복수의 서로 다른 물질로 이루어진 복수의 층을 갖는 다층 구조를 가질 수 있다. The hole transport region may have i) a single-layer structure consisting of a single layer made of a single material, ii) a single-layer structure consisting of a single layer made of a plurality of different materials, or iii) a multilayer structure having a plurality of layers made of a plurality of different materials. It can have a structure.
상기 정공 수송 영역은, 정공 주입층(HIL), 정공 수송층(HTL), 발광 보조층 및 전자 저지층(EBL) 중에서 선택된 적어도 하나의 층을 포함할 수 있다.The hole transport region may include at least one layer selected from a hole injection layer (HIL), a hole transport layer (HTL), an emission auxiliary layer, and an electron blocking layer (EBL).
예를 들어, 상기 정공 수송 영역은, 복수의 서로 다른 물질로 이루어진 단일층으로 이루어진 단층 구조를 갖거나, 제1전극(110)으로부터 차례로 적층된 정공 주입층/정공 수송층, 정공 주입층/정공 수송층/발광 보조층, 정공 주입층/발광 보조층, 정공 수송층/발광 보조층 또는 정공 주입층/정공 수송층/전자 저지층의 다층 구조를 가질 수 있으나, 이에 한정되는 것은 아니다.For example, the hole transport region has a single-layer structure consisting of a single layer made of a plurality of different materials, or a hole injection layer/hole transport layer or a hole injection layer/hole transport layer sequentially stacked from the first electrode 110. /It may have a multi-layer structure of a light-emitting auxiliary layer, a hole injection layer/light-emitting auxiliary layer, a hole transport layer/light-emitting auxiliary layer, or a hole injection layer/hole transport layer/electron blocking layer, but is not limited thereto.
상기 정공 수송 영역은, m-MTDATA, TDATA, 2-TNATA, NPB, β-NPB, TPD, Spiro-TPD, Spiro-NPB, 메틸화된-NPB, TAPC, HMTPD, TCTA(4,4',4"-트리스(N-카바졸일)트리페닐아민(4,4',4"-tris(N-carbazolyl)triphenylamine)), Pani/DBSA (Polyaniline/Dodecylbenzenesulfonic acid:폴리아닐린/도데실벤젠술폰산), PEDOT/PSS(Poly(3,4-ethylenedioxythiophene)/Poly(4-styrenesulfonate):폴리(3,4-에틸렌디옥시티오펜)/폴리(4-스티렌술포네이트)), Pani/CSA (Polyaniline/Camphor sulfonicacid:폴리아닐린/캠퍼술폰산), PANI/PSS (Polyaniline)/Poly(4-styrenesulfonate):폴리아닐린)/폴리(4-스티렌술포네이트)), 하기 화학식 201로 표시되는 화합물 및 하기 화학식 202로 표시되는 화합물 중 적어도 하나를 더 포함할 수 있다:The hole transport region is m-MTDATA, TDATA, 2-TNATA, NPB, β-NPB, TPD, Spiro-TPD, Spiro-NPB, methylated-NPB, TAPC, HMTPD, TCTA (4,4',4" -Tris(N-carbazolyl)triphenylamine (4,4',4"-tris(N-carbazolyl)triphenylamine), Pani/DBSA (Polyaniline/Dodecylbenzenesulfonic acid), PEDOT/PSS (Poly(3,4-ethylenedioxythiophene)/Poly(4-styrenesulfonate):Poly(3,4-ethylenedioxythiophene)/Poly(4-styrenesulfonate)), Pani/CSA (Polyaniline/Camphor sulfonicacid:Polyaniline/ Camphorsulfonic acid), PANI/PSS (Polyaniline)/Poly(4-styrenesulfonate):polyaniline)/poly(4-styrenesulfonate)), at least one of the compound represented by Formula 201 below and the compound represented by Formula 202 below More may include:
<화학식 201><Formula 201>
<화학식 202><Formula 202>
상기 화학식 201 및 202 중, In formulas 201 and 202,
L201 내지 L204는 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬렌기, 치환 또는 비치환된 C1-C10헤테로시클로알킬렌기, 치환 또는 비치환된 C3-C10시클로알케닐렌기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐렌기, 치환 또는 비치환된 C6-C60아릴렌기, 치환 또는 비치환된 C1-C60헤테로아릴렌기, 치환 또는 비치환된 2가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 2가 비-방향족 헤테로축합다환 그룹 중에서 선택되고, L 201 to L 204 are each independently selected from a substituted or unsubstituted C 3 -C 10 cycloalkylene group, a substituted or unsubstituted C 1 -C 10 heterocycloalkylene group, or a substituted or unsubstituted C 3 -C 10 cyclo Alkenylene group, substituted or unsubstituted C 1 -C 10 heterocycloalkenylene group, substituted or unsubstituted C 6 -C 60 arylene group, substituted or unsubstituted C 1 -C 60 heteroarylene group, substituted or unsubstituted selected from a substituted divalent non-aromatic condensed polycyclic group and a substituted or unsubstituted divalent non-aromatic heterocondensed polycyclic group,
L205은, *-O-*', *-S-*', *-N(Q201)-*', 치환 또는 비치환된 C1-C20알킬렌기, 치환 또는 비치환된 C2-C20알케닐렌기, 치환 또는 비치환된 C3-C10시클로알킬렌기, 치환 또는 비치환된 C1-C10헤테로시클로알킬렌기, 치환 또는 비치환된 C3-C10시클로알케닐렌기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐렌기, 치환 또는 비치환된 C6-C60아릴렌기, 치환 또는 비치환된 C1-C60헤테로아릴렌기, 치환 또는 비치환된 2가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 2가 비-방향족 헤테로축합다환 그룹 중에서 선택되고, L 205 is, *-O-*', *-S-*', *-N(Q 201 )-*', substituted or unsubstituted C 1 -C 20 alkylene group, substituted or unsubstituted C 2 - C 20 alkenylene group, substituted or unsubstituted C 3 -C 10 cycloalkylene group, substituted or unsubstituted C 1 -C 10 heterocycloalkylene group, substituted or unsubstituted C 3 -C 10 cycloalkenylene group, Substituted or unsubstituted C 1 -C 10 heterocycloalkenylene group, substituted or unsubstituted C 6 -C 60 arylene group, substituted or unsubstituted C 1 -C 60 heteroarylene group, substituted or unsubstituted divalent selected from non-aromatic condensed polycyclic groups and substituted or unsubstituted divalent non-aromatic condensed polycyclic groups,
xa1 내지 xa4는 서로 독립적으로, 0 내지 3의 정수 중에서 선택되고, xa1 to xa4 are independently selected from integers from 0 to 3,
xa5는 1 내지 10의 정수 중에서 선택되고, xa5 is selected from an integer from 1 to 10,
R201 내지 R204 및 Q201은 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C6-C60아릴옥시기, 치환 또는 비치환된 C6-C60아릴티오기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹 중에서 선택될 수 있다. R 201 to R 204 and Q 201 are each independently selected from a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, or a substituted or unsubstituted C 3 -C 10 Cycloalkenyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 6 -C 60 aryloxy group, substituted or unsubstituted C 6 -C 60 arylthio group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and substituted or unsubstituted monovalent non-aromatic heterocondensed group. It may be selected from polycyclic groups.
예를 들어, 상기 화학식 202 중 R201과 R202는, 선택적으로(optionally), 단일 결합, 디메틸-메틸렌기 또는 디페닐-메틸렌기를 통하여 서로 연결될 수 있고, R203과 R204는, 선택적으로, 단일 결합, 디메틸-메틸렌기 또는 디페닐-메틸렌기를 통하여 서로 연결될 수 있다.For example, in Formula 202, R 201 and R 202 may be optionally connected to each other through a single bond, a dimethyl-methylene group, or a diphenyl-methylene group, and R 203 and R 204 may be optionally connected to each other, They may be linked to each other through a single bond, a dimethyl-methylene group, or a diphenyl-methylene group.
일 구현예에 따르면, 상기 화학식 201 및 202 중, According to one embodiment, among Formulas 201 and 202,
L201 내지 L205는 서로 독립적으로, L 201 to L 205 are independently of each other,
페닐렌기, 펜탈레닐렌기, 인데닐렌기, 나프틸렌기, 아줄레닐렌기, 헵탈레닐렌기, 인다세닐렌기, 아세나프틸렌기, 플루오레닐렌기, 스파이로-비플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페날레닐렌기, 페난트레닐렌기, 안트라세닐렌기, 플루오란테닐렌기, 트리페닐레닐렌기, 파이레닐렌기, 크라이세닐렌기, 나프타세닐렌기, 피세닐렌기, 페릴레닐렌기, 펜타페닐렌기, 헥사세닐렌기, 펜타세닐렌기, 루비세닐렌기, 코로네닐렌기, 오발레닐렌기, 티오페닐렌기, 퓨라닐렌기, 카바졸일렌기, 인돌일렌기, 이소인돌일렌기, 벤조퓨라닐렌기, 벤조티오페닐렌기, 디벤조퓨라닐렌기, 디벤조티오페닐렌기, 벤조카바졸일렌기, 디벤조카바졸일렌기, 디벤조실롤일렌기 및 피리디닐렌기; 및Phenylene group, pentalenylene group, indenylene group, naphthylene group, azulenylene group, hepthalenylene group, indacenylene group, acenaphthylene group, fluorenylene group, spiro-bifluorenylene group, benzofluore Nylene group, dibenzofluorenylene group, phenalenylene group, phenanthrenylene group, anthracenylene group, fluoranthenylene group, triphenylenylene group, pyrenylene group, chrysenylene group, naphthacenylene group, picenylene group, pe Relenylene group, pentaphenylene group, hexacenylene group, pentacenylene group, rubcenylene group, coronenylene group, ovalenylene group, thiophenylene group, furanylene group, carbazonylene group, indolylene group, isoindolylene group , benzofuranylene group, benzothiophenylene group, dibenzofuranylene group, dibenzothiophenylene group, benzocarbazolylene group, dibenzocarbazolylene group, dibenzosylrollylene group and pyridinylene group; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, C1-C10알킬기로 치환된 페닐기, -F로 치환된 페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기, 피리디닐기, -Si(Q31)(Q32)(Q33) 및 -N(Q31)(Q32) 중에서 선택된 적어도 하나로 치환된, 페닐렌기, 펜탈레닐렌기, 인데닐렌기, 나프틸렌기, 아줄레닐렌기, 헵탈레닐렌기, 인다세닐렌기, 아세나프틸렌기, 플루오레닐렌기, 스파이로-비플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페날레닐렌기, 페난트레닐렌기, 안트라세닐렌기, 플루오란테닐렌기, 트리페닐레닐렌기, 파이레닐렌기, 크라이세닐렌기, 나프타세닐렌기, 피세닐렌기, 페릴레닐렌기, 펜타페닐렌기, 헥사세닐렌기, 펜타세닐렌기, 루비세닐렌기, 코로네닐렌기, 오발레닐렌기, 티오페닐렌기, 퓨라닐렌기, 카바졸일렌기, 인돌일렌기, 이소인돌일렌기, 벤조퓨라닐렌기, 벤조티오페닐렌기, 디벤조퓨라닐렌기, 디벤조티오페닐렌기, 벤조카바졸일렌기, 디벤조카바졸일렌기, 디벤조실롤일렌기 및 피리디닐렌기;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, phenyl group substituted with C 1 -C 10 alkyl group, phenyl group substituted with -F, pentale Nyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group, acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group , phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, naphthacenyl group, picenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, Rubisenyl group, coronenyl group, ovalenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazole Phenyl substituted with at least one selected from the group consisting of dibenzocarbazolyl group, dibenzosilolyl group, pyridinyl group, -Si(Q 31 )(Q 32 )(Q 33 ) and -N(Q 31 )(Q 32 ) Len group, pentalenylene group, indenylene group, naphthylene group, azulenylene group, hepthalenylene group, indacenylene group, acenaphthylene group, fluorenylene group, spiro-bifluorenylene group, benzofluorenyl Len group, dibenzofluorenylene group, phenalenylene group, phenanthrenylene group, anthracenylene group, fluoranthenylene group, triphenylenylene group, pyrenylene group, chrysenylene group, naphthacenylene group, picenylene group, perile Nylene group, pentaphenylene group, hexacenylene group, pentacenylene group, rubisenylene group, coronenylene group, ovalenylene group, thiophenylene group, furanylene group, carbazonylene group, indolelylene group, isoindolylene group, Benzofuranylene group, benzothiophenylene group, dibenzofuranylene group, dibenzothiophenylene group, benzocarbazolylene group, dibenzocarbazolylene group, dibenzosylrollylene group and pyridinylene group;
중에서 선택되고, is selected from,
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택될 수 있다.Q 31 to Q 33 may be independently selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.
다른 구현예에 따르면, xa1 내지 xa4는 서로 독립적으로, 0, 1 또는 2일 수 있다. According to another embodiment, xa1 to xa4 may be independently 0, 1, or 2.
또 다른 구현예에 따르면, xa5는 1, 2, 3 또는 4일 수 있다.According to another embodiment, xa5 may be 1, 2, 3, or 4.
또 다른 구현예에 따르면, R201 내지 R204 및 Q201은 서로 독립적으로, 페닐기, 비페닐기, 터페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기 및 피리디닐기; 및According to another embodiment, R 201 to R 204 and Q 201 are each independently selected from a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a hepthalenyl group, an indacenyl group, Acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pi Renyl group, chrysenyl group, naphthacenyl group, picenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group, ovalenyl group, thiophenyl group, furanyl group, carbazole diyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group and pyridinyl group; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, C1-C10알킬기로 치환된 페닐기, -F로 치환된 페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기, 피리디닐기, -Si(Q31)(Q32)(Q33) 및 -N(Q31)(Q32) 중에서 선택된 적어도 하나로 치환된, 페닐기, 비페닐기, 터페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기 및 피리디닐기;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, phenyl group substituted with C 1 -C 10 alkyl group, phenyl group substituted with -F, pentale Nyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group, acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group , phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, naphthacenyl group, picenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, Rubisenyl group, coronenyl group, ovalenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazole A phenyl group substituted with at least one selected from the group consisting of dibenzocarbazolyl group, dibenzosilolyl group, pyridinyl group, -Si(Q 31 )(Q 32 )(Q 33 ) and -N(Q 31 )(Q 32 ) , biphenyl group, terphenyl group, pentalenyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group, acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, Dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, naphthacenyl group, picenyl group, perylenyl group, pentaphenyl group , hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group, ovalenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindoleyl group, benzofuranyl group, benzothiophenyl group, dibenzofuranyl group. , dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group and pyridinyl group;
중에서 선택될 수 있고,can be selected from,
상기 Q31 내지 Q33에 대한 설명은 본 명세서에 기재된 바를 참조한다.For a description of Q 31 to Q 33 , refer to what is described in the present specification.
또 다른 구현예에 따르면, 상기 화학식 201 중 R201 내지 R203 중 적어도 하나는, 서로 독립적으로, According to another embodiment, at least one of R 201 to R 203 in Formula 201 is independently of each other,
플루오레닐기, 스파이로-비플루오레닐기, 카바졸일기, 디벤조퓨라닐기 및 디벤조티오페닐기; 및fluorenyl group, spiro-bifluorenyl group, carbazolyl group, dibenzofuranyl group and dibenzothiophenyl group; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, C1-C10알킬기로 치환된 페닐기, -F로 치환된 페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 카바졸일기, 디벤조퓨라닐기 및 디벤조티오페닐기 중에서 선택된 적어도 하나로 치환된, 플루오레닐기, 스파이로-비플루오레닐기, 카바졸일기, 디벤조퓨라닐기 및 디벤조티오페닐기;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, phenyl group substituted with C 1 -C 10 alkyl group, phenyl group substituted with -F, naphthyl group. , fluorenyl group, spiro-bifluorenyl group, carbazolyl group, dibenzofuranyl group and dibenzothiophenyl group, substituted with at least one selected from fluorenyl group, spiro-bifluorenyl group, carbazolyl group, di benzofuranyl group and dibenzothiophenyl group;
중에서 선택될 수 있으나, 이에 한정되는 것은 아니다.It may be selected from among, but is not limited to.
또 다른 구현예에 따르면, 상기 화학식 202 중 i) R201과 R202은 단일 결합을 통하여 서로 연결될 수 있거나, 및/또는 ii) R203과 R204은 단일 결합을 통하여 서로 연결될 수 있다.According to another embodiment, in Formula 202, i) R 201 and R 202 may be connected to each other through a single bond, and/or ii) R 203 and R 204 may be connected to each other through a single bond.
또 다른 구현예에 따르면, 상기 화학식 202 중 R201 내지 R204 중 적어도 하나는, According to another embodiment, at least one of R 201 to R 204 in Formula 202 is,
카바졸일기; 및Carbazole diary; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, C1-C10알킬기로 치환된 페닐기, -F로 치환된 페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 카바졸일기, 디벤조퓨라닐기 및 디벤조티오페닐기 중에서 선택된 적어도 하나로 치환된 카바졸일기;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, phenyl group substituted with C 1 -C 10 alkyl group, phenyl group substituted with -F, naphthyl group. , a carbazolyl group substituted with at least one selected from a fluorenyl group, a spiro-bifluorenyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl group;
중에서 선택될 수 있으나, 이에 한정되는 것은 아니다.It may be selected from among, but is not limited to.
상기 화학식 201로 표시되는 화합물은 하기 화학식 201A로 표시될 수 있다:The compound represented by Formula 201 may be represented by the following Formula 201A:
<화학식 201A><Formula 201A>
예를 들어, 상기 화학식 201로 표시되는 화합물은 하기 화학식 201A(1)로 표시될 수 있으나, 이에 한정되는 것은 아니다:For example, the compound represented by Formula 201 may be represented by the following Formula 201A(1), but is not limited thereto:
<화학식 201A(1)><Formula 201A(1)>
또 다른 예로서, 상기 화학식 201로 표시되는 화합물은 하기 화학식 201A-1로 표시될 수 있으나, 이에 한정되는 것은 아니다:As another example, the compound represented by Formula 201 may be represented by the following Formula 201A-1, but is not limited thereto:
<화학식 201A-1><Formula 201A-1>
한편, 상기 화학식 202로 표시되는 화합물은 하기 화학식 202A로 표시될 수 있다:Meanwhile, the compound represented by Formula 202 may be represented by the following Formula 202A:
<화학식 202A><Formula 202A>
또 다른 구현예에 따르면, 상기 화학식 202로 표시되는 화합물은 하기 화학식 202A-1로 표시될 수 있다:According to another embodiment, the compound represented by Formula 202 may be represented by the following Formula 202A-1:
<화학식 202A-1><Formula 202A-1>
상기 화학식 201A, 201A(1), 201A-1, 202A 및 202A-1 중, Among the formulas 201A, 201A(1), 201A-1, 202A and 202A-1,
L201 내지 L203, xa1 내지 xa3, xa5 및 R202 내지 R204에 대한 설명은 본 명세서에 기재된 바를 참조하고, For descriptions of L 201 to L 203 , xa1 to xa3, xa5 and R 202 to R 204 , refer to what is described herein,
R211 및 R212에 대한 설명은 본 명세서 중 R203에 대한 설명을 참조하고, For descriptions of R 211 and R 212 , refer to the description of R 203 in this specification,
R213 내지 R217은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, C1-C10알킬기로 치환된 페닐기, -F로 치환된 페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기 및 피리디닐기 중에서 선택될 수 있다.R 213 to R 217 are independently of each other hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group, cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, C 1 -C 10 substituted with alkyl group. phenyl group, phenyl group substituted with -F, pentalenyl group, indenyl group, naphthyl group, azulenyl group, heptalenyl group, indacenyl group, acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzoflu Orenyl group, dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, naphthacenyl group, picenyl group, perylenyl group , pentaphenyl group, hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group, ovalenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group, di It may be selected from benzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group, and pyridinyl group.
상기 정공 수송 영역은 하기 화합물 HT1 내지 HT39 중에서 선택된 적어도 하나의 화합물을 포함할 수 있으나, 이에 한정되는 것은 아니다:The hole transport region may include at least one compound selected from the following compounds HT1 to HT39, but is not limited thereto:
상기 정공 수송 영역의 두께는 약 100Å 내지 약 10000Å, 예를 들면, 약 100Å 내지 약 1000Å일 수 있다. 상기 정공 수송 영역이 정공 주입층 및 정공 수송층 중 적어도 하나를 포함한다면, 상기 정공 주입층의 두께는 약 100Å 내지 약 9000Å, 예를 들면, 약 100Å 내지 약 1000Å이고, 상기 정공 수송층의 두께는 약 50Å 내지 약 2000Å, 예를 들면 약 100Å 내지 약 1500Å일 수 있다. 상기 정공 수송 영역, 정공 주입층 및 정공 수송층의 두께가 전술한 바와 같은 범위를 만족할 경우, 실질적인 구동 전압 상승없이 만족스러운 정도의 정공 수송 특성을 얻을 수 있다. The thickness of the hole transport region may be about 100Å to about 10000Å, for example, about 100Å to about 1000Å. If the hole transport region includes at least one of a hole injection layer and a hole transport layer, the thickness of the hole injection layer is about 100 Å to about 9000 Å, for example, about 100 Å to about 1000 Å, and the thickness of the hole transport layer is about 50 Å. It may be from about 2000 Å, for example from about 100 Å to about 1500 Å. When the thickness of the hole transport region, hole injection layer, and hole transport layer satisfies the above-mentioned ranges, satisfactory hole transport characteristics can be obtained without a substantial increase in driving voltage.
상기 발광 보조층은 발광층에서 방출되는 광의 파장에 따른 광학적 공진 거리를 보상하여 광 방출 효율을 증가시키는 역할을 하는 층이고, 상기 전자 저지층은 전자 수송 영역으로부터의 전자 주입을 방지하는 역할을 하는 층이다. 상기 발광 보조층 및 전자 저지층에는 상술한 바와 같은 물질이 포함될 수 있다.The light emitting auxiliary layer is a layer that serves to increase light emission efficiency by compensating for the optical resonance distance according to the wavelength of light emitted from the light emitting layer, and the electron blocking layer is a layer that serves to prevent electron injection from the electron transport region. am. The light emitting auxiliary layer and the electron blocking layer may include materials as described above.
[p-도펀트][p-dopant]
상기 정공 수송 영역은 상술한 바와 같은 물질 외에, 도전성 향상을 위하여 전하-생성 물질을 더 포함할 수 있다. 상기 전하-생성 물질은 상기 정공 수송 영역 내에 균일하게 또는 불균일하게 분산되어 있을 수 있다. In addition to the materials described above, the hole transport region may further include a charge-generating material to improve conductivity. The charge-generating material may be uniformly or non-uniformly dispersed within the hole transport region.
상기 전하-생성 물질은 예를 들면, p-도펀트일 수 있다. The charge-generating material may be, for example, a p-dopant.
일 구현예에 따르면, 상기 p-도펀트의 LUMO는 -3.5eV 이하일 수 있다. According to one embodiment, the LUMO of the p-dopant may be -3.5 eV or less.
상기 p-도펀트는, 퀴논 유도체, 금속 산화물 및 시아노기-함유 화합물 중에서 선택된 적어도 하나를 포함할 수 있으나, 이에 한정되는 것은 아니다. The p-dopant may include at least one selected from quinone derivatives, metal oxides, and cyano group-containing compounds, but is not limited thereto.
예를 들어, 상기 p-도펀트는, For example, the p-dopant is,
TCNQ (Tetracyanoquinodimethane) 및 F4-TCNQ (2,3,5,6-Tetrafluoro-7,7,8,8-tetracyanoquinodimethane) 등과 같은 퀴논 유도체; Quinone derivatives such as TCNQ (Tetracyanoquinodimethane) and F4-TCNQ (2,3,5,6-Tetrafluoro-7,7,8,8-tetracyanoquinodimethane);
텅스텐 산화물 및 몰리브덴 산화물 등과 같은 금속 산화물;metal oxides such as tungsten oxide and molybdenum oxide;
HAT-CN (1,4,5,8,9,11-hexaazatriphenylene-hexacarbonitrile); 및HAT-CN (1,4,5,8,9,11-hexaazatriphenylene-hexacarbonitrile); and
하기 화학식 221로 표시되는 화합물;A compound represented by the following formula 221;
중에서 선택된 적어도 하나를 포함할 수 있으나, 이에 한정되는 것은 아니다:It may include, but is not limited to, at least one selected from:
<HAT-CN> <F4-TCNQ><HAT-CN> <F4-TCNQ>
<화학식 221><Formula 221>
상기 화학식 221 중,In Formula 221,
R221 내지 R223은 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹 중에서 선택되되, 상기 R221 내지 R223 중 적어도 하나는 시아노기, -F, -Cl, -Br, -I, -F로 치환된 C1-C20알킬기, -Cl로 치환된 C1-C20알킬기, -Br로 치환된 C1-C20알킬기 및 -I로 치환된 C1-C20알킬기 중에서 선택된 적어도 하나의 치환기를 갖는다. R 221 to R 223 are each independently a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, or a substituted or unsubstituted C 3 -C 10 cycloalkenyl group. , substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted monovalent selected from a non-aromatic condensed polycyclic group and a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, wherein at least one of R 221 to R 223 is a cyano group, -F, -Cl, -Br, -I, At least one selected from a C 1 -C 20 alkyl group substituted with -F, a C 1 -C 20 alkyl group substituted with -Cl, a C 1 -C 20 alkyl group substituted with -Br, and a C 1 -C 20 alkyl group substituted with -I It has one substituent.
[유기층(150) 중 발광층][Emitting layer of organic layer (150)]
상기 유기 발광 소자(10)가 풀 컬러 유기 발광 소자일 경우, 발광층은, 개별 부화소별로, 적색 발광층, 녹색 발광층 및 청색 발광층으로 패터닝될 수 있다. 또는, 상기 발광층은, 적색 발광층, 녹색 발광층 및 청색 발광층 중에서 선택된 2 이상의 층이 접촉 또는 이격되어 적층된 구조를 갖거나, 적색광 방출 물질, 녹색광 방출 물질 및 청색광 방출 물질 중에서 선택된 2 이상의 물질이 층구분없이 혼합된 구조를 가져, 백색광을 방출할 수 있다. When the organic light emitting device 10 is a full color organic light emitting device, the light emitting layer may be patterned into a red light emitting layer, a green light emitting layer, and a blue light emitting layer for each subpixel. Alternatively, the light-emitting layer may have a structure in which two or more layers selected from a red light-emitting layer, a green light-emitting layer, and a blue light-emitting layer are stacked in contact or spaced apart, or two or more materials selected from a red light-emitting material, a green light-emitting material, and a blue light-emitting material may be layered. It has a mixed structure and can emit white light.
상기 발광층은 호스트 및 도펀트를 포함할 수 있다. 상기 도펀트는 인광 도펀트 및 형광 도펀트 중 적어도 하나를 포함할 수 있다.The light emitting layer may include a host and a dopant. The dopant may include at least one of a phosphorescent dopant and a fluorescent dopant.
상기 발광층 중 도펀트의 함량은 통상적으로 호스트 약 100 중량부에 대하여, 약 0.01 내지 약 15 중량부의 범위에서 선택될 수 있으며, 이에 한정되는 것은 아니다.The content of the dopant in the light-emitting layer can typically be selected in the range of about 0.01 to about 15 parts by weight based on about 100 parts by weight of the host, but is not limited thereto.
상기 발광층의 두께는 약 100Å 내지 약 1000Å, 예를 들면 약 200Å 내지 약 600Å일 수 있다. 상기 발광층의 두께가 전술한 바와 같은 범위를 만족할 경우, 실질적인 구동 전압 상승없이 우수한 발광 특성을 나타낼 수 있다.The thickness of the light emitting layer may be about 100Å to about 1000Å, for example, about 200Å to about 600Å. When the thickness of the light-emitting layer satisfies the range described above, excellent light-emitting characteristics can be exhibited without a substantial increase in driving voltage.
[발광층 중 호스트] [Host in the emitting layer]
상기 호스트는 상술한 바와 같은 축합환 화합물을 포함할 수 있다.The host may include a condensed ring compound as described above.
일 구현예에 따르면, 상기 호스트는 상술한 바와 같은 제1화합물로 이루어질 수 있다. According to one embodiment, the host may be composed of the first compound as described above.
[유기층(150) 중 발광층에 포함된 인광 도펀트] [Phosphorescent dopant included in the light-emitting layer of the organic layer 150]
상기 인광 도펀트는 하기 화학식 401로 표시되는 유기금속 착체를 포함할 수 있다:The phosphorescent dopant may include an organometallic complex represented by the following chemical formula 401:
<화학식 401><Formula 401>
M(L401)xc1(L402)xc2 M(L 401 ) xc1 (L 402 ) xc2
<화학식 402><Formula 402>
상기 화학식 401 및 402 중, Among the formulas 401 and 402,
M은 이리듐(Ir), 백금(Pt), 팔라듐(Pd), 오스뮴(Os), 티탄(Ti), 지르코늄(Zr), 하프늄(Hf), 유로퓸(Eu), 테르븀(Tb), 로듐(Rh) 및 툴륨(Tm) 중에서 선택되고, M is iridium (Ir), platinum (Pt), palladium (Pd), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), rhodium (Rh) ) and thulium (Tm),
L401은 상기 화학식 402로 표시되는 리간드 중에서 선택되고, xc1은 1, 2 또는 3이고, xc1이 2 이상일 경우 2 이상의 L401은 서로 동일하거나 상이하고, L 401 is selected from the ligands represented by formula 402, xc1 is 1, 2, or 3, and when xc1 is 2 or more, 2 or more L 401 are the same or different from each other,
L402는 유기 리간드이고, xc2는 0 내지 4의 정수 중에서 선택되고, xc2가 2 이상일 경우 2 이상의 L402는 서로 동일하거나 상이하고, L 402 is an organic ligand, xc2 is selected from an integer of 0 to 4, and when xc2 is 2 or more, 2 or more L 402 are the same or different from each other,
X401 내지 X404는 서로 독립적으로, 질소 또는 탄소이고,X 401 to X 404 are each independently nitrogen or carbon,
X401과 X403은 단일 결합 또는 이중 결합을 통하여 연결되고, X402와 X404는 단일 결합 또는 이중 결합을 통하여 연결되고, X 401 and X 403 are connected through a single bond or double bond, X 402 and X 404 are connected through a single bond or double bond,
A401 및 A402는 서로 독립적으로, C5-C60카보시클릭 그룹 또는 C1-C60헤테로시클릭 그룹이고,A 401 and A 402 are, independently of each other, a C 5 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group,
X405는 단일 결합, *-O-*', *-S-*', *-C(=O)-*', *-N(Q411)-*', *-C(Q411)(Q412)-*', *-C(Q411)=C(Q412)-*', *-C(Q411)=*' 또는 *=C(Q411)=*'이고, 상기 Q411 및 Q412는, 수소, 중수소, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기 또는 나프틸기이고,X 405 is a single binding, *-o- *', *-S- *', *-c (= o)- *', *-n (Q 411 )- *', *-c (Q 411 ) Q 412 )-*', *-C(Q 411 )=C(Q 412 )-*', *-C(Q 411 )=*' or *=C(Q 411 )=*', and the Q 411 and Q 412 is hydrogen, deuterium, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group, phenyl group, biphenyl group, terphenyl group, or naphthyl group,
X406은 단일 결합, O 또는 S이고, X 406 is a single bond, O or S,
R401 및 R402는 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, 치환 또는 비치환된 C1-C20알킬기, 치환 또는 비치환된 C1-C20알콕시기, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C6-C60아릴옥시기, 치환 또는 비치환된 C6-C60아릴티오기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹 -Si(Q401)(Q402)(Q403), -N(Q401)(Q402), -B(Q401)(Q402), -C(=O)(Q401), -S(=O)2(Q401) 및 -P(=O)(Q401)(Q402) 중에서 선택되고, 상기 Q401 내지 Q403은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, C6-C20아릴기 및 C1-C20헤테로아릴기 중에서 선택되고, R 401 and R 402 are independently of each other hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, substituted or Unsubstituted C 1 -C 20 alkyl group, substituted or unsubstituted C 1 -C 20 alkoxy group, substituted or unsubstituted C 3 -C 10 cycloalkyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, Substituted or unsubstituted C 3 -C 10 cycloalkenyl group, substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 6 - C 60 aryloxy group, substituted or unsubstituted C 6 -C 60 arylthio group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted monovalent non-aromatic condensed polycyclic group and substituted or Unsubstituted monovalent non-aromatic heterocondensed polycyclic group -Si(Q 401 )(Q 402 )(Q 403 ), -N(Q 401 )(Q 402 ), -B(Q 401 )(Q 402 ), - C(=O)(Q 401 ), -S(=O) 2 (Q 401 ) and -P(=O)(Q 401 )(Q 402 ), wherein Q 401 to Q 403 are independently of each other. , C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group, C 6 -C 20 aryl group and C 1 -C 20 heteroaryl group,
xc11 및 xc12는 서로 독립적으로, 0 내지 10의 정수 중에서 선택되고, xc11 and xc12 are independently selected from integers from 0 to 10,
상기 화학식 402 중 * 및 *'은 상기 화학식 401 중 M과의 결합 사이트이다. * and *' in Formula 402 are binding sites with M in Formula 401.
일 구현예에 따르면, 상기 화학식 402 중 A401 및 A402는 서로 독립적으로, 벤젠 그룹, 나프탈렌 그룹, 플루오렌 그룹, 스파이로-바이플루오렌 그룹, 인덴 그룹, 피롤 그룹, 티오펜 그룹, 퓨란(furan) 그룹, 이미다졸 그룹, 피라졸 그룹, 티아졸 그룹, 이소티아졸 그룹, 옥사졸 그룹, 이속사졸(isoxazole) 그룹, 피리딘 그룹, 피라진 그룹, 피리미딘 그룹, 피리다진 그룹, 퀴놀린 그룹, 이소퀴놀린 그룹, 벤조퀴놀린 그룹, 퀴녹살린 그룹, 퀴나졸린 그룹, 카바졸 그룹, 벤조이미다졸 그룹, 벤조퓨란(benzofuran) 그룹, 벤조티오펜 그룹, 이소벤조티오펜 그룹, 벤조옥사졸 그룹, 이소벤조옥사졸 그룹, 트리아졸 그룹, 테트라졸 그룹, 옥사디아졸 그룹, 트리아진 그룹, 디벤조퓨란(dibenzofuran) 그룹 및 디벤조티오펜 그룹 중에서 선택될 수 있다. According to one embodiment, in Formula 402, A 401 and A 402 are each independently selected from a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, an indene group, a pyrrole group, a thiophene group, and a furan ( furan) group, imidazole group, pyrazole group, thiazole group, isothiazole group, oxazole group, isoxazole group, pyridine group, pyrazine group, pyrimidine group, pyridazine group, quinoline group, iso Quinoline group, benzoquinoline group, quinoxaline group, quinazoline group, carbazole group, benzoimidazole group, benzofuran group, benzothiophene group, isobenzothiophene group, benzoxazole group, isobenzooxa It may be selected from the sol group, triazole group, tetrazole group, oxadiazole group, triazine group, dibenzofuran group and dibenzothiophene group.
다른 구현예에 따르면, 상기 화학식 402 중 i) X401은 질소이고, X402는 탄소이거나, 또는 ii) X401과 X402가 모두 질소일 수 있다. According to another embodiment, in Formula 402, i) X 401 may be nitrogen and X 402 may be carbon, or ii) both X 401 and X 402 may be nitrogen.
또 다른 구현예에 따르면, 상기 화학식 402 중 R401 및 R402는 서로 독립적으로, According to another embodiment, in Formula 402, R 401 and R 402 are independently of each other,
수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기 및 C1-C20알콕시기;Hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group and C 1 -C 20 Alkoxy group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, 페닐기, 나프틸기, 시클로펜틸기, 시클로헥실기, 아다만타닐기, 노르보나닐기 및 노르보네닐기 중에서 선택된 적어도 하나로 치환된, C1-C20알킬기 및 C1-C20알콕시기;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, phenyl group, naphthyl group, cyclopentyl group, cyclohexyl group, ada C 1 -C 20 alkyl group and C 1 -C 20 alkoxy group substituted with at least one selected from mantanyl group, norbonanyl group and norbornenyl group;
시클로펜틸기, 시클로헥실기, 아다만타닐기, 노르보나닐기, 노르보네닐기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 트리아지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 디벤조퓨라닐기 및 디벤조티오페닐기; Cyclopentyl group, cyclohexyl group, adamantanyl group, norbonanyl group, norbornenyl group, phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group, quinolinyl group, isoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group, dibenzofuranyl group and dibenzothiophenyl group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 아다만타닐기, 노르보나닐기, 노르보네닐기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 트리아지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 디벤조퓨라닐기 및 디벤조티오페닐기 중에서 선택된 적어도 하나로 치환된, 시클로펜틸기, 시클로헥실기, 아다만타닐기, 노르보나닐기, 노르보네닐기 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 트리아지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 디벤조퓨라닐기 및 디벤조티오페닐기; 및Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, adamantanyl group, norbonanyl group, norbornenyl group, phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyrida Cyclopentyl group, cyclohexyl group substituted with at least one selected from zinyl group, triazinyl group, quinolinyl group, isoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group, dibenzofuranyl group and dibenzothiophenyl group. Syl group, adamantanyl group, norbonanyl group, norbornenyl group, phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group, quinium Nolinyl group, isoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group, dibenzofuranyl group and dibenzothiophenyl group; and
-Si(Q401)(Q402)(Q403), -N(Q401)(Q402), -B(Q401)(Q402), -C(=O)(Q401), -S(=O)2(Q401) 및 -P(=O)(Q401)(Q402); -Si(Q 401 )(Q 402 )(Q 403 ), -N(Q 401 )(Q 402 ), -B(Q 401 )(Q 402 ), -C(=O)(Q 401 ), -S (=O) 2 (Q 401 ) and -P(=O)(Q 401 )(Q 402 );
중에서 선택되고, is selected from,
상기 Q401 내지 Q403은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기 및 나프틸기 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다. Q 401 to Q 403 may be independently selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, and a naphthyl group, but are not limited thereto.
또 다른 구현예에 따르면, 상기 화학식 401 중 xc1이 2 이상일 경우, 2 이상의 L401 중 2개의 A401은 선택적으로(optionally), 연결기인 X407을 통하여 서로 연결되거나, 2개의 A402는 선택적으로, 연결기인 X408을 통하여 서로 연결될 수 있다 (하기 화합물 PD1 내지 PD4 및 PD7 참조). 상기 X407 및 X408은 서로 독립적으로, 단일 결합, *-O-*', *-S-*', *-C(=O)-*', *-N(Q413)-*', *-C(Q413)(Q414)-*' 또는 *-C(Q413)=C(Q414)-*' (여기서, Q413 및 Q414는 서로 독립적으로, 수소, 중수소, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기 또는 나프틸기임)일 수 있으나, 이에 한정되는 것은 아니다.According to another embodiment, when xc1 in Formula 401 is 2 or more, two A 401 out of two or more L 401 are optionally connected to each other through X 407 , which is a linking group, or two A 402 are optionally connected to each other. , can be connected to each other through the linking group X 408 (see compounds PD1 to PD4 and PD7 below). Wherein X 407 and *-C(Q 413 )(Q 414 )-*' or *-C(Q 413 )=C(Q 414 )-*' (where Q 413 and Q 414 are independently of each other, hydrogen, deuterium, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group, phenyl group, biphenyl group, terphenyl group, or naphthyl group), but is not limited thereto.
상기 화학식 401 중 L402는 임의의 1가, 2가 또는 3가의 유기 리간드일 수 있다. 예를 들어, 상기 L402는 할로겐, 디케톤 (예를 들면, 아세틸아세토네이트), 카르복실산(예를 들면, 피콜리네이트), -C(=O), 이소니트릴, -CN 및 포스포러스 (예를 들면, 포스핀(phosphine), 포스파이트(phosphite)) 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다. In Formula 401, L 402 may be any monovalent, divalent, or trivalent organic ligand. For example, the L 402 is halogen, diketone (e.g., acetylacetonate), carboxylic acid (e.g., picolinate), -C(=O), isonitrile, -CN, and phosphorus. (For example, phosphine, phosphite), but is not limited thereto.
또는, 상기 인광 도펀트는 예를 들어, 하기 화합물 PD1 내지 PD25 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다:Alternatively, the phosphorescent dopant may be selected from, for example, the following compounds PD1 to PD25, but is not limited thereto:
[발광층 중 형광 도펀트] [Fluorescent dopant in the emitting layer]
상기 형광 도펀트는 아릴아민 화합물 또는 스티릴아민 화합물을 포함할 수 있다.The fluorescent dopant may include an arylamine compound or a styrylamine compound.
상기 형광 도펀트는 하기 화학식 501로 표시되는 화합물을 포함할 수 있다:The fluorescent dopant may include a compound represented by the following formula 501:
<화학식 501><Formula 501>
상기 화학식 501 중, In formula 501,
Ar501은 치환 또는 비치환된 C5-C60카보시클릭 그룹 또는 치환 또는 비치환된 C1-C60헤테로시클릭 그룹이고,Ar 501 is a substituted or unsubstituted C 5 -C 60 carbocyclic group or a substituted or unsubstituted C 1 -C 60 heterocyclic group,
L501 내지 L503은 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬렌기, 치환 또는 비치환된 C1-C10헤테로시클로알킬렌기, 치환 또는 비치환된 C3-C10시클로알케닐렌기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐렌기, 치환 또는 비치환된 C6-C60아릴렌기, 치환 또는 비치환된 C1-C60헤테로아릴렌기, 치환 또는 비치환된 2가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 2가 비-방향족 헤테로축합다환 그룹 중에서 선택되고, L 501 to L 503 are each independently selected from a substituted or unsubstituted C 3 -C 10 cycloalkylene group, a substituted or unsubstituted C 1 -C 10 heterocycloalkylene group, or a substituted or unsubstituted C 3 -C 10 cycloalkylene group. Alkenylene group, substituted or unsubstituted C 1 -C 10 heterocycloalkenylene group, substituted or unsubstituted C 6 -C 60 arylene group, substituted or unsubstituted C 1 -C 60 heteroarylene group, substituted or unsubstituted selected from a substituted divalent non-aromatic condensed polycyclic group and a substituted or unsubstituted divalent non-aromatic heterocondensed polycyclic group,
xd1 내지 xd3는 서로 독립적으로, 0 내지 3의 정수 중에서 선택되고, xd1 to xd3 are independently selected from integers from 0 to 3,
R501 및 R502는 서로 독립적으로, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C6-C60아릴옥시기, 치환 또는 비치환된 C6-C60아릴티오기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹 중에서 선택되고, R 501 and R 502 are independently of each other, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, or a substituted or unsubstituted C 3 -C 10 cycloalkenyl group. , substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 6 -C 60 aryloxy group, substituted or unsubstituted C 6 -C 60 arylthio group, substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group. selected,
Xd4는 1 내지 6의 정수 중에서 선택될 수 있다. Xd4 may be selected from an integer of 1 to 6.
일 구현예에 따르면, 상기 화학식 501 중 Ar501은,According to one embodiment, Ar 501 in Formula 501 is,
나프탈렌 그룹, 헵탈렌 그룹, 플루오렌 그룹, 스파이로-비플루오렌 그룹, 벤조플루오렌 그룹, 디벤조플루오렌 그룹, 페날렌 그룹, 페난트렌 그룹, 안트라센 그룹, 플루오란텐 그룹, 트리페닐렌 그룹, 파이렌 그룹, 크라이센 그룹, 나프타센 그룹, 피센 그룹, 페릴렌 그룹, 펜타펜 그룹, 인데노안트라센 그룹 및 인데노페난트렌 그룹; 및Naphthalene group, hepthalene group, fluorene group, spiro-bifluorene group, benzofluorene group, dibenzofluorene group, phenalene group, phenanthrene group, anthracene group, fluoranthene group, triphenylene group , pyrene group, chrysene group, naphthacene group, picene group, perylene group, pentaphene group, indenoanthracene group and indenophenanthrene group; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택된 적어도 하나로 치환된, 나프탈렌 그룹, 헵탈렌 그룹, 플루오렌 그룹, 스파이로-비플루오렌 그룹, 벤조플루오렌 그룹, 디벤조플루오렌 그룹, 페날렌 그룹, 페난트렌 그룹, 안트라센 그룹, 플루오란텐 그룹, 트리페닐렌 그룹, 파이렌 그룹, 크라이센 그룹, 나프타센 그룹, 피센 그룹, 페릴렌 그룹, 펜타펜 그룹, 인데노안트라센 그룹 및 인데노페난트렌 그룹;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , naphthalene group, hepthalene group, fluorene group, spiro-bifluorene group, benzofluorene group, dibenzofluorene group, phenalene, substituted with at least one selected from phenyl group, biphenyl group, terphenyl group and naphthyl group. group, phenanthrene group, anthracene group, fluoranthene group, triphenylene group, pyrene group, chrysene group, naphthacene group, picene group, perylene group, pentaphene group, indenoanthracene group and indenophenan. Tren Group;
중에서 선택될 수 있다. can be selected from among.
다른 구현예에 따르면, 상기 화학식 501 중 L501 내지 L503은 서로 독립적으로, According to another embodiment, in Formula 501, L 501 to L 503 are independently of each other,
페닐렌기, 나프틸렌기, 플루오레닐렌기, 스파이로-비플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페난트레닐렌기, 안트라세닐렌기, 플루오란테닐렌기, 트리페닐레닐렌기, 파이레닐렌기, 크라이세닐렌기, 페릴레닐렌기, 펜타페닐렌기, 헥사세닐렌기, 펜타세닐렌기, 티오페닐렌기, 퓨라닐렌기, 카바졸일렌기, 인돌일렌기, 이소인돌일렌기, 벤조퓨라닐렌기, 벤조티오페닐렌기, 디벤조퓨라닐렌기, 디벤조티오페닐렌기, 벤조카바졸일렌기, 디벤조카바졸일렌기, 디벤조실롤일렌기, 피리디닐렌기; 및Phenylene group, naphthylene group, fluorenylene group, spiro-bifluorenylene group, benzofluorenylene group, dibenzofluorenylene group, phenanthrenylene group, anthracenylene group, fluoranthenylene group, triphenyl Lenylene group, pyrenylene group, chrysenylene group, perylenylene group, pentaphenylene group, hexacenylene group, pentacenylene group, thiophenylene group, furanylene group, carbazonylene group, indolylene group, isoindolylene group, benzoyl group furanylene group, benzothiophenylene group, dibenzofuranylene group, dibenzothiophenylene group, benzocarbazolylene group, dibenzocarbazolylene group, dibenzosylrollylene group, pyridinylene group; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기 및 피리디닐기 중에서 선택된 적어도 하나로 치환된, 페닐렌기, 나프틸렌기, 플루오레닐렌기, 스파이로-비플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페난트레닐렌기, 안트라세닐렌기, 플루오란테닐렌기, 트리페닐레닐렌기, 파이레닐렌기, 크라이세닐렌기, 페릴레닐렌기, 펜타페닐렌기, 헥사세닐렌기, 펜타세닐렌기, 티오페닐렌기, 퓨라닐렌기, 카바졸일렌기, 인돌일렌기, 이소인돌일렌기, 벤조퓨라닐렌기, 벤조티오페닐렌기, 디벤조퓨라닐렌기, 디벤조티오페닐렌기, 벤조카바졸일렌기, 디벤조카바졸일렌기, 디벤조실롤일렌기, 피리디닐렌기;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenyl Renyl group, pyrenyl group, chrysenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group. , dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group and pyridinyl group, substituted with at least one selected from phenylene group, naphthylene group, fluorenylene group, spy Rho-bifluorenylene group, benzofluorenylene group, dibenzofluorenylene group, phenanthrenylene group, anthracenylene group, fluoranthenylene group, triphenylenylene group, pyrenylene group, chrysenylene group, perile Nylene group, pentaphenylene group, hexacenylene group, pentacenylene group, thiophenylene group, furanylene group, carbazoylene group, indolylene group, isoindolylene group, benzofuranylene group, benzothiophenylene group, dibenzofuranyl Len group, dibenzothiophenylene group, benzocarbazolylene group, dibenzocarbazolylene group, dibenzosylrollylene group, pyridinylene group;
중에서 선택될 수 있다.can be selected from among.
또 다른 구현예에 따르면, 상기 화학식 501 중 R501 및 R502는 서로 독립적으로, According to another embodiment, in Formula 501, R 501 and R 502 are independently of each other,
페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기 및 피리디닐기; 및Phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenyl group Nyl group, pyrenyl group, chrysenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group, Dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group and pyridinyl group; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기, 피리디닐기 및 -Si(Q31)(Q32)(Q33) 중에서 선택된 적어도 하나로 치환된, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기 및 피리디닐기;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenyl Renyl group, pyrenyl group, chrysenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group. , dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group, pyridinyl group and -Si (Q 31 ) (Q 32 ) (Q 33 ). phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, tri Phenylenyl group, pyrenyl group, chrysenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothio phenyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group and pyridinyl group;
중에서 선택되고, is selected from,
상기 Q31 내지 Q33은 C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택될 수 있다. Q 31 to Q 33 may be selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.
또 다른 구현예에 따르면, 상기 화학식 501 중 xd4는 2일 수 있으나, 이에 한정되는 것은 아니다. According to another embodiment, xd4 in Formula 501 may be 2, but is not limited thereto.
예를 들어, 상기 형광 도펀트는 하기 화합물 FD1 내지 FD22 중에서 선택될 수 있다: For example, the fluorescent dopant may be selected from the following compounds FD1 to FD22:
또는, 상기 형광 도펀트는 하기 화합물들 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다.Alternatively, the fluorescent dopant may be selected from the following compounds, but is not limited thereto.
[유기층(150) 중 전자 수송 영역] [Electron transport area in organic layer 150]
상기 전자 수송 영역은 i) 단일 물질로 이루어진 단일층으로 이루어진 단층 구조, ii) 복수의 서로 다른 물질로 이루어진 단일층으로 이루어진 단층 구조 또는 iii) 복수의 서로 다른 물질로 이루어진 복수의 층을 갖는 다층 구조를 가질 수 있다. The electron transport region has i) a single-layer structure consisting of a single layer made of a single material, ii) a single-layer structure consisting of a single layer made of a plurality of different materials, or iii) a multi-layer structure having a plurality of layers made of a plurality of different materials. You can have
상기 전자 수송 영역은, 버퍼층, 정공 저지층, 전자 조절층, 전자 수송층(ETL) 및 전자 주입층 중에서 선택된 적어도 하나의 층을 포함할 수 있으나, 이에 한정되는 것은 아니다.The electron transport region may include at least one layer selected from a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer (ETL), and an electron injection layer, but is not limited thereto.
예를 들어, 상기 전자 수송 영역은, 발광층으로부터 차례로 적층된 전자 수송층/전자 주입층, 정공 저지층/전자 수송층/전자 주입층, 전자 조절층/전자 수송층/전자 주입층, 또는 버퍼층/전자 수송층/전자 주입층 등의 구조를 가질 수 있으나, 이에 한정되는 것은 아니다.For example, the electron transport region may be an electron transport layer/electron injection layer, a hole blocking layer/electron transport layer/electron injection layer, an electron control layer/electron transport layer/electron injection layer, or a buffer layer/electron transport layer/ It may have a structure such as an electron injection layer, but is not limited thereto.
상기 전자 수송 영역(예를 들면, 상기 전자 수송 영역 중 버퍼층, 정공 저지층, 전자 조절층 또는 전자 수송층)은, π 전자 결핍성 함질소 고리를 적어도 하나 포함한 금속-비함유 화합물을 포함할 수 있다. The electron transport region (e.g., a buffer layer, a hole blocking layer, an electron control layer, or an electron transport layer in the electron transport region) may include a metal-free compound including at least one π electron-deficient nitrogen-containing ring. .
상기 "π 전자 결핍성 함질소 고리"는, 고리-형성 모이어티로서, 적어도 하나의 *-N=*' 모이어티를 갖는 C1-C60헤테로시클릭 그룹을 의미한다.The "π electron-deficient nitrogen ring" refers to a C 1 -C 60 heterocyclic group having at least one *-N=*' moiety as a ring-forming moiety.
예를 들어, 상기 "π 전자 결핍성 함질소 고리"는, i) 적어도 하나의 *-N=*' 모이어티를 갖는 5원 내지 7원 헤테로모노시클릭 그룹이거나, ii) 적어도 하나의 *-N=*' 모이어티를 갖는 5원 내지 7원 헤테로모노시클릭 그룹 중 2 이상이 서로 축합되어 있는 헤테로폴리시클릭 그룹이거나, 또는 iii) 적어도 하나의 *-N=*' 모이어티를 갖는 5원 내지 7원 헤테로모노시클릭 그룹 중 적어도 하나와, 적어도 하나의 C5-C60카보시클릭 그룹이 서로 축합되어 있는 헤테로폴리시클릭 그룹일 수 있다.For example, the "π electron deficient nitrogen ring" is i) a 5-7 membered heteromonocyclic group with at least one *-N=*' moiety, or ii) at least one *- a heteropolycyclic group in which two or more of the 5- to 7-membered heteromonocyclic groups having an N=*' moiety are condensed with each other, or iii) a 5-membered group having at least one *-N=*' moiety. It may be a heteropolycyclic group in which at least one of the to 7-membered heteromonocyclic group and at least one C 5 -C 60 carbocyclic group are condensed with each other.
상기 π 전자 결핍성 함질소 고리의 구체예로는, 이미다졸, 피라졸, 티아졸, 이소티아졸, 옥사졸, 이속사졸, 피리딘, 피라진, 피리미딘, 피리다진, 인다졸, 푸린(purie), 퀴놀린, 이소퀴놀린, 벤조퀴놀린, 프탈라진, 나프티리딘, 퀴녹살린, 퀴나졸린, 시놀린, 페난트리딘, 아크리딘, 페난트롤린, 페나진, 벤조이미다졸, 이소벤조티아졸, 벤조옥사졸, 이소벤조옥사졸, 트리아졸, 테트라졸, 옥사디아졸, 트리아진, 티아디아졸, 이미다조피리딘, 이미다조피리미딘, 아자카바졸 등을 들 수 있으나, 이에 한정되는 것은 아니다. Specific examples of the π electron-deficient nitrogen-containing ring include imidazole, pyrazole, thiazole, isothiazole, oxazole, isoxazole, pyridine, pyrazine, pyrimidine, pyridazine, indazole, and purine. , quinoline, isoquinoline, benzoquinoline, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, phenanthridine, acridine, phenanthroline, phenazine, benzoimidazole, isobenzothiazole, benzoline. Examples include oxazole, isobenzooxazole, triazole, tetrazole, oxadiazole, triazine, thiadiazole, imidazopyridine, imidazopyrimidine, and azacarbazole, but are not limited thereto.
예를 들어, 상기 전자 수송 영역은 하기 화학식 601로 표시되는 화합물을 포함할 수 있다. For example, the electron transport region may include a compound represented by Chemical Formula 601 below.
<화학식 601><Formula 601>
[Ar601]xe11-[(L601)xe1-R601]xe21 [Ar 601 ] xe11 -[(L 601 ) xe1 -R 601 ] xe21
상기 화학식 601 중, In the above formula 601,
Ar601은 치환 또는 비치환된 C5-C60카보시클릭 그룹 또는 치환 또는 비치환된 C1-C60헤테로시클릭 그룹이고,Ar 601 is a substituted or unsubstituted C 5 -C 60 carbocyclic group or a substituted or unsubstituted C 1 -C 60 heterocyclic group,
xe11은 1, 2 또는 3이고, xe11 is 1, 2, or 3,
L601은, 치환 또는 비치환된 C3-C10시클로알킬렌기, 치환 또는 비치환된 C1-C10헤테로시클로알킬렌기, 치환 또는 비치환된 C3-C10시클로알케닐렌기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐렌기, 치환 또는 비치환된 C6-C60아릴렌기, 치환 또는 비치환된 C1-C60헤테로아릴렌기, 치환 또는 비치환된 2가 비-방향족 축합다환 그룹 및 치환 또는 비치환된 2가 비-방향족 헤테로축합다환 그룹 중에서 선택되고, L 601 is a substituted or unsubstituted C 3 -C 10 cycloalkylene group, a substituted or unsubstituted C 1 -C 10 heterocycloalkylene group, a substituted or unsubstituted C 3 -C 10 cycloalkenylene group, substituted or Unsubstituted C 1 -C 10 heterocycloalkenylene group, substituted or unsubstituted C 6 -C 60 arylene group, substituted or unsubstituted C 1 -C 60 heteroarylene group, substituted or unsubstituted divalent non- selected from aromatic condensed polycyclic groups and substituted or unsubstituted divalent non-aromatic heterocondensed polycyclic groups,
xe1는 0 내지 5의 정수 중에서 선택되고,xe1 is selected from integers from 0 to 5,
R601은, 치환 또는 비치환된 C3-C10시클로알킬기, 치환 또는 비치환된 C1-C10헤테로시클로알킬기, 치환 또는 비치환된 C3-C10시클로알케닐기, 치환 또는 비치환된 C1-C10헤테로시클로알케닐기, 치환 또는 비치환된 C6-C60아릴기, 치환 또는 비치환된 C6-C60아릴옥시기, 치환 또는 비치환된 C6-C60아릴티오기, 치환 또는 비치환된 C1-C60헤테로아릴기, 치환 또는 비치환된 1가 비-방향족 축합다환 그룹, 치환 또는 비치환된 1가 비-방향족 헤테로축합다환 그룹, -Si(Q601)(Q602)(Q603), - -C(=O)(Q601), -S(=O)2(Q601) 및 -P(=O)(Q601)(Q602) 중에서 선택되고, R 601 is a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, substituted or unsubstituted C 6 -C 60 aryl group, substituted or unsubstituted C 6 -C 60 aryloxy group, substituted or unsubstituted C 6 -C 60 arylthio group , substituted or unsubstituted C 1 -C 60 heteroaryl group, substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, -Si(Q 601 ) (Q 602 )(Q 603 ), -C(=O)(Q 601 ), -S(=O) 2 (Q 601 ) and -P(=O)(Q 601 )(Q 602 ) and ,
상기 Q601 내지 Q603은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 또는 나프틸기이고,Q 601 to Q 603 are each independently a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group,
xe21는 1 내지 5의 정수 중에서 선택된다.xe21 is selected from an integer from 1 to 5.
일 구현예에 따르면, 상기 xe11개의 Ar601 및 xe21개의 R601 중 적어도 하나는, 상술한 바와 같은 π 전자 결핍성 함질소 고리를 포함할 수 있다.According to one embodiment, at least one of the xe11 Ar 601s and the xe21 R 601s may include a π electron-deficient nitrogen-containing ring as described above.
일 구현예에 따르면, 상기 화학식 601 중 고리 Ar601은,According to one embodiment, ring Ar 601 in Formula 601 is,
벤젠 그룹, 나프탈렌 그룹, 플루오렌 그룹, 스파이로-비플루오렌 그룹, 벤조플루오렌 그룹, 디벤조플루오렌 그룹, 페날렌 그룹, 페난트렌 그룹, 안트라센 그룹, 플루오란텐 그룹, 트리페닐렌 그룹, 파이렌 그룹, 크라이센 그룹, 나프타센 그룹, 피센 그룹, 페릴렌 그룹, 펜타펜 그룹, 인데노안트라센 그룹, 디벤조퓨란 그룹, 디벤조티오펜 그룹, 카바졸 그룹, 이미다졸 그룹, 피라졸 그룹, 티아졸 그룹, 이소티아졸 그룹, 옥사졸 그룹, 이속사졸 그룹, 피리딘 그룹, 피라진 그룹, 피리미딘 그룹, 피리다진 그룹, 인다졸 그룹, 푸린 그룹, 퀴놀린 그룹, 이소퀴놀린 그룹, 벤조퀴놀린 그룹, 프탈라진 그룹, 나프티리딘 그룹, 퀴녹살린 그룹, 퀴나졸린 그룹, 시놀린 그룹, 페난트리딘 그룹, 아크리딘 그룹, 페난트롤린 그룹, 페나진 그룹, 벤조이미다졸 그룹, 이소벤조티아졸 그룹, 벤조옥사졸 그룹, 이소벤조옥사졸 그룹, 트리아졸 그룹, 테트라졸 그룹, 옥사디아졸 그룹, 트리아진 그룹, 티아디아졸 그룹, 이미다조피리딘 그룹, 이미다조피리미딘 그룹 및 아자카바졸 그룹; 및Benzene group, naphthalene group, fluorene group, spiro-bifluorene group, benzofluorene group, dibenzofluorene group, phenalene group, phenanthrene group, anthracene group, fluoranthene group, triphenylene group, Pyrene group, chrysene group, naphthacene group, picene group, perylene group, pentaphene group, indenoanthracene group, dibenzofuran group, dibenzothiophene group, carbazole group, imidazole group, pyrazole group , thiazole group, isothiazole group, oxazole group, isoxazole group, pyridine group, pyrazine group, pyrimidine group, pyridazine group, indazole group, purine group, quinoline group, isoquinoline group, benzoquinoline group, Phthalazine group, naphthyridine group, quinoxaline group, quinazoline group, cinoline group, phenanthridine group, acridine group, phenanthroline group, phenazine group, benzoimidazole group, isobenzothiazole group , benzoxazole group, isobenzoxazole group, triazole group, tetrazole group, oxadiazole group, triazine group, thiadiazole group, imidazopyridine group, imidazopyrimidine group and azacarbazole group. ; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, -Si(Q31)(Q32)(Q33), -S(=O)2(Q31) 및 -P(=O)(Q31)(Q32) 중에서 선택된 적어도 하나로 치환된, 벤젠 그룹, 나프탈렌 그룹, 플루오렌 그룹, 스파이로-비플루오렌 그룹, 벤조플루오렌 그룹, 디벤조플루오렌 그룹, 페날렌 그룹, 페난트렌 그룹, 안트라센 그룹, 플루오란텐 그룹, 트리페닐렌 그룹, 파이렌 그룹, 크라이센 그룹, 나프타센 그룹, 피센 그룹, 페릴렌 그룹, 펜타펜 그룹, 인데노안트라센 그룹, 디벤조퓨란 그룹, 디벤조티오펜 그룹, 카바졸 그룹, 이미다졸 그룹, 피라졸 그룹, 티아졸 그룹, 이소티아졸 그룹, 옥사졸 그룹, 이속사졸 그룹, 피리딘 그룹, 피라진 그룹, 피리미딘 그룹, 피리다진 그룹, 인다졸 그룹, 푸린 그룹, 퀴놀린 그룹, 이소퀴놀린 그룹, 벤조퀴놀린 그룹, 프탈라진 그룹, 나프티리딘 그룹, 퀴녹살린 그룹, 퀴나졸린 그룹, 시놀린 그룹, 페난트리딘 그룹, 아크리딘 그룹, 페난트롤린 그룹, 페나진 그룹, 벤조이미다졸 그룹, 이소벤조티아졸 그룹, 벤조옥사졸 그룹, 이소벤조옥사졸 그룹, 트리아졸 그룹, 테트라졸 그룹, 옥사디아졸 그룹, 트리아진 그룹, 티아디아졸 그룹, 이미다조피리딘 그룹, 이미다조피리미딘 그룹 및 아자카바졸 그룹;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , phenyl group, biphenyl group, terphenyl group, naphthyl group, -Si(Q 31 )(Q 32 )(Q 33 ), -S(=O) 2 (Q 31 ) and -P(=O)(Q 31 )( Q 32 ) substituted with at least one selected from a benzene group, a naphthalene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, Fluoranthene group, triphenylene group, pyrene group, chrysene group, naphthacene group, picene group, perylene group, pentaphene group, indenoanthracene group, dibenzofuran group, dibenzothiophene group, carba Sol group, imidazole group, pyrazole group, thiazole group, isothiazole group, oxazole group, isoxazole group, pyridine group, pyrazine group, pyrimidine group, pyridazine group, indazole group, purine group, quinoline group, isoquinoline group, benzoquinoline group, phthalazine group, naphthyridine group, quinoxaline group, quinazoline group, cinoline group, phenanthridine group, acridine group, phenanthroline group, phenazine group, Benzoimidazole group, isobenzothiazole group, benzoxazole group, isobenzoxazole group, triazole group, tetrazole group, oxadiazole group, triazine group, thiadiazole group, imidazopyridine group, imidazopyridine group, polyzopyrimidine group and azacarbazole group;
중에서 선택될 수 있고, can be selected from,
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택될 수 있다. Q 31 to Q 33 may be independently selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.
상기 화학식 601 중 xe11이 2 이상일 경우 2 이상의 Ar601은 단일 결합을 통하여 서로 연결될 수 있다. In Formula 601, when xe11 is 2 or more, 2 or more Ar 601 may be connected to each other through a single bond.
다른 구현예에 따르면, 상기 화학식 601 중 Ar601은 안트라센 그룹일 수 있다. According to another embodiment, Ar 601 in Formula 601 may be an anthracene group.
또 다른 구현예에 따르면, 상기 601로 표시되는 화합물은 하기 화학식 601-1로 표시될 수 있다:According to another embodiment, the compound represented by 601 may be represented by the following formula 601-1:
<화학식 601-1><Formula 601-1>
상기 화학식 601-1 중,In the above formula 601-1,
X614는 N 또는 C(R614)이고, X615는 N 또는 C(R615)이고, X616은 N 또는 C(R616)이고, X614 내지 X616 중 적어도 하나는 N이고,X 614 is N or C(R 614 ), X 615 is N or C(R 615 ) , X 616 is N or C(R 616 ), and at least one of
L611 내지 L613은 서로 독립적으로, 상기 L601에 대한 설명을 참조하고, L 611 to L 613 are independent of each other, refer to the description of L 601 above,
xe611 내지 xe613은 서로 독립적으로, 상기 xe1에 대한 설명을 참조하고,xe611 to xe613 are independent of each other, refer to the description of xe1 above,
R611 내지 R613은 서로 독립적으로, 상기 R601에 대한 설명을 참조하고, R 611 to R 613 are independent of each other, refer to the description of R 601 above,
R614 내지 R616은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택될 수 있다. R 614 to R 616 are independently of each other hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 It may be selected from -C 20 alkyl group, C 1 -C 20 alkoxy group, phenyl group, biphenyl group, terphenyl group, and naphthyl group.
일 구현예에 따르면, 상기 화학식 601 및 601-1 중 L601 및 L611 내지 L613은 서로 독립적으로,According to one embodiment, in Formulas 601 and 601-1, L 601 and L 611 to L 613 are independently of each other,
페닐렌기, 나프틸렌기, 플루오레닐렌기, 스파이로-비플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페난트레닐렌기, 안트라세닐렌기, 플루오란테닐렌기, 트리페닐레닐렌기, 파이레닐렌기, 크라이세닐렌기, 페릴레닐렌기, 펜타페닐렌기, 헥사세닐렌기, 펜타세닐렌기, 티오페닐렌기, 퓨라닐렌기, 카바졸일렌기, 인돌일렌기, 이소인돌일렌기, 벤조퓨라닐렌기, 벤조티오페닐렌기, 디벤조퓨라닐렌기, 디벤조티오페닐렌기, 벤조카바졸일렌기, 디벤조카바졸일렌기, 디벤조실롤일렌기, 피리디닐렌기, 이미다졸일렌기, 피라졸일렌기, 티아졸일렌기, 이소티아졸일렌기, 옥사졸일렌기, 이속사졸일렌기, 티아디아졸일렌기, 옥사디아졸일렌기, 피라지닐렌기, 피리미디닐렌기, 피리다지닐렌기, 트리아지닐렌기, 퀴놀리닐렌기, 이소퀴놀리닐렌기, 벤조퀴놀리닐렌기, 프탈라지닐렌기, 나프티리디닐렌기, 퀴녹살리닐렌기, 퀴나졸리닐렌기, 시놀리닐렌기, 페난트리디닐렌기, 아크리디닐렌기, 페난트롤리닐렌기, 페나지닐렌기, 벤조이미다졸일렌기, 이소벤조티아졸일렌기, 벤조옥사졸일렌기, 이소벤조옥사졸일렌기, 트리아졸일렌기, 테트라졸일렌기, 이미다조피리디닐렌기, 이미다조피리미디닐렌기 및 아자카바졸일렌기; 및Phenylene group, naphthylene group, fluorenylene group, spiro-bifluorenylene group, benzofluorenylene group, dibenzofluorenylene group, phenanthrenylene group, anthracenylene group, fluoranthenylene group, triphenyl Lenylene group, pyrenylene group, chrysenylene group, perylenylene group, pentaphenylene group, hexacenylene group, pentacenylene group, thiophenylene group, furanylene group, carbazonylene group, indolylene group, isoindolylene group, benzoyl group Furanylene group, benzothiophenylene group, dibenzofuranylene group, dibenzothiophenylene group, benzocarbazolylene group, dibenzocarbazolylene group, dibenzosylrollylene group, pyridinylene group, imidazolylene group, pyrazonylene group , thiazonylene group, isothiazolylene group, oxazonylene group, isoxazonylene group, thiadiazolylene group, oxadiazolylene group, pyrazinylene group, pyrimidinylene group, pyridazinylene group, triazinylene group, quinolinyl Len group, isoquinolinylene group, benzoquinolinylene group, phthalazinylene group, naphthyridinylene group, quinoxalinilene group, quinazolinylene group, cynolinylene group, phenanthridinylene group, acridinylene group, phenane Trolinylene group, phenazinylene group, benzoimidazolylene group, isobenzothiazonylene group, benzoxazonylene group, isobenzooxazolylene group, triazonylene group, tetrazolylene group, imidazopyridinylene group, imidazopyrimidi nylene group and azacarbazolylene group; and
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기, 피리디닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 티아디아졸일기, 옥사디아졸일기, 피라지닐기, 피리미디닐기, 피리다지닐기, 트리아지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 트리아졸일기, 테트라졸일기, 이미다조피리디닐기, 이미다조피리미디닐기 및 아자카바졸일기 중에서 선택된 적어도 하나로 치환된, 페닐렌기, 나프틸렌기, 플루오레닐렌기, 스파이로-비플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페난트레닐렌기, 안트라세닐렌기, 플루오란테닐렌기, 트리페닐레닐렌기, 파이레닐렌기, 크라이세닐렌기, 페릴레닐렌기, 펜타페닐렌기, 헥사세닐렌기, 펜타세닐렌기, 티오페닐렌기, 퓨라닐렌기, 카바졸일렌기, 인돌일렌기, 이소인돌일렌기, 벤조퓨라닐렌기, 벤조티오페닐렌기, 디벤조퓨라닐렌기, 디벤조티오페닐렌기, 벤조카바졸일렌기, 디벤조카바졸일렌기, 디벤조실롤일렌기, 피리디닐렌기, 이미다졸일렌기, 피라졸일렌기, 티아졸일렌기, 이소티아졸일렌기, 옥사졸일렌기, 이속사졸일렌기, 티아디아졸일렌기, 옥사디아졸일렌기, 피라지닐렌기, 피리미디닐렌기, 피리다지닐렌기, 트리아지닐렌기, 퀴놀리닐렌기, 이소퀴놀리닐렌기, 벤조퀴놀리닐렌기, 프탈라지닐렌기, 나프티리디닐렌기, 퀴녹살리닐렌기, 퀴나졸리닐렌기, 시놀리닐렌기, 페난트리디닐렌기, 아크리디닐렌기, 페난트롤리닐렌기, 페나지닐렌기, 벤조이미다졸일렌기, 이소벤조티아졸일렌기, 벤조옥사졸일렌기, 이소벤조옥사졸일렌기, 트리아졸일렌기, 테트라졸일렌기, 이미다조피리디닐렌기, 이미다조피리미디닐렌기 및 아자카바졸일렌기;Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenyl Renyl group, pyrenyl group, chrysenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group. , dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group, pyridinyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazole Diary group, isoxazolyl group, thiadiazolyl group, oxadiazolyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group, naphthyridinyl group, quinoxalinyl group, quinazolinyl group, cynolinyl group, phenanthridinyl group, acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, isobenzothiazolyl group, benzoxazolyl group , isobenzooxazolyl group, triazolyl group, tetrazolyl group, imidazopyridinyl group, imidazopyrimidinyl group and azacarbazolyl group, substituted with at least one selected from phenylene group, naphthylene group, fluorenylene group, Spiro-bifluorenylene group, benzofluorenylene group, dibenzofluorenylene group, phenanthrenylene group, anthracenylene group, fluoranthenylene group, triphenylenylene group, pyrenylene group, chrysenylene group, pe Relenylene group, pentaphenylene group, hexacenylene group, pentacenylene group, thiophenylene group, furanylene group, carbazoylene group, indolylene group, isoindolylene group, benzofuranylene group, benzothiophenylene group, dibenzofu Lanylene group, dibenzothiophenylene group, benzocarbazolylene group, dibenzocarbazolylene group, dibenzosylrollylene group, pyridinylene group, imidazolylene group, pyrazoylene group, thiazonylene group, isothiazolylene group, oxazolyl Len group, isoxazolylene group, thiadiazolylene group, oxadiazolylene group, pyrazinylene group, pyrimidinylene group, pyridazinylene group, triazinylene group, quinolinylene group, isoquinolinylene group, benzoquinolinyl Len group, phthalazinylene group, naphthyridinylene group, quinoxalinilene group, quinazolinylene group, cinolinylene group, phenanthridinylene group, acridinylene group, phenanthrolinylene group, phenazynylene group, benzoimidazolyl Len group, isobenzothiazonylene group, benzoxazonylene group, isobenzooxazonylene group, triazonylene group, tetrazolylene group, imidazopyridinylene group, imidazopyrimidinylene group and azacarbazolylene group;
중에서 선택될 수 있으나, 이에 한정되는 것은 아니다. It may be selected from among, but is not limited to.
다른 구현예에 따르면, 상기 화학식 601 및 601-1 중 xe1 및 xe611 내지 xe613은 서로 독립적으로, 0, 1 또는 2일 수 있다.According to another embodiment, xe1 and xe611 to xe613 in Formulas 601 and 601-1 may be independently 0, 1, or 2.
또 다른 구현예에 따르면, 상기 화학식 601 및 601-1 중 R601 및 R611 내지 R613은 서로 독립적으로, According to another embodiment, in Formulas 601 and 601-1, R 601 and R 611 to R 613 are independently of each other,
페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기, 피리디닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 티아디아졸일기, 옥사디아졸일기, 피라지닐기, 피리미디닐기, 피리다지닐기, 트리아지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 트리아졸일기, 테트라졸일기, 이미다조피리디닐기, 이미다조피리미디닐기 및 아자카바졸일기; Phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenyl group Nyl group, pyrenyl group, chrysenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group, Dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group, pyridinyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group , isoxazolyl group, thiadiazolyl group, oxadiazolyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group. , naphthyridinyl group, quinoxalinyl group, quinazolinyl group, cynolinyl group, phenanthridinyl group, acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzooxazolyl group, triazolyl group, tetrazolyl group, imidazopyridinyl group, imidazopyrimidinyl group and azacarbazolyl group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기, 피리디닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 티아디아졸일기, 옥사디아졸일기, 피라지닐기, 피리미디닐기, 피리다지닐기, 트리아지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 트리아졸일기, 테트라졸일기, 이미다조피리디닐기, 이미다조피리미디닐기 및 아자카바졸일기 중에서 선택된 적어도 하나로 치환된, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 티오페닐기, 퓨라닐기, 카바졸일기, 인돌일기, 이소인돌일기, 벤조퓨라닐기, 벤조티오페닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 디벤조실롤일기, 피리디닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 티아디아졸일기, 옥사디아졸일기, 피라지닐기, 피리미디닐기, 피리다지닐기, 트리아지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 트리아졸일기, 테트라졸일기, 이미다조피리디닐기, 이미다조피리미디닐기 및 아자카바졸일기; 및Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenyl Renyl group, pyrenyl group, chrysenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group. , dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, dibenzosilolyl group, pyridinyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazole Diary group, isoxazolyl group, thiadiazolyl group, oxadiazolyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group, naphthyridinyl group, quinoxalinyl group, quinazolinyl group, cynolinyl group, phenanthridinyl group, acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, isobenzothiazolyl group, benzoxazolyl group , isobenzooxazolyl group, triazolyl group, tetrazolyl group, imidazopyridinyl group, imidazopyrimidinyl group and azacarbazolyl group, substituted with at least one selected from phenyl group, biphenyl group, terphenyl group, naphthyl group, flu Orenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, perile Nyl group, pentaphenyl group, hexacenyl group, pentacenyl group, thiophenyl group, furanyl group, carbazolyl group, indolyl group, isoindolyl group, benzofuranyl group, benzothiophenyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarba Zolyl group, dibenzocarbazolyl group, dibenzosilolyl group, pyridinyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, thiadiazolyl group, oxadia Zolyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, triazinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group, naphthyridinyl group, quinoxalinyl group, quinazolinyl group , cinolinyl group, phenanthridinyl group, acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzooxazolyl group, triazolyl group, tetrazole diary group, imidazopyridinyl group, imidazopyrimidinyl group and azacarbazolyl group; and
-S(=O)2(Q601) 및 -P(=O)(Q601)(Q602);-S(=O) 2 (Q 601 ) and -P(=O)(Q 601 )(Q 602 );
중에서 선택되고,is selected from,
상기 Q601 및 Q602에 대한 설명은 본 명세서에 기재된 바를 참조한다. For descriptions of Q 601 and Q 602 , refer to what is described herein.
상기 전자 수송 영역은 하기 화합물 ET1 내지 ET36 중에서 선택된 적어도 하나의 화합물을 포함할 수 있으나, 이에 한정되는 것은 아니다:The electron transport region may include at least one compound selected from the following compounds ET1 to ET36, but is not limited thereto:
또는, 상기 전자 수송 영역은 BCP(2,9-Dimethyl-4,7-diphenyl-1,10-phenanthroline), Bphen(4,7-Diphenyl-1,10-phenanthroline), Alq3, Balq, TAZ(3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole) 및 NTAZ 중에서 선택된 적어도 하나의 화합물을 포함할 수 있다. Alternatively, the electron transport region may be BCP (2,9-Dimethyl-4,7-diphenyl-1,10-phenanthroline), Bphen (4,7-Diphenyl-1,10-phenanthroline), Alq 3 , Balq, TAZ ( It may include at least one compound selected from 3-(Biphenyl-4-yl)-5-(4- tert -butylphenyl)-4-phenyl- 4H -1,2,4-triazole) and NTAZ.
상기 버퍼층, 정공 저지층 또는 전자 조절층의 두께는 서로 독립적으로, 약 20Å 내지 약 1000Å, 예를 들면 약 30Å 내지 약 300Å일 수 있다. 상기 버퍼층, 정공 저지층 또는 전자 조절층의 두께가 전술한 바와 같은 범위를 만족할 경우, 실질적인 구동 전압 상승없이 우수한 정공 저지 특성 또는 전자 조절 특성을 얻을 수 있다. The thickness of the buffer layer, hole blocking layer, or electron control layer may independently range from about 20 Å to about 1000 Å, for example, from about 30 Å to about 300 Å. When the thickness of the buffer layer, hole blocking layer, or electron control layer satisfies the range described above, excellent hole blocking characteristics or electron control characteristics can be obtained without a substantial increase in driving voltage.
상기 전자 수송층의 두께는 약 100Å 내지 약 1000Å, 예를 들면 약 150Å 내지 약 500Å일 수 있다. 상기 전자 수송층의 두께가 전술한 바와 같은 범위를 만족할 경우, 실질적인 구동 전압 상승없이 만족스러운 정도의 전자 수송 특성을 얻을 수 있다.The thickness of the electron transport layer may be about 100Å to about 1000Å, for example, about 150Å to about 500Å. When the thickness of the electron transport layer satisfies the range described above, satisfactory electron transport characteristics can be obtained without a substantial increase in driving voltage.
상기 전자 수송 영역(예를 들면, 상기 전자 수송 영역 중 전자 수송층)은 상술한 바와 같은 물질 외에, 금속-함유 물질을 더 포함할 수 있다. The electron transport region (eg, an electron transport layer in the electron transport region) may further include a metal-containing material in addition to the materials described above.
상기 금속-함유 물질은 알칼리 금속 착체 및 알칼리 토금속 착체 중에서 선택된 적어도 하나를 포함할 수 있다. 상기 알칼리 금속 착체의 금속 이온은, Li 이온, Na 이온, K 이온, Rb 이온 및 Cs 이온 중에서 선택될 수 있고, 상기 알칼리 토금속 착체의 금속 이온은 Be 이온, Mg 이온, Ca 이온, Sr 이온 및 Ba 이온 중에서 선택될 수 있다. 상기 알칼리 금속 착체 및 알칼리 토금속 착체의 금속 이온에 배위된 리간드는, 서로 독립적으로, 히드록시퀴놀린, 히드록시이소퀴놀린, 히드록시벤조퀴놀린, 히드록시아크리딘, 히드록시페난트리딘, 히드록시페닐옥사졸, 히드록시페닐티아졸, 히드록시디페닐옥사디아졸, 히드록시디페닐티아디아졸, 히드록시페닐피리딘, 히드록시페닐벤조이미다졸, 히드록시페닐벤조티아졸, 비피리딘, 페난트롤린 및 시클로펜타다이엔 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다.The metal-containing material may include at least one selected from an alkali metal complex and an alkaline earth metal complex. The metal ion of the alkaline metal complex may be selected from Li ions, Na ions, K ions, Rb ions, and Cs ions, and the metal ions of the alkaline earth metal complex may be Be ions, Mg ions, Ca ions, Sr ions, and Ba ions may be selected. The ligands coordinated to the metal ions of the alkali metal complex and the alkaline earth metal complex are, independently of each other, hydroxyquinoline, hydroxyisoquinoline, hydroxybenzoquinoline, hydroxyacridine, hydroxyphenanthridine, and hydroxyphenyl. Oxazole, hydroxyphenylthiazole, hydroxydiphenyloxadiazole, hydroxydiphenylthiadiazole, hydroxyphenylpyridine, hydroxyphenylbenzoimidazole, hydroxyphenylbenzothiazole, bipyridine, phenanthroline and cyclopentadiene, but is not limited thereto.
예를 들면, 상기 금속-함유 물질은 Li 착체를 포함할 수 있다. 상기 Li 착체는, 예를 들면, 하기 화합물 ET-D1(리튬 퀴놀레이트, LiQ) 또는 ET-D2을 포함할 수 있다.For example, the metal-containing material may include a Li complex. The Li complex may include, for example, the following compound ET-D1 (lithium quinolate, LiQ) or ET-D2.
상기 전자 수송 영역은, 제2전극(190)으로부터의 전자 주입을 용이하게 하는 전자 주입층을 포함할 수 있다. 상기 전자 주입층은 상기 제2전극(190)과 직접(directly) 접촉할 수 있다.The electron transport region may include an electron injection layer that facilitates electron injection from the second electrode 190. The electron injection layer may directly contact the second electrode 190.
상기 전자 주입층은 i) 단일 물질로 이루어진 단일층으로 이루어진 단층 구조, ii) 복수의 서로 다른 물질로 이루어진 단일층으로 이루어진 단층 구조 또는 iii) 복수의 서로 다른 물질로 이루어진 복수의 층을 갖는 다층 구조를 가질 수 있다. The electron injection layer has i) a single-layer structure consisting of a single layer made of a single material, ii) a single-layer structure consisting of a single layer made of a plurality of different materials, or iii) a multi-layer structure having a plurality of layers made of a plurality of different materials. You can have
상기 전자 주입층은 알칼리 금속, 알칼리 토금속, 희토류 금속, 알칼리 금속 화합물, 알칼리 토금속 화합물, 희토류 금속 화합물, 알칼리 금속 착체, 알칼리 토금속 착체, 희토류 금속 착체 또는 이들 중 임의의 조합을 포함할 수 있다.The electron injection layer may include an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal compound, an alkaline earth metal compound, a rare earth metal compound, an alkali metal complex, an alkaline earth metal complex, a rare earth metal complex, or any combination thereof.
상기 알칼리 금속은, Li, Na, K, Rb 및 Cs 중에서 선택될 수 있다. 일 구현예에 따르면, 상기 알칼리 금속은 Li, Na 또는 Cs일 수 있다. 다른 구현예에 따르면, 상기 알칼리 금속은 Li 또는 Cs일 수 있으나, 이에 한정되는 것은 아니다.The alkali metal may be selected from Li, Na, K, Rb, and Cs. According to one embodiment, the alkali metal may be Li, Na, or Cs. According to another embodiment, the alkali metal may be Li or Cs, but is not limited thereto.
상기 알칼리 토금속은, Mg, Ca, Sr, 및 Ba 중에서 선택될 수 있다.The alkaline earth metal may be selected from Mg, Ca, Sr, and Ba.
상기 희토류 금속은 Sc, Y, Ce, Tb, Yb, Gd 및 Tb 중에서 선택될 수 있다.The rare earth metal may be selected from Sc, Y, Ce, Tb, Yb, Gd, and Tb.
상기 알칼리 금속 화합물, 알칼리 토금속 화합물 및 상기 희토류 금속 화합물은, 상기 알칼리 금속, 상기 알칼리 토금속 및 희토류 금속의 산화물 및 할로겐화물(예를 들면, 불화물, 염화물, 브롬화물, 요오드화물 등) 중에서 선택될 수 있다.The alkali metal compound, the alkaline earth metal compound, and the rare earth metal compound may be selected from oxides and halides (e.g., fluoride, chloride, bromide, iodide, etc.) of the alkali metal, alkaline earth metal, and rare earth metal. there is.
상기 알칼리 금속 화합물은, Li2O, Cs2O, K2O 등과 같은 알칼리 금속 산화물 및 LiF, NaF, CsF, KF, LiI, NaI, CsI, KI 등과 같은 알칼리 금속 할로겐화물 중에서 선택될 수 있다. 일 구현예에 따르면, 상기 알칼리 금속 화합물은, LiF, Li2O, NaF, LiI, NaI, CsI, KI 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다.The alkali metal compound may be selected from alkali metal oxides such as Li 2 O, Cs 2 O, K 2 O, and alkali metal halides such as LiF, NaF, CsF, KF, LiI, NaI, CsI, KI, etc. According to one embodiment, the alkali metal compound may be selected from LiF, Li 2 O, NaF, LiI, NaI, CsI, and KI, but is not limited thereto.
상기 알칼리 토금속 화합물은, BaO, SrO, CaO, BaxSr1-xO(0<x<1), BaxCa1-xO(0<x<1) 등과 같은 알칼리 토금속 화합물 중에서 선택될 수 있다. 일 구현예에 따르면, 상기 알칼리 토금속 화합물은, BaO, SrO 및 CaO 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다. The alkaline earth metal compound may be selected from alkaline earth metal compounds such as BaO, SrO, CaO, Ba x Sr 1-x O (0<x<1), Ba x Ca 1-x O (0<x<1), etc. there is. According to one embodiment, the alkaline earth metal compound may be selected from BaO, SrO, and CaO, but is not limited thereto.
상기 희토류 금속 화합물은, YbF3, ScF3, ScO3, Y2O3, Ce2O3, GdF3, 및 TbF3 중에서 선택될 수 있다. 일 구현예에 따르면, 상기 희토류 금속 화합물은 YbF3, ScF3, TbF3, YbI3, ScI3, TbI3 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다.The rare earth metal compound may be selected from YbF 3 , ScF 3 , ScO 3 , Y 2 O 3 , Ce 2 O 3 , GdF 3 , and TbF 3 . According to one embodiment, the rare earth metal compound may be selected from YbF 3 , ScF 3 , TbF 3 , YbI 3 , ScI 3 , and TbI 3 , but is not limited thereto.
상기 알칼리 금속 착체, 알칼리 토금속 착체 및 희토류 금속 착체는, 상술한 바와 같은 알칼리 금속, 알칼리 토금속 및 희토류 금속의 이온을 포함하고, 상기 알칼리 금속 착체, 알칼리 토금속 착체 및 희토류 금속 착체의 금속 이온에 배위된 리간드는, 서로 독립적으로, 히드록시퀴놀린, 히드록시이소퀴놀린, 히드록시벤조퀴놀린, 히드록시아크리딘, 히드록시페난트리딘, 히드록시페닐옥사졸, 히드록시페닐티아졸, 히드록시디페닐옥사디아졸, 히드록시디페닐티아디아졸, 히드록시페닐피리딘, 히드록시페닐벤조이미다졸, 히드록시페닐벤조티아졸, 비피리딘, 페난트롤린 및 시클로펜타다이엔 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다.The alkali metal complex, alkaline earth metal complex, and rare earth metal complex include ions of the alkali metal, alkaline earth metal, and rare earth metal as described above, and are coordinated to the metal ions of the alkali metal complex, alkaline earth metal complex, and rare earth metal complex. The ligands are, independently of each other, hydroxyquinoline, hydroxyisoquinoline, hydroxybenzoquinoline, hydroxyacridine, hydroxyphenanthridine, hydroxyphenyloxazole, hydroxyphenylthiazole, and hydroxydiphenyloxa. It may be selected from diazole, hydroxydiphenylthiadiazole, hydroxyphenylpyridine, hydroxyphenylbenzoimidazole, hydroxyphenylbenzothiazole, bipyridine, phenanthroline and cyclopentadiene, but is limited thereto. That is not the case.
상기 전자 주입층은 상술한 바와 같은 알칼리 금속, 알칼리 토금속, 희토류 금속, 알칼리 금속 화합물, 알칼리 토금속 화합물, 희토류 금속 화합물, 알칼리 금속 착체, 알칼리 토금속 착체, 희토류 금속 착체 또는 이들 중 임의의 조합만으로 이루어져 있거나, 상기 유기물을 더 포함할 수 있다. 상기 전자 주입층이 유기물을 더 포함할 경우, 상기 알칼리 금속, 알칼리 토금속, 희토류 금속, 알칼리 금속 화합물, 알칼리 토금속 화합물, 희토류 금속 화합물, 알칼리 금속 착체, 알칼리 토금속 착체, 희토류 금속 착체 또는 이들 중 임의의 조합은 상기 유기물로 이루어진 매트릭스에 균일 또는 불균일하게 분산되어 있을 수 있다.The electron injection layer is composed of only an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal compound, an alkaline earth metal compound, a rare earth metal compound, an alkali metal complex, an alkaline earth metal complex, a rare earth metal complex, or any combination thereof as described above. , may further include the above organic matter. When the electron injection layer further includes an organic material, the alkali metal, alkaline earth metal, rare earth metal, alkali metal compound, alkaline earth metal compound, rare earth metal compound, alkali metal complex, alkaline earth metal complex, rare earth metal complex, or any of these. The combination may be uniformly or non-uniformly dispersed in the matrix made of the organic material.
상기 전자 주입층의 두께는 약 1Å 내지 약 100Å, 약 3Å 내지 약 90Å일 수 있다. 상기 전자 주입층의 두께가 전술한 바와 같은 범위를 만족할 경우, 실질적인 구동 전압 상승없이 만족스러운 정도의 전자 주입 특성을 얻을 수 있다.The thickness of the electron injection layer may be about 1Å to about 100Å, or about 3Å to about 90Å. When the thickness of the electron injection layer satisfies the range described above, satisfactory electron injection characteristics can be obtained without a substantial increase in driving voltage.
[제2전극(190)][Second electrode (190)]
상술한 바와 같은 유기층(150) 상부에는 제2전극(190)이 배치되어 있다. 상기 제2전극(190)은 전자 주입 전극인 캐소드(cathode)일 수 있는데, 이 때, 상기 제2전극(190)용 물질로는 낮은 일함수를 가지는 금속, 합금, 전기전도성 화합물 및 이들의 혼합물을 사용할 수 있다. The second electrode 190 is disposed on the organic layer 150 as described above. The second electrode 190 may be a cathode, which is an electron injection electrode. In this case, materials for the second electrode 190 include metals, alloys, electrically conductive compounds, and mixtures thereof having a low work function. can be used.
상기 제2전극(190)은, 리튬(Li), 은(Ag), 마그네슘(Mg), 알루미늄(Al), 알루미늄-리튬(Al-Li), 칼슘(Ca), 마그네슘-인듐(Mg-In), 마그네슘-은(Mg-Ag), ITO 및 IZO 중에서 선택된 적어도 하나를 포함할 수 있으나, 이에 한정되는 것은 아니다. 상기 제2전극(190)은 투과형 전극, 반투과형 전극 또는 반사형 전극일 수 있다. The second electrode 190 includes lithium (Li), silver (Ag), magnesium (Mg), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), and magnesium-indium (Mg-In). ), magnesium-silver (Mg-Ag), ITO, and IZO, but is not limited thereto. The second electrode 190 may be a transmissive electrode, a semi-transmissive electrode, or a reflective electrode.
상기 제2전극(190)은 단일층인 단층 구조 또는 복수의 층을 갖는 다층 구조를 가질 수 있다. The second electrode 190 may have a single-layer structure or a multi-layer structure having a plurality of layers.
[도 2 내지 4에 대한 설명] [Description of Figures 2 to 4]
한편, 도 2의 유기 발광 소자(20)는 제1캡핑층(210), 제1전극(110), 유기층(150) 및 제2전극(190)이 차례로 적층된 구조를 갖고, 도 3의 유기 발광 소자(30)는 제1전극(110), 유기층(150), 제2전극(190) 및 제2캡핑층(220)이 차례로 적층된 구조를 갖고, 도 4의 유기 발광 소자(40)는 제1캡핑층(210), 제1전극(110), 유기층(150), 제2전극(190) 및 제2캡핑층(220)이 차례로 적층된 구조를 갖는다.Meanwhile, the organic light emitting device 20 of FIG. 2 has a structure in which a first capping layer 210, a first electrode 110, an organic layer 150, and a second electrode 190 are sequentially stacked, and the organic light emitting device 20 of FIG. 3 The light emitting device 30 has a structure in which a first electrode 110, an organic layer 150, a second electrode 190, and a second capping layer 220 are sequentially stacked, and the organic light emitting device 40 of FIG. 4 is It has a structure in which the first capping layer 210, the first electrode 110, the organic layer 150, the second electrode 190, and the second capping layer 220 are sequentially stacked.
도 2 내지 4 중 제1전극(110), 유기층(150) 및 제2전극(190)에 대한 설명은 도 1에 대한 설명을 참조한다. For descriptions of the first electrode 110, the organic layer 150, and the second electrode 190 in FIGS. 2 to 4, refer to the description of FIG. 1.
유기 발광 소자(20, 40)의 유기층(150) 중 발광층에서 생성된 광은 반투과형 전극 또는 투과형 전극인 제1전극(110) 및 제1캡핑층(210)을 지나 외부로 취출될 수 있고, 유기 발광 소자(30, 40)의 유기층(150) 중 발광층에서 생성된 광은 반투과형 전극 또는 투과형 전극인 제2전극(190) 및 제2캡핑층(220)을 지나 외부로 취출될 수 있다. The light generated in the light-emitting layer of the organic layer 150 of the organic light-emitting device 20 and 40 may pass through the first electrode 110 and the first capping layer 210, which are semi-transmissive electrodes or transmissive electrodes, and be extracted to the outside. Light generated in the light-emitting layer of the organic layer 150 of the organic light-emitting devices 30 and 40 may be extracted to the outside through the second electrode 190 and the second capping layer 220, which are semi-transmissive or transmissive electrodes.
상기 제1캡핑층(210) 및 제2캡핑층(220)은 보강 간섭의 원리에 의하여 외부 발광 효율을 향상시키는 역할을 할 수 있다. The first capping layer 210 and the second capping layer 220 may serve to improve external light emission efficiency based on the principle of constructive interference.
상기 제1캡핑층(210) 및 제2캡핑층(220)은 서로 독립적으로, 유기물로 이루어진 유기 캡핑층, 무기물로 이루어진 무기 캡핑층, 또는 유기물 및 무기물을 포함한 복합 캡핑층일 수 있다.The first capping layer 210 and the second capping layer 220 may independently be an organic capping layer made of an organic material, an inorganic capping layer made of an inorganic material, or a composite capping layer including an organic material and an inorganic material.
상기 제1캡핑층(210) 및 제2캡핑층(220) 중 적어도 하나는, 서로 독립적으로, 카보시클릭 화합물, 헤테로시클릭 화합물, 아민계 화합물, 포르핀 유도체 (porphine derivatives), 프탈로시아닌 유도체 (phthalocyanine derivatives), 나프탈로시아닌 유도체 (naphthalocyanine derivatives), 알칼리 금속 착체 및 알칼리 토금속 착체 중에서 선택된 적어도 하나의 물질을 포함할 수 있다. 상기 카보시클릭 화합물, 헤테로시클릭 화합물 및 아민계 화합물은, 선택적으로, O, N, S, Se, Si, F, Cl, Br 및 I 중에서 선택된 적어도 하나의 원소를 포함한 치환기로 치환될 수 있다. 일 구현예에 따르면, 상기 제1캡핑층(210) 및 제2캡핑층(220) 중 적어도 하나는, 서로 독립적으로, 아민계 화합물을 포함할 수 있다.At least one of the first capping layer 210 and the second capping layer 220 is, independently of each other, a carbocyclic compound, a heterocyclic compound, an amine-based compound, a porphine derivative, a phthalocyanine derivative ( It may include at least one material selected from phthalocyanine derivatives, naphthalocyanine derivatives, alkali metal complexes, and alkaline earth metal complexes. The carbocyclic compounds, heterocyclic compounds and amine compounds may be optionally substituted with a substituent containing at least one element selected from O, N, S, Se, Si, F, Cl, Br and I. . According to one embodiment, at least one of the first capping layer 210 and the second capping layer 220 may independently include an amine-based compound.
다른 구현예에 따르면, 상기 제1캡핑층(210) 및 제2캡핑층(220) 중 적어도 하나는, 서로 독립적으로, 상기 화학식 201로 표시되는 화합물 또는 상기 화학식 202로 표시되는 화합물을 포함할 수 있다.According to another embodiment, at least one of the first capping layer 210 and the second capping layer 220 may independently include a compound represented by Formula 201 or a compound represented by Formula 202. there is.
또 다른 구현예에 따르면, 상기 제1캡핑층(210) 및 제2캡핑층(220) 중 적어도 하나는, 서로 독립적으로, 상기 화합물 HT28 내지 HT33 및 하기 화합물 CP1 내지 CP5 중에서 선택된 화합물을 포함할 수 있으나, 이에 한정되는 것은 아니다.According to another embodiment, at least one of the first capping layer 210 and the second capping layer 220 may independently include a compound selected from the compounds HT28 to HT33 and the following compounds CP1 to CP5. However, it is not limited to this.
이상, 상기 유기 발광 소자를 도 1 내지 4를 참조하여 설명하였으나, 이에 한정되는 것은 아니다. Above, the organic light emitting device has been described with reference to FIGS. 1 to 4, but is not limited thereto.
상기 정공 수송 영역에 포함된 각 층, 발광층 및 전자 수송 영역에 포함된 각 층은 각각, 진공 증착법, 스핀 코팅법, 캐스트법, LB법(Langmuir-Blodgett), 잉크젯 프린팅법, 레이저 프린팅법, 레이저 열전사법(Laser Induced Thermal Imaging, LITI) 등과 같은 다양한 방법을 이용하여, 소정 영역에 형성될 수 있다. Each layer included in the hole transport region, the light-emitting layer, and each layer included in the electron transport region are, respectively, vacuum deposition method, spin coating method, cast method, LB method (Langmuir-Blodgett), inkjet printing method, laser printing method, and laser method. It can be formed in a predetermined area using various methods such as thermal transfer (Laser Induced Thermal Imaging, LITI).
진공 증착법에 의하여 상기 정공 수송 영역에 포함된 각 층, 발광층 및 전자 수송 영역에 포함된 각 층을 각각 형성할 경우, 증착 조건은, 예를 들면, 약 100 내지 약 500℃의 증착 온도, 약 10-8 내지 약 10-3 torr의 진공도 및 약 0.01 내지 약 100Å/sec의 증착 속도 범위 내에서, 형성하고자 하는 층에 포함될 화합물 및 형성하고자 하는 층의 구조를 고려하여 선택될 수 있다. When forming each layer included in the hole transport region, the light emitting layer, and each layer included in the electron transport region by vacuum deposition, the deposition conditions are, for example, a deposition temperature of about 100 to about 500° C., about 10 A vacuum degree of -8 to about 10 -3 torr and a deposition rate of about 0.01 to about 100 Å/sec may be selected in consideration of the compound to be included in the layer to be formed and the structure of the layer to be formed.
스핀 코팅법에 의하여 상기 정공 수송 영역에 포함된 각 층, 발광층 및 전자 수송 영역에 포함된 각 층을 각각 형성할 경우, 코팅 조건은, 예를 들면, 약 2000rpm 내지 약 5000rpm의 코팅 속도 및 약 80℃ 내지 200℃의 열처리 온도 범위 내에서, 형성하고자 하는 층에 포함될 화합물 및 형성하고자 하는 층의 구조를 고려하여 선택될 수 있다. When forming each layer included in the hole transport region, the light emitting layer, and each layer included in the electron transport region by spin coating, the coating conditions include, for example, a coating speed of about 2000 rpm to about 5000 rpm and a coating speed of about 80 rpm. The heat treatment temperature within the range of ℃ to 200℃ may be selected in consideration of the compound to be included in the layer to be formed and the structure of the layer to be formed.
[치환기의 일반적인 정의] [General definition of substituent]
본 명세서 중 C1-C60알킬기는, 탄소수 1 내지 60의 선형 또는 분지형 지방족 탄화수소 1가(monovalent) 그룹을 의미하며, 구체적인 예에는, 메틸기, 에틸기, 프로필기, 이소부틸기, sec-부틸기, ter-부틸기, 펜틸기, iso-아밀기, 헥실기 등이 포함된다. 본 명세서 중 C1-C60알킬렌기는 상기 C1-C60알킬기와 동일한 구조를 갖는 2가(divalent) 그룹을 의미한다. As used herein, C 1 -C 60 alkyl group refers to a linear or branched aliphatic hydrocarbon monovalent group having 1 to 60 carbon atoms, and specific examples include methyl group, ethyl group, propyl group, isobutyl group, and sec-butyl group. group, ter-butyl group, pentyl group, iso-amyl group, hexyl group, etc. As used herein, the C 1 -C 60 alkylene group refers to a divalent group having the same structure as the C 1 -C 60 alkyl group.
본 명세서 중 C2-C60알케닐기는, 상기 C2-C60알킬기의 중간 또는 말단에 하나 이상의 탄소 이중 결합을 포함한 탄화수소 그룹을 의미하며, 이의 구체적인 예에는, 에테닐기, 프로페닐기, 부테닐기 등이 포함된다. 본 명세서 중 C2-C60알케닐렌기는 상기 C2-C60알케닐기와 동일한 구조를 갖는 2가 그룹을 의미한다. As used herein, the C 2 -C 60 alkenyl group refers to a hydrocarbon group containing at least one carbon double bond at the middle or end of the C 2 -C 60 alkyl group, and specific examples thereof include ethenyl group, propenyl group, and butenyl group. etc. are included. As used herein, the C 2 -C 60 alkenylene group refers to a divalent group having the same structure as the C 2 -C 60 alkenyl group.
본 명세서 중 C2-C60알키닐기는, 상기 C2-C60알킬기의 중간 또는 말단에 하나 이상의 탄소 삼중 결합을 포함한 탄화수소 그룹을 의미하며, 이의 구체적인 예에는, 에티닐기, 프로피닐기, 등이 포함된다. 본 명세서 중 C2-C60알키닐렌기는 상기 C2-C60알키닐기와 동일한 구조를 갖는 2가 그룹을 의미한다. As used herein, the C 2 -C 60 alkynyl group refers to a hydrocarbon group containing one or more carbon triple bonds at the middle or end of the C 2 -C 60 alkyl group, and specific examples thereof include ethynyl group, propynyl group, etc. Included. As used herein, the C 2 -C 60 alkynylene group refers to a divalent group having the same structure as the C 2 -C 60 alkynyl group.
본 명세서 중 C1-C60알콕시기는, -OA101(여기서, A101은 상기 C1-C60알킬기임)의 화학식을 갖는 1가 그룹을 의미하며, 이의 구체적인 예에는, 메톡시기, 에톡시기, 이소프로필옥시기 등이 포함된다. As used herein, C 1 -C 60 alkoxy group refers to a monovalent group having the formula -OA 101 (where A 101 is the C 1 -C 60 alkyl group), and specific examples thereof include methoxy group and ethoxy group. , isopropyloxy group, etc.
본 명세서 중 C3-C10시클로알킬기는, 탄소수 3 내지 10의 1가 포화 탄화수소 모노시클릭 그룹을 의미하며, 이의 구체예에는는 시클로프로필기, 시클로부틸기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기 등이 포함된다. 본 명세서 중 C3-C10시클로알킬렌기는 상기 C3-C10시클로알킬기와 동일한 구조를 갖는 2가 그룹을 의미한다.As used herein, C 3 -C 10 cycloalkyl group refers to a monovalent saturated hydrocarbon monocyclic group having 3 to 10 carbon atoms, and specific examples thereof include cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, and cyclo Heptyl group, etc. are included. As used herein, the C 3 -C 10 cycloalkylene group refers to a divalent group having the same structure as the C 3 -C 10 cycloalkyl group.
본 명세서 중 C1-C10헤테로시클로알킬기는, N, O, Si, P 및 S 중에서 선택된 적어도 하나의 헤테로 원자를 고리-형성 원자로서 포함한 탄소수 1 내지 10의 1가 모노시클릭 그룹을 의미하며, 이의 구체예에는 1,2,3,4-옥사트리아졸리디닐기(1,2,3,4-oxatriazolidinyl), 테트라히드로퓨라닐기(tetrahydrofuranyl), 테트라히드로티오페닐기 등이 포함된다. 본 명세서 중 C1-C10헤테로시클로알킬렌기는 상기 C1-C10헤테로시클로알킬기와 동일한 구조를 갖는 2가 그룹을 의미한다.As used herein, C 1 -C 10 heterocycloalkyl group refers to a monovalent monocyclic group having 1 to 10 carbon atoms containing at least one hetero atom selected from N, O, Si, P and S as a ring-forming atom. , Specific examples thereof include 1,2,3,4-oxatriazolidinyl, tetrahydrofuranyl, tetrahydrothiophenyl, etc. As used herein, the C 1 -C 10 heterocycloalkylene group refers to a divalent group having the same structure as the C 1 -C 10 heterocycloalkyl group.
본 명세서 중 C3-C10시클로알케닐기는 탄소수 3 내지 10의 1가 모노시클릭 그룹으로서, 고리 내에 적어도 하나의 이중 결합을 가지나, 방향족성(aromaticity)을 갖지 않는 그룹을 의미하며, 이의 구체예에는 시클로펜테닐기, 시클로헥세닐기, 시클로헵테닐기 등이 포함된다. 본 명세서 중 C3-C10시클로알케닐렌기는 상기 C3-C10시클로알케닐기와 동일한 구조를 갖는 2가 그룹을 의미한다.As used herein, C 3 -C 10 cycloalkenyl group refers to a monovalent monocyclic group having 3 to 10 carbon atoms, which has at least one double bond in the ring but does not have aromaticity, and its specific details Examples include cyclopentenyl group, cyclohexenyl group, cycloheptenyl group, etc. As used herein, the C 3 -C 10 cycloalkenylene group refers to a divalent group having the same structure as the C 3 -C 10 cycloalkenyl group.
본 명세서 중 C1-C10헤테로시클로알케닐기는 N, O, Si, P 및 S 중에서 선택된 적어도 하나의 헤테로 원자를 고리-형성 원자로서 포함한 탄소수 1 내지 10의 1가 모노시클릭 그룹으로서, 고리 내에 적어도 하나의 이중 결합을 갖는다. 상기 C1-C10헤테로시클로알케닐기의 구체예에는, 4,5-디히드로-1,2,3,4-옥사트리아졸일기, 2,3-히드로퓨라닐기, 2,3-히드로티오페닐기 등이 포함된다. 본 명세서 중 C1-C10헤테로시클로알케닐렌기는 상기 C1-C10헤테로시클로알케닐기와 동일한 구조를 갖는 2가 그룹을 의미한다.As used herein, the C 1 -C 10 heterocycloalkenyl group is a monovalent monocyclic group having 1 to 10 carbon atoms containing at least one hetero atom selected from N, O, Si, P and S as a ring-forming atom, forming a ring. It has at least one double bond within it. Specific examples of the C 1 -C 10 heterocycloalkenyl group include 4,5-dihydro-1,2,3,4-oxatriazolyl group, 2,3-hydrofuranyl group, and 2,3-hydrothiophenyl group. etc. are included. As used herein, the C 1 -C 10 heterocycloalkenylene group refers to a divalent group having the same structure as the C 1 -C 10 heterocycloalkenyl group.
본 명세서 중 C6-C60아릴기는 탄소수 6 내지 60개의 카보시클릭 방향족 시스템을 갖는 1가(monovalent) 그룹을 의미하며, C6-C60아릴렌기는 탄소수 6 내지 60개의 카보시클릭 방향족 시스템을 갖는 2가(divalent) 그룹을 의미한다. 상기 C6-C60아릴기의 구체예에는, 페닐기, 나프틸기, 안트라세닐기, 페난트레닐기, 파이레닐기, 크라이세닐기 등을 포함된다. 상기 C6-C60아릴기 및 C6-C60아릴렌기가 2 이상의 고리를 포함할 경우, 상기 2 이상의 고리들은 서로 축합될 수 있다. As used herein, the C 6 -C 60 aryl group refers to a monovalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms, and the C 6 -C 60 arylene group refers to a carbocyclic aromatic system having 6 to 60 carbon atoms. It means a divalent group with . Specific examples of the C 6 -C 60 aryl group include phenyl group, naphthyl group, anthracenyl group, phenanthrenyl group, pyrenyl group, chrysenyl group, etc. When the C 6 -C 60 aryl group and the C 6 -C 60 arylene group include two or more rings, the two or more rings may be condensed with each other.
본 명세서 중 C1-C60헤테로아릴기는 N, O, Si, P 및 S 중에서 선택된 적어도 하나의 헤테로 원자를 고리-형성 원자로서 포함하고 탄소수 1 내지 60개의 헤테로시클릭 방향족 시스템을 갖는 1가 그룹을 의미하고, C1-C60헤테로아릴렌기는 N, O, Si, P 및 S 중에서 선택된 적어도 하나의 헤테로 원자를 고리-형성 원자로서 포함하고 탄소수 1 내지 60개의 헤테로시클릭 방향족 시스템을 갖는 2가 그룹을 의미한다. 상기 C1-C60헤테로아릴기의 구체예에는, 피리디닐기, 피리미디닐기, 피라지닐기, 피리다지닐기, 트리아지닐기, 퀴놀리닐기, 이소퀴놀리닐기 등이 포함되다. 상기 C1-C60헤테로아릴기 및 C1-C60헤테로아릴렌기가 2 이상의 고리를 포함할 경우, 2 이상의 고리들은 서로 축합될 수 있다. As used herein, the C 1 -C 60 heteroaryl group is a monovalent group containing at least one hetero atom selected from N, O, Si, P and S as a ring-forming atom and having a heterocyclic aromatic system having 1 to 60 carbon atoms. means, and the C 1 -C 60 heteroarylene group is 2 which contains at least one hetero atom selected from N, O, Si, P and S as a ring-forming atom and has a heterocyclic aromatic system having 1 to 60 carbon atoms. means group. Specific examples of the C 1 -C 60 heteroaryl group include pyridinyl group, pyrimidinyl group, pyrazinyl group, pyridazinyl group, triazinyl group, quinolinyl group, isoquinolinyl group, etc. When the C 1 -C 60 heteroaryl group and the C 1 -C 60 heteroarylene group include two or more rings, the two or more rings may be condensed with each other.
본 명세서 중 C6-C60아릴옥시기는 -OA102(여기서, A102는 상기 C6-C60아릴기임)를 가리키고, 상기 C6-C60아릴티오기(arylthio)는 -SA103(여기서, A103은 상기 C6-C60아릴기기임)를 가리킨다.As used herein, the C 6 -C 60 aryloxy group refers to -OA 102 (where A 102 is the C 6 -C 60 aryl group), and the C 6 -C 60 arylthio group refers to -SA 103 (where A 102 is the C 6 -C 60 aryl group). , A 103 refers to the C 6 -C 60 aryl group).
본 명세서 중 1가 비-방향족 축합다환 그룹(non-aromatic condensed polycyclic group)은 2 이상의 고리가 서로 축합되어 있고, 고리 형성 원자로서 탄소만을 포함하고, 분자 전체가 비-방향족성(non-aromaticity)을 갖는 1가 그룹(예를 들면, 탄소수 8 내지 60을 가짐)을 의미한다. 상기 1가 비-방향족 축합다환 그룹의 구체예에는, 플루오레닐기 등이 포함되다. 본 명세서 중 2가 비-방향족 축합다환 그룹은 상기 1가 비-방향족 축합다환 그룹과 동일한 구조를 갖는 2가 그룹을 의미한다.As used herein, a monovalent non-aromatic condensed polycyclic group has two or more rings condensed with each other, contains only carbon as a ring forming atom, and the entire molecule is non-aromatic. It means a monovalent group having (for example, having 8 to 60 carbon atoms). Specific examples of the monovalent non-aromatic condensed polycyclic group include a fluorenyl group and the like. As used herein, a divalent non-aromatic condensed polycyclic group refers to a divalent group having the same structure as the monovalent non-aromatic condensed polycyclic group.
본 명세서 중 1가 비-방향족 헤테로축합다환 그룹(non-aromatic condensed heteropolycyclic group)은 2 이상의 고리가 서로 축합되어 있고, 고리 형성 원자로서 탄소 외에 N, O, Si, P 및 S 중에서 선택된 적어도 하나의 헤테로 원자를 포함하고, 분자 전체가 비-방향족성을 갖는 1가 그룹(예를 들면, 탄소수 1 내지 60을 가짐)을 의미한다. 상기 1가 비-방향족 헤테로축합다환 그룹의 구체예에는, 카바졸일기 등이 포함된다. 본 명세서 중 2가 비-방향족 헤테로축합다환 그룹은 상기 1가 비-방향족 헤테로축합다환 그룹과 동일한 구조를 갖는 2가 그룹을 의미한다.As used herein, a monovalent non-aromatic condensed heteropolycyclic group (non-aromatic condensed heteropolycyclic group) has two or more rings condensed with each other, and at least one selected from N, O, Si, P and S in addition to carbon as a ring forming atom. It refers to a monovalent group (for example, having 1 to 60 carbon atoms) that contains a heteroatom and the entire molecule is non-aromatic. Specific examples of the monovalent non-aromatic condensed heteropolycyclic group include carbazolyl group and the like. As used herein, a divalent non-aromatic condensed heteropolycyclic group refers to a divalent group having the same structure as the monovalent non-aromatic condensed heteropolycyclic group.
본 명세서 중 C5-C60카보시클릭 그룹이란, 고리-형성 원자로서 탄소만을 포함한 탄소수 5 내지 60의 모노시클릭 또는 폴리시클릭 그룹을 의미한다. 상기 C5-C60카보시클릭 그룹은 방향족 카보시클릭 그룹 또는 비-방향족 카보시클릭 그룹일 수 있다. 상기 C5-C60카보시클릭 그룹은 벤젠과 같은 고리, 페닐기와 같은 1가 그룹 또는 페닐렌기와 같은 2가 그룹일 수 있다. 또는, 상기 C5-C60카보시클릭 그룹에 연결된 치환기에 개수에 따라, 상기 C5-C60카보시클릭 그룹은 3가 그룹 또는 4가 그룹일 수 있는 등 다양한 변형이 가능하다. As used herein, the C 5 -C 60 carbocyclic group refers to a monocyclic or polycyclic group having 5 to 60 carbon atoms containing only carbon as a ring-forming atom. The C 5 -C 60 carbocyclic group may be an aromatic carbocyclic group or a non-aromatic carbocyclic group. The C 5 -C 60 carbocyclic group may be a ring such as benzene, a monovalent group such as a phenyl group, or a divalent group such as a phenylene group. Alternatively, depending on the number of substituents connected to the C 5 -C 60 carbocyclic group, various modifications are possible, such as the C 5 -C 60 carbocyclic group being a trivalent group or a tetravalent group.
본 명세서 중 C1-C60헤테로시클릭 그룹이란, 상기 C5-C60카보시클릭 그룹과 동일한 구조를 갖되, 고리-형성 원자로서, 탄소(탄소수는 1 내지 60일 수 있음) 외에, N, O, Si, P 및 S 중에서 선택된 적어도 하나의 헤테로 원자를 포함한 그룹을 의미한다. As used herein, the C 1 -C 60 heterocyclic group has the same structure as the C 5 -C 60 carbocyclic group, but as ring-forming atoms, in addition to carbon (carbon number may be 1 to 60), N , refers to a group containing at least one hetero atom selected from O, Si, P and S.
본 명세서 중, 상기 치환된 C5-C60카보시클릭 그룹, 치환된 C1-C60헤테로시클릭 그룹, 치환된 C3-C10시클로알킬렌기, 치환된 C1-C10헤테로시클로알킬렌기, 치환된 C3-C10시클로알케닐렌기, 치환된 C1-C10헤테로시클로알케닐렌기, 치환된 C6-C60아릴렌기, 치환된 C1-C60헤테로아릴렌기, 치환된 2가 비-방향족 축합다환 그룹, 치환된 2가 비-방향족 헤테로축합다환 그룹, 치환된 C1-C60알킬기, 치환된 C2-C60알케닐기, 치환된 C2-C60알키닐기, 치환된 C1-C60알콕시기, 치환된 C3-C10시클로알킬기, 치환된 C1-C10헤테로시클로알킬기, 치환된 C3-C10시클로알케닐기, 치환된 C1-C10헤테로시클로알케닐기, 치환된 C6-C60아릴기, 치환된 C6-C60아릴옥시기, 치환된 C6-C60아릴티오기, 치환된 C1-C60헤테로아릴기, 치환된 1가 비-방향족 축합다환 그룹 및 치환된 1가 비-방향족 헤테로축합다환 그룹의 치환기 중 적어도 하나는, As used herein, the substituted C 5 -C 60 carbocyclic group, substituted C 1 -C 60 heterocyclic group, substituted C 3 -C 10 cycloalkylene group, substituted C 1 -C 10 heterocycloalkyl Len group, substituted C 3 -C 10 cycloalkenylene group, substituted C 1 -C 10 heterocycloalkenylene group, substituted C 6 -C 60 arylene group, substituted C 1 -C 60 heteroarylene group, substituted Divalent non-aromatic condensed polycyclic group, substituted divalent non-aromatic condensed heteropolycyclic group, substituted C 1 -C 60 alkyl group, substituted C 2 -C 60 alkenyl group, substituted C 2 -C 60 alkynyl group, Substituted C 1 -C 60 alkoxy group, substituted C 3 -C 10 cycloalkyl group, substituted C 1 -C 10 heterocycloalkyl group, substituted C 3 -C 10 cycloalkenyl group, substituted C 1 -C 10 hetero Cycloalkenyl group, substituted C 6 -C 60 aryl group, substituted C 6 -C 60 aryloxy group, substituted C 6 -C 60 arylthio group, substituted C 1 -C 60 heteroaryl group, substituted 1 At least one of the substituents of the divalent non-aromatic condensed polycyclic group and the substituted monovalent non-aromatic condensed heteropolycyclic group is,
중수소(-D), -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기 및 C1-C60알콕시기; Deuterium (-D), -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 - C 60 alkenyl group, C 2 -C 60 alkynyl group and C 1 -C 60 alkoxy group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹, 1가 비-방향족 헤테로축합다환 그룹, -Si(Q11)(Q12)(Q13), -N(Q11)(Q12), -B(Q11)(Q12), -C(=O)(Q11), -S(=O)2(Q11) 및 -P(=O)(Q11)(Q12) 중에서 선택된 적어도 하나로 치환된, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기 및 C1-C60알콕시기; Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 3 -C 10 cycloalkyl group, C 1 -C 10 hetero Cycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group, monovalent non-aromatic condensed heteropolycyclic group, -Si(Q 11 )(Q 12 )(Q 13 ), -N(Q 11 )(Q 12 ), -B(Q 11 )(Q 12 ), -C(=O)(Q 11 ), -S(=O) 2 (Q 11 ), and -P(=O)(Q 11 )(Q 12 ). C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group, C 2 -C 60 alkynyl group and C 1 -C 60 alkoxy group substituted with at least one selected from among;
C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹 및 1가 비-방향족 헤테로축합다환 그룹;C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryl Oxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group and monovalent non-aromatic condensed heteropolycyclic group;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기, C1-C60알콕시기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹, 1가 비-방향족 헤테로축합다환 그룹, -Si(Q21)(Q22)(Q23), -N(Q21)(Q22), -B(Q21)(Q22), -C(=O)(Q21), -S(=O)2(Q21) 및 -P(=O)(Q21)(Q22) 중에서 선택된 적어도 하나로 치환된, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹 및 1가 비-방향족 헤테로축합다환 그룹; 및Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group , C 2 -C 60 alkynyl group, C 1 -C 60 alkoxy group, C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocyclo Alkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group, monovalent non-aromatic group -aromatic heterocondensed polycyclic group, -Si(Q 21 )(Q 22 )(Q 23 ), -N(Q 21 )(Q 22 ), -B(Q 21 )(Q 22 ), -C(=O) (Q 21 ), -S(=O) 2 (Q 21 ) and -P(=O)(Q 21 )(Q 22 ), C 3 -C 10 cycloalkyl group, C 1 -C substituted with at least one selected from 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group and monovalent non-aromatic condensed heteropolycyclic group; and
-Si(Q31)(Q32)(Q33), -N(Q31)(Q32), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31) 및 -P(=O)(Q31)(Q32); -Si(Q 31 )(Q 32 )(Q 33 ), -N(Q 31 )(Q 32 ), -B(Q 31 )(Q 32 ), -C(=O)(Q 31 ), -S (=O) 2 (Q 31 ) and -P(=O)(Q 31 )(Q 32 );
중에서 선택되고,is selected from,
상기 Q11 내지 Q13, Q21 내지 Q23 및 Q31 내지 Q33은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기, C1-C60알콕시기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹, 1가 비-방향족 헤테로축합다환 그룹, 비페닐기 및 터페닐기 중에서 선택될 수 있다.Q 11 to Q 13 , Q 21 to Q 23 and Q 31 to Q 33 are each independently selected from hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amine Dino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group, C 2 -C 60 alkynyl group, C 1 -C 60 alkoxy group, C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 1 -C 60 heteroaryl group, monovalent non-aromatic It may be selected from a condensed polycyclic group, a monovalent non-aromatic heterocondensed polycyclic group, a biphenyl group, and a terphenyl group.
본 명세서 중 "Ph"은 페닐기를 의미하고, "Me"은 메틸기를 의미하고, "Et"은 에틸기를 의미하고, "ter-Bu" 또는 "But"은 tert-부틸기를 의미하고, "OMe"는 메톡시기를 의미한다. In this specification, “Ph” refers to a phenyl group, “Me” refers to a methyl group, “Et” refers to an ethyl group, “ter-Bu” or “Bu t ” refers to a tert-butyl group, and “OMe " means a methoxy group.
본 명세서 중 "비페닐기"는 "페닐기로 치환된 페닐기"를 의미한다. 상기 "비페닐기"는, 치환기가 "C6-C60아릴기"인 "치환된 페닐기"에 속한다. As used herein, “biphenyl group” means “a phenyl group substituted with a phenyl group.” The “biphenyl group” belongs to the “substituted phenyl group” in which the substituent is a “C 6 -C 60 aryl group”.
본 명세서 중 "터페닐기"는 "비페닐기로 치환된 페닐기"를 의미한다. 상기 "터페닐기"는, 치환기가 "C6-C60아릴기로 치환된 C6-C60아릴기"인 "치환된 페닐기"에 속한다.As used herein, “terphenyl group” means “a phenyl group substituted with a biphenyl group.” The “terphenyl group” belongs to the “substituted phenyl group” in which the substituent is a “C 6 -C 60 aryl group substituted with a C 6 -C 60 aryl group.”
본 명세서 중 * 및 *'은, 다른 정의가 없는 한, 해당 화학식 중 이웃한 원자와의 결합 사이트를 의미한다.In this specification, * and *' refer to bonding sites with neighboring atoms in the corresponding chemical formula, unless otherwise defined.
이하에서, 합성예 및 실시예를 들어, 본 발명의 일 구현예를 따르는 화합물 및 유기 발광 소자에 대하여 보다 구체적으로 설명한다. 하기 합성예 중 "A 대신 B를 사용하였다"란 표현 중 A의 몰당량과 B의 몰당량은 서로 동일하다.Hereinafter, a compound and an organic light-emitting device according to an embodiment of the present invention will be described in more detail through synthesis examples and examples. In the following synthesis example, in the expression "B was used instead of A," the molar equivalent of A and the molar equivalent of B are the same.
[실시예] [Example]
합성예Synthesis example
합성예 1: 화합물 H1의 합성Synthesis Example 1: Synthesis of Compound H1
중간체 A의 합성Synthesis of Intermediate A
하기 반응식 1-1에 따라 중간체 A를 합성하였다:Intermediate A was synthesized according to Scheme 1-1 below:
<반응식 1-1><Scheme 1-1>
(1) 중간체 A-1의 합성(1) Synthesis of intermediate A-1
아르곤 분위기 하에서, (2,3-dimethoxynaphthalen-1-yl) boronic acid 22.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL 및 2M sodium carbonate solution 150mL를 플라스크에 투입하고 8 시간 동안 가열하고 환류 교반하였다. 실온까지 냉각한 후 물층을 제거하고 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 A-1 23.9g (수율: 84.8 %)을 얻었다.
Under argon atmosphere, 22.0 g of (2,3-dimethoxynaphthalen-1-yl) boronic acid, 17.5 g of 1-bromo-2-fluorobenzene, 2.32 g of tetrakistriphenylphosphine palladium (0), 300 mL of 1,2-dimethoxyethane, and 150 mL of 2M sodium carbonate solution. was added to the flask, heated, refluxed, and stirred for 8 hours. After cooling to room temperature, the water layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 23.9 g of Intermediate A-1 (yield: 84.8 %).
(2) 중간체 A-2의 합성(2) Synthesis of intermediate A-2
아르곤 분위기 하에서 중간체 A-1 23.9g 및 무수 THF 5mL를 플라스크에 투입하고 1.6M n-butyllithium의 hexane 용액 60mL를 첨가하고 반응 용액을 실온에서 4 시간 교반하였다. -78℃까지 냉각하고 trimethyl borate 28.1g의 THF 30mL 용액을 적하했다. 반응 용액을 실온까지 승온시키면서 8 시간 동안 교반하였다. 반응 용액에 10 % HCl 200mL를 가하고 2 시간 동안 교반하였다. 반응 용액을 ether를 사용하여 추출하여 물층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4에서 건조시킨 후 농축하고 잔류물을 hexane으로 세척하고 중간체 A-2 18.0g (수율: 64.9%)을 얻었다.
Under an argon atmosphere, 23.9 g of Intermediate A-1 and 5 mL of anhydrous THF were added to the flask, 60 mL of a 1.6 M n-butyllithium hexane solution was added, and the reaction solution was stirred at room temperature for 4 hours. It was cooled to -78°C, and 30 mL of a solution of 28.1 g of trimethyl borate in THF was added dropwise. The reaction solution was stirred for 8 hours while raising the temperature to room temperature. 200 mL of 10% HCl was added to the reaction solution and stirred for 2 hours. The reaction solution was extracted using ether, the water layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was washed with hexane to obtain 18.0 g of Intermediate A-2 (yield: 64.9%).
(3) 중간체 A-3의 합성(3) Synthesis of intermediate A-3
아르곤 분위기 하에서 중간체 A-2 18.0g, 4-bromo-1-fluoro-2-iodobenzene 16.6g, Tetrakis(triphenylphosphine) palladium(0) 1.28g, toluene 180mL, 2M sodium carbonate solution 90mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후, 반응 용액을 toluene을 이용하여 추출하여 물층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 A-3 20.0g (수율: 79.8 %)를 얻었다.
Under argon atmosphere, 18.0g of intermediate A-2, 16.6g of 4-bromo-1-fluoro-2-iodobenzene, 1.28g of Tetrakis(triphenylphosphine) palladium(0), 180mL of toluene, and 90mL of 2M sodium carbonate solution were added to the flask and incubated for 8 hours. It was refluxed and stirred while heating. After cooling to room temperature, the reaction solution was extracted using toluene, the water layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 20.0 g of Intermediate A-3 (yield: 79.8%).
(4) 중간체 A-4의 합성(4) Synthesis of intermediate A-4
중간체 A-3 20.0g, dichloromethane (탈수) 250mL를 플라스크에 넣고 0 ℃로 냉각하였다. 상기 플라스크에 BBr3 27.5g을 가한 후 실온에서 24 시간 동안 교반하였다. 반응 종료 후, 용액을 -78 ℃로 냉각하고 methanol에서 신중하게 불활성화하고, 충분한 양의 물로 불활성화하였다. 용액을 분액 깔때기에 옮기고 dichloromethane으로 추출하고 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하고 얻어진 시료를 진공 건조하여 중간체 A-4 18.6g (수율 99.6 %)을 얻었다.
20.0 g of Intermediate A-3 and 250 mL of dichloromethane (dehydrated) were added to the flask and cooled to 0°C. 27.5 g of BBr 3 was added to the flask and stirred at room temperature for 24 hours. After completion of the reaction, the solution was cooled to -78 °C and carefully inactivated in methanol and inactivated with a sufficient amount of water. The solution was transferred to a separatory funnel, extracted with dichloromethane, dried with MgSO 4 , then impurities of origin were removed through a silica gel short column, the solution was concentrated, and the obtained sample was vacuum dried to obtain 18.6 g of intermediate A-4 (yield 99.6%).
(5) 중간체 A의 합성(5) Synthesis of intermediate A
중간체 A-4 18.6g, N-methyl-2-pyrrolidinone (dehydrated) 300mL 및 K2CO3 24.5g을 플라스크에 가한 후 200 ℃에서 2 시간 동안 교반 하였다. 반응 종료 후, 용액을 실온까지 냉각하고, 상기 용액에 Toluene 2L를 추가한 후 상기 용액을 분액 깔때기에 옮기고 물로 세척했다. 이 용액을 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하고, toluene / methanol 혼합 용매에서 재결정하여 중간체 A 11.6g (수율 68.5 %)을 얻었다.
18.6 g of intermediate A-4, 300 mL of N-methyl-2-pyrrolidinone (dehydrated), and 24.5 g of K 2 CO 3 were added to the flask and stirred at 200°C for 2 hours. After completion of the reaction, the solution was cooled to room temperature, 2L of Toluene was added to the solution, and the solution was transferred to a separatory funnel and washed with water. After drying this solution with MgSO 4 , origin impurities were removed through a silica gel short column, the solution was concentrated, and recrystallized in a toluene/methanol mixed solvent to obtain 11.6 g of intermediate A (yield 68.5%).
화합물 H1의 합성Synthesis of Compound H1
하기 반응식 1-2에 따라 화합물 H1을 합성하였다:Compound H1 was synthesized according to Scheme 1-2 below:
<반응식 1-2><Scheme 1-2>
아르곤 분위기 하에서, 중간체 A 4.3g, (10-(naphthalen-2-yl)-anthracen-9-yl) boronic acid 3.8g, Tetrakis (triphenylphosphine) palladium (0) 0.232g 1 2-dimethoxyethane 40mL, 2M sodium carbonate solution 20mL를 투입하고 8 시간 동안 환류 교반하였다. 실온까지 냉각한 후 석출된 고체를 여과 분리했다. 수득된 고체를 물 및 메탄올의 혼합물로 세척한 후 톨루엔으로 재결정하여 화합물 H1 4.4g (수율: 66.2%)을 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.Under argon atmosphere, 4.3g of intermediate A, 3.8g of (10-(naphthalen-2-yl)-anthracen-9-yl) boronic acid, 0.232g of Tetrakis (triphenylphosphine) palladium (0) 1 2-dimethoxyethane 40mL, 2M sodium carbonate 20mL of solution was added and stirred under reflux for 8 hours. After cooling to room temperature, the precipitated solid was separated by filtration. The obtained solid was washed with a mixture of water and methanol and then recrystallized with toluene to obtain 4.4 g of compound H1 (yield: 66.2%). The produced compound was confirmed through MS/FAB.
계산값: 610.71 측정값: 610.19
Calculated value: 610.71 Measured value: 610.19
합성예 2: 화합물 H2의 합성Synthesis Example 2: Synthesis of Compound H2
하기 반응식 2에 따라 화합물 H2를 합성하였다:Compound H2 was synthesized according to Scheme 2 below:
<반응식 2><Scheme 2>
(1) 중간체 H2-1의 합성(1) Synthesis of intermediate H2-1
중간체 A 38.7g, 테트라 하이드로 푸란 (탈수) 500mL를 플라스크에 투입하고 -78℃로 냉각했다. 여기에 n-BuLi (1.6M in hexane) 66mL을 넣고 0℃까지 승온시키면서 2 시간 동안 교반하였다. 이어서, 다시 -78 ℃로 냉각하고, B(OMe)3 327.5g을 넣고 -78 ℃에서 10 분간 교반한 후 실온에서 5 시간 교반하였다. 반응 종료 후 1N HCl aq. 200mL를 첨가하여 실온에서 1 시간 동안 교반하였다. 그 후 분액 깔때기에 옮기고 에틸 아세테이트로 추출하였다. 이 용액을 MgSO4로 건조한 후 농축하고 n-헥산으로 세척하고 중간체 H2-1 22.8g (수율: 65.3 %)을 얻었다.
38.7 g of Intermediate A and 500 mL of tetrahydrofuran (dehydrated) were added to the flask and cooled to -78°C. 66mL of n-BuLi (1.6M in hexane) was added thereto and stirred for 2 hours while raising the temperature to 0°C. Then, it was cooled again to -78°C, 327.5 g of B(OMe) 3 was added, and the mixture was stirred at -78°C for 10 minutes and then stirred at room temperature for 5 hours. After completion of the reaction, 1N HCl aq. 200 mL was added and stirred at room temperature for 1 hour. Afterwards, it was transferred to a separatory funnel and extracted with ethyl acetate. This solution was dried over MgSO 4 , concentrated, and washed with n-hexane to obtain 22.8 g of intermediate H2-1 (yield: 65.3%).
(2) 중간체 H2-2의 합성(2) Synthesis of intermediate H2-2
아르곤 분위기 하에서, 중간체 H2-1 22.8g, 1-bromo-4-iodobenzene 8.4g, Tetrakis (triphenylphosphine) palladium(0) 1.52g, 톨루엔 200mL, 2M sodium carbonate solution 100mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후, 반응 용액을 톨루엔으로 추출하였다. 물층을 제거하고 유기층을 MgSO4로 건조시킨 후 농축하였다. 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 H2-2 23.7g (수율: 71.7%)을 얻었다.
Under argon atmosphere, 22.8g of intermediate H2-1, 8.4g of 1-bromo-4-iodobenzene, 1.52g of Tetrakis (triphenylphosphine) palladium(0), 200mL of toluene, and 100mL of 2M sodium carbonate solution were added to the flask and heated for 8 hours. It was refluxed and stirred. After cooling to room temperature, the reaction solution was extracted with toluene. The water layer was removed, and the organic layer was dried with MgSO 4 and concentrated. The residue was purified by silica gel column chromatography to obtain 23.7 g of intermediate H2-2 (yield: 71.7%).
(3) 화합물 H2의 합성(3) Synthesis of compound H2
중간체 A 대신 중간체 H2-2를 사용하였다는 점을 제외하고는, 상기 화합물 H1의 합성과 동일한 방법을 이용하여 화합물 H2 20.5 g (수율: 64.3 %)를 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.20.5 g of compound H2 (yield: 64.3%) was obtained using the same method as the synthesis of compound H1, except that intermediate H2-2 was used instead of intermediate A. The produced compound was confirmed through MS/FAB.
계산값: 686.81 측정값: 686.22
Calculated value: 686.81 Measured value: 686.22
합성예 3: 화합물 H3의 합성Synthesis Example 3: Synthesis of Compound H3
중간체 B의 합성Synthesis of Intermediate B
하기 반응식 3-1에 따라 중간체 B를 합성하였다:Intermediate B was synthesized according to Scheme 3-1 below:
<반응식 3-1><Scheme 3-1>
(1) 중간체 B-1의 합성(1) Synthesis of intermediate B-1
아르곤 분위기 하에서, (2,3-bis (methylthio) naphthalen-1-yl) boronic acid 25.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL, 2M sodium carbonate solution 150mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후 물층을 제거하고 유기층을 포화 식염수로 세척 하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 B-1 24.5g (수율: 82.1 %)을 얻었다.
Under argon atmosphere, (2,3-bis (methylthio) naphthalen-1-yl) boronic acid 25.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL, 2M 150 mL of sodium carbonate solution was added to the flask and stirred under reflux while heating for 8 hours. After cooling to room temperature, the water layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO4, concentrated, and the residue was purified by silica gel column chromatography to obtain 24.5g of Intermediate B-1 (yield: 82.1%).
(2) 중간체 B-2의 합성(2) Synthesis of intermediate B-2
아르곤 분위기 하에서, 중간체 B-1 24.5g, 무수 THF 500mL를 플라스크에 투입하고 1.6M n-butyllithium의 hexane 용액 55mL를 첨가하고 반응 용액을 실온에서 4 시간 동안 교반하였다. -78℃까지 냉각하고 trimethyl borate 28.1g의 THF 30mL 용액을 적하했다. 반응 용액을 실온까지 승온시키면서 8 시간 동안 교반하였다. 반응 용액에 10 % HCl 200mL를 더해 2 시간 동안 교반하였다. 반응 용액을 에테르를 사용하여 추출하여 수용액 층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 Mg2So4에서 건조시킨 후 농축하고 잔류물을 hexane으로 세척하고 중간체 B-2 17.7g (수율: 63.4%)를 얻었다.
Under an argon atmosphere, 24.5 g of Intermediate B-1 and 500 mL of anhydrous THF were added to the flask, 55 mL of a 1.6 M n-butyllithium hexane solution was added, and the reaction solution was stirred at room temperature for 4 hours. It was cooled to -78°C, and 30 mL of a solution of 28.1 g of trimethyl borate in THF was added dropwise. The reaction solution was stirred for 8 hours while raising the temperature to room temperature. 200 mL of 10% HCl was added to the reaction solution and stirred for 2 hours. The reaction solution was extracted with ether, the aqueous layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over Mg 2 So 4 and concentrated, and the residue was washed with hexane to obtain 17.7 g of intermediate B-2 (yield: 63.4%).
(3) 중간체 B-3의 합성(3) Synthesis of intermediate B-3
아르곤 분위기 하에서 (4- (2-fluorophenyl) -2,3-bis (methylthio) naphthalen-1-yl) boronic acid 17.7g, Tetrakis (triphenylphosphine) palladium (0) 1.28g, toluene 180mL, 2M sodium carbonate solution 90mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반 하였다. 실온까지 냉각 후, 반응 용액을 toluene을 이용하여 추출하여 수용액 층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 B-3 18.3g (수율: 76.2 %)을 얻었다.
Under argon atmosphere, (4- (2-fluorophenyl) -2,3-bis (methylthio) naphthalen-1-yl) boronic acid 17.7g, Tetrakis (triphenylphosphine) palladium (0) 1.28g, toluene 180mL, 2M sodium carbonate solution 90mL was added to the flask and stirred under reflux while heating for 8 hours. After cooling to room temperature, the reaction solution was extracted using toluene, the aqueous solution layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 18.3 g of intermediate B-3 (yield: 76.2%).
(4) 중간체 B-4의 합성(4) Synthesis of intermediate B-4
중간체 B-3 18.3g, dichloromethane (탈수) 250mL를 플라스크에 넣고 0℃로 냉각하였다. BBr3 27.5g을 가한 후 실온에서 24 시간 동안 교반하였다. 반응 종료 후, 용액을 -78 ℃로 냉각하고 methanol에서 신중하게 불활성화하고, 충분한 양의 물로 불활성화하였다. 용액을 분액 깔때기에 옮기고 dichloromethane으로 추출하고 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하고 얻어진 시료를 진공 건조하여 중간체 B-4 17.2g (수율: 99.5 %)을 얻었다.
18.3 g of Intermediate B-3 and 250 mL of dichloromethane (dehydrated) were added to the flask and cooled to 0°C. 27.5 g of BBr 3 was added and stirred at room temperature for 24 hours. After completion of the reaction, the solution was cooled to -78 °C and carefully inactivated in methanol and inactivated with a sufficient amount of water. The solution was transferred to a separatory funnel, extracted with dichloromethane, dried with MgSO 4 , then impurities of origin were removed through a silica gel short column, the solution was concentrated, and the obtained sample was vacuum dried to obtain 17.2 g of intermediate B-4 (yield: 99.5%). .
(5) 중간체 B의 합성(5) Synthesis of intermediate B
중간체 B-4 17.2g, N-methyl-2-pyrrolidinone (dehydrated) 300mL, K2CO3 24.2g을 플라스크에 가한 후 200 ℃에서 2 시간 동안 교반하였다. 반응 종료 후, 용액을 실온까지 냉각하고, Toluene 2L를 추가 분액 깔때기에 옮기고 물로 세척했다. 이 용액을 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하고, toluene/methanol 혼합 용매에서 재결정하여 중간체 B 10.1g (수율: 64.3 %)을 얻었다.
17.2 g of Intermediate B-4, 300 mL of N-methyl-2-pyrrolidinone (dehydrated), and 24.2 g of K2CO3 were added to the flask and stirred at 200°C for 2 hours. After completion of the reaction, the solution was cooled to room temperature, 2L of Toluene was transferred to an additional separatory funnel, and the solution was washed with water. After drying this solution with MgSO4, origin impurities were removed through a silica gel short column, the solution was concentrated, and recrystallized in a toluene/methanol mixed solvent to obtain 10.1 g of intermediate B (yield: 64.3%).
화합물 H3의 합성Synthesis of compound H3
하기 반응식 3-2에 따라 화합물 H3를 합성하였다:Compound H3 was synthesized according to Scheme 3-2 below:
<반응식 3-2><Scheme 3-2>
(1) 중간체 H3-1의 합성(1) Synthesis of intermediate H3-1
중간체 B 10.1g 및 테트라하이드로푸란 (탈수) 500mL를 플라스크에 투입하고 -78℃로 냉각했다. 여기에 n-BuLi (1.6M in hexane) 66mL을 넣고 0℃까지 승온시키면서 2 시간 동안 교반하였다. 이어서, 다시 -78 ℃로 냉각하고, B(OMe)3 327.5g을 넣고 -78 ℃에서 10 분간 교반한 후 실온에서 5 시간 동안 교반하였다. 반응 종료 후 1N HCl aq. 200mL를 첨가하여 실온에서 1 시간 동안 교반하였다. 그 후 분액 깔때기에 옮기고 에틸 아세테이트로 추출하였다. 이 용액을 MgSO4로 건조한 후 농축하고 n- 헥산으로 세척하고 중간체 H3-1 5.9g (수율: 64.1 %)을 얻었다.
10.1 g of Intermediate B and 500 mL of tetrahydrofuran (dehydrated) were added to the flask and cooled to -78°C. 66mL of n-BuLi (1.6M in hexane) was added thereto and stirred for 2 hours while raising the temperature to 0°C. Then, it was cooled again to -78°C, 327.5 g of B(OMe) 3 was added, and the mixture was stirred at -78°C for 10 minutes and then stirred at room temperature for 5 hours. After completion of the reaction, 1N HCl aq. 200 mL was added and stirred at room temperature for 1 hour. Afterwards, it was transferred to a separatory funnel and extracted with ethyl acetate. This solution was dried over MgSO 4 , concentrated, and washed with n-hexane to obtain 5.9 g of intermediate H3-1 (yield: 64.1%).
(2) 중간체 H3-2의 합성(2) Synthesis of intermediate H3-2
아르곤 분위기 하에서, 중간체 H3-1 5.9g, 1-bromo-4-iodobenzene 4.2g, Tetrakis (triphenylphosphine) palladium(0) 0.8g, 톨루엔 200mL, 2M sodium carbonate solution 100mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후, 반응 용액을 톨루엔으로 추출하였다. 물층을 제거하고 유기층을 MgSO4로 건조시킨 후 농축하였다. 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 H3-2 6.0g (수율: 71.6%)을 얻었다.
Under argon atmosphere, 5.9g of intermediate H3-1, 4.2g of 1-bromo-4-iodobenzene, 0.8g of Tetrakis (triphenylphosphine) palladium(0), 200mL of toluene, and 100mL of 2M sodium carbonate solution were added to the flask and heated for 8 hours. It was refluxed and stirred. After cooling to room temperature, the reaction solution was extracted with toluene. The water layer was removed, and the organic layer was dried with MgSO 4 and concentrated. The residue was purified by silica gel column chromatography to obtain 6.0 g of intermediate H3-2 (yield: 71.6%).
(3) 화합물 H3의 합성(3) Synthesis of compound H3
중간체 A 대신 중간체 H3-2를 사용하였다는 점을 제외하고는, 상기 화합물 H1의 합성과 동일한 방법을 이용하여 화합물 H3 5.1g (수율: 63.8%)를 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.5.1 g of compound H3 (yield: 63.8%) was obtained using the same method as the synthesis of compound H1, except that intermediate H3-2 was used instead of intermediate A. The produced compound was confirmed through MS/FAB.
계산값: 718.93 측정값: 718.18
Calculated value: 718.93 Measured value: 718.18
합성예 4: 화합물 H4의 합성Synthesis Example 4: Synthesis of Compound H4
하기 반응식 4에 따라 화합물 H4를 합성하였다:Compound H4 was synthesized according to Scheme 4 below:
<반응식 4><Scheme 4>
(1) 중간체 H4-2의 합성(1) Synthesis of intermediate H4-2
1-bromo-4-iodobenzene 대신 1-bromo-3-iodobenzene을 사용하고, (사용하였다는 점을 제외하고는 중간체 H2-2의 합성과 동일한 방법을 이용하여 중간체 H4-2 23.5g (수율: 70.6%)을 얻었다.
23.5g of intermediate H4-2 (yield: 70.6 %) was obtained.
(2) 화합물 H4의 합성 (2) Synthesis of compound H4
중간체 A 대신 중간체 H4-2를 사용하고, 10-(naphthalen-2-yl) anthracen-9-yl) boronic acid 대신에 (10-phenylanthracen-9-yl) boronic acid를 사용하였다는 점을 제외하고는, 상기 화합물 H1의 합성과 동일한 방법을 이용하여 화합물 H4 18.9g (수율: 64.3%)를 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.Except that intermediate H4-2 was used instead of intermediate A, and (10-phenylanthracen-9-yl) boronic acid was used instead of 10-(naphthalen-2-yl) anthracen-9-yl) boronic acid. , 18.9g of compound H4 (yield: 64.3%) was obtained using the same method as the synthesis of compound H1. The produced compound was confirmed through MS/FAB.
계산값: 636.21, 측정값: 636.75
Calculated value: 636.21, Measured value: 636.75
합성예 5: 화합물 H5의 합성Synthesis Example 5: Synthesis of Compound H5
중간체 C의 합성Synthesis of Intermediate C
하기 반응식 5-1에 따라 중간체 C를 합성하였다:Intermediate C was synthesized according to Scheme 5-1 below:
(1) 중간체 C-1의 합성(1) Synthesis of intermediate C-1
아르곤 분위기 하에서 5-iodonaphtho [2,1-b] benzofuran 10.3g (5-bromo-2- (ethoxycarbonyl) phenyl) boronic acid 8.2g, Tetrakis (triphenylphosphine) palladium (0) 0.4g, 2M 탄산나트륨 수용액 30mL 및 톨루엔 60mL의 혼합물을 8 시간 동안 가열하면서 환류했다. 얻어진 혼합물을 실온으로 냉각하고 톨루엔으로 추출하고 유기층을 포화 식염수로 세척한 후 무수 황산나트륨으로 건조시키고 용매를 감압 증류했다. 얻어진 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 C-1 8.8g (수율: 66.2 %) 얻었다.
Under argon atmosphere, 10.3 g of 5-iodonaphtho [2,1-b] benzofuran (5-bromo-2- (ethoxycarbonyl) phenyl) boronic acid 8.2 g, Tetrakis (triphenylphosphine) palladium (0) 0.4 g, 30 mL of 2M sodium carbonate aqueous solution and toluene. 60 mL of the mixture was heated to reflux for 8 hours. The resulting mixture was cooled to room temperature, extracted with toluene, and the organic layer was washed with saturated saline solution, dried over anhydrous sodium sulfate, and the solvent was distilled under reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain 8.8 g of intermediate C-1 (yield: 66.2%).
(2) 중간체 C-2의 합성(2) Synthesis of intermediate C-2
아르곤 분위기 하에서 중간체 C-1 8.8g의 테트라 히드로 푸란 90mL 용액에 빙냉 하에서 1M 브롬화 메틸 마그네슘 테트라히드로푸란 용액 30mL를 가한 후 실온에서 5 시간 동안 교반하였다. 반응 용액에 빙냉 하에서 물을 첨가하고 톨루엔으로 추출하고 유기층을 포화 식염수로 세정한 후, 무수 황산나트륨으로 건조시키고 용매를 감압 증류했다. 얻어진 잔류물을 실리카겔 컬럼 크로마토 그래피로 정제하여 중간체 C-2 6.3g (수율: 74.1 %) 얻었다.
Under an argon atmosphere, 30 mL of 1 M methyl magnesium bromide tetrahydrofuran solution was added to 90 mL of tetrahydrofuran solution of 8.8 g of intermediate C-1 under ice cooling, and then stirred at room temperature for 5 hours. Water was added to the reaction solution under ice cooling, extracted with toluene, and the organic layer was washed with saturated saline solution, dried over anhydrous sodium sulfate, and the solvent was distilled under reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain 6.3g of intermediate C-2 (yield: 74.1%).
(3) 중간체 C의 합성(3) Synthesis of intermediate C
중간체 C-2 6.3g의 아세트산 70mL 용액에 황산 0.7mL를 적하하여 50℃에서 8 시간 동안 교반을 실시했다. 얻어진 혼합물을 실온으로 냉각하고 톨루엔 및 물을 가하여 분액하고, 톨루엔 층을 물과 포화 식염수로 세척하고 무수 황산나트륨으로 건조하고 용매를 감압 증류했다. 얻어진 잔류물을 크로마토 그래피로 정제하여 중간체 C를 2.1g (수율: 34.6 %) 얻었다
0.7 mL of sulfuric acid was added dropwise to a solution of 6.3 g of Intermediate C-2 in 70 mL of acetic acid, and the mixture was stirred at 50°C for 8 hours. The resulting mixture was cooled to room temperature and toluene and water were added to separate the layers. The toluene layer was washed with water and saturated saline solution, dried over anhydrous sodium sulfate, and the solvent was distilled under reduced pressure. The obtained residue was purified by chromatography to obtain 2.1g of intermediate C (yield: 34.6%).
화합물 H5의 합성Synthesis of compound H5
하기 반응식 5-2에 따라 화합물 H5를 합성하였다:Compound H5 was synthesized according to Scheme 5-2 below:
<반응식 5-2><Scheme 5-2>
중간체 A 대신 중간체 C를 사용하고, 10-(naphthalen-2-yl) anthracen-9-yl) boronic acid 대신에 (10-phenylanthracen-9-yl) boronic acid를 사용하였다는 점을 제외하고는, 상기 화합물 H1의 합성과 동일한 방법을 이용하여 화합물 H5 2.2g (수율: 62.4%)를 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.Except that intermediate C was used instead of intermediate A, and (10-phenylanthracen-9-yl) boronic acid was used instead of 10-(naphthalen-2-yl) anthracen-9-yl) boronic acid. 2.2g of compound H5 (yield: 62.4%) was obtained using the same method as the synthesis of compound H1. The produced compound was confirmed through MS/FAB.
계산값: 712.89, 측정값: 712.28
Calculated value: 712.89, Measured value: 712.28
합성예 6: 화합물 H6의 합성Synthesis Example 6: Synthesis of Compound H6
중간체 D의 합성Synthesis of Intermediate D
하기 반응식 6-1에 따라 중간체 B를 합성하였다:Intermediate B was synthesized according to Scheme 6-1 below:
<반응식 2-1><Scheme 2-1>
(1) 중간체 D-1의 합성(1) Synthesis of intermediate D-1
아르곤 분위기 하에서, (1,6-dimethoxynaphthalen-2-yl) boronic acid 32.4g, 1-bromo-2-fluorobenzene 17.6g, tetrakistriphenylphosphine palladium (0) 2.34g, 1,2-dimethoxyethane 300mL 및 2M sodium carbonate solution 150mL를 플라스크에 투입하고 8 시간 가열하고 환류 교반하였다. 실온까지 냉각한 후 수용액 층을 제거하고 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 D-1 53.9g (수율: 84.8 %)을 얻었다.
Under argon atmosphere, (1,6-dimethoxynaphthalen-2-yl) boronic acid 32.4g, 1-bromo-2-fluorobenzene 17.6g, tetrakistriphenylphosphine palladium (0) 2.34g, 1,2-dimethoxyethane 300mL and 2M sodium carbonate solution 150mL was added to the flask, heated for 8 hours, and stirred under reflux. After cooling to room temperature, the aqueous solution layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 53.9 g of intermediate D-1 (yield: 84.8 %).
(2) 중간체 D-2의 합성(2) Synthesis of intermediate D-2
아르곤 분위기 하에서 중간체 D-1 53.9g, 무수 THF500mL을 플라스크에 투입하고 1.6M n-butyllithium의 hexane 용액 55mL를 첨가하고 반응 용액을 실온 에서 4 시간 동안 교반 하였다. -78 ℃까지 냉각하고 trimethyl borate 28.1g의 THF 30mL 용액을 적하했다. 반응 용액을 실온까지 승온시키면서 8 시간 동안 교반하였다. 반응 용액에 10 % HCl 200mL를 가한 후 2 시간 동안 교반하였다. 반응 용액을 에테르를 사용하여 추출하여 수용액 층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 Mg2SO4에서 건조시킨 후 농축하고 잔류물을 hexane으로 세척하고 중간체 D-2 25.1g (수율: 64.9%)을 얻었다.
Under an argon atmosphere, 53.9 g of intermediate D-1 and 500 mL of anhydrous THF were added to the flask, 55 mL of a 1.6 M n-butyllithium hexane solution was added, and the reaction solution was stirred at room temperature for 4 hours. It was cooled to -78°C, and 30 mL of THF solution containing 28.1 g of trimethyl borate was added dropwise. The reaction solution was stirred for 8 hours while raising the temperature to room temperature. 200 mL of 10% HCl was added to the reaction solution and stirred for 2 hours. The reaction solution was extracted with ether, the aqueous layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over Mg 2 SO 4 and concentrated, and the residue was washed with hexane to obtain 25.1 g of intermediate D-2 (yield: 64.9%).
(3) 중간체 D-3의 합성(3) Synthesis of intermediate D-3
아르곤 분위기 하에서 중간체 D-2 25.1g, 4-bromo-1-fluoro-2-iodobenzene 16.5g, Tetrakis (triphenylphosphine) palladium (0) 1.28g, toluene 180mL, 2M sodium carbonate solution 95mL를 플라스크에 투입하고 8 시간 동안 가열하고 환류 교반하였다. 실온까지 냉각한 후, 반응 용액을 toluene을 이용하여 추출하여 수용액 층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류 물을 실리카겔 컬럼 크로마토로 정제하여 중간체 D-3 16.5g (수율: 79.8 %)를 얻었다.
Under an argon atmosphere, 25.1 g of intermediate D-2, 16.5 g of 4-bromo-1-fluoro-2-iodobenzene, 1.28 g of Tetrakis (triphenylphosphine) palladium (0), 180 mL of toluene, and 95 mL of 2M sodium carbonate solution were added to the flask and incubated for 8 hours. It was heated and stirred under reflux. After cooling to room temperature, the reaction solution was extracted using toluene, the aqueous solution layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 16.5 g of intermediate D-3 (yield: 79.8%).
(4) 중간체 D-4의 합성(4) Synthesis of intermediate D-4
중간체 D-3 16.5g, N, N-dimethylformamide 480mL를 플라스크에 투입하고 N-bromosuccinimide 6.4g의 N, N-dimethylformamide 20mL 용액을 첨가했다. 반응 용액을 40 ℃에서 5 시간 동안 교반을 계속하였다. N-bromosuccinimide을 2.2g 더 첨가하고 50 ℃에서 8 시간 동안 교반을 계속하였다. 실온까지 냉각한 후 물 300mL를 가한 후, 반응 용액을 toluene을 이용하여 추출하여 수용액 층을 제거한 후 포화 식염수(sodium thiosulfate)로 순차적으로 세정하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 D-4 19.5g (수율: 97.9 %) 을 얻었다.
16.5 g of intermediate D-3 and 480 mL of N, N-dimethylformamide were added to the flask, and 20 mL of N, N-dimethylformamide solution containing 6.4 g of N-bromosuccinimide was added. Stirring of the reaction solution was continued at 40°C for 5 hours. An additional 2.2 g of N-bromosuccinimide was added, and stirring was continued at 50°C for 8 hours. After cooling to room temperature and adding 300 mL of water, the reaction solution was extracted using toluene to remove the aqueous solution layer, and then sequentially washed with saturated saline solution (sodium thiosulfate). The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 19.5 g of intermediate D-4 (yield: 97.9%).
(5) 중간체 D-5의 합성(5) Synthesis of intermediate D-5
아르곤 분위기 하에서 중간체 D-4 19.5g, dichloromethane (탈수) 300mL를 플라스크에 투입하고 교반하면서 -78 ℃까지 냉각하고 1M boron tribromide (BBr3)의 dichloromethane 용액 90mL를 가했다. 반응 용액을 실온까지 승온시키면서 3 시간 동안 교반을 계속하였다. 반응 용액을 빙냉하고 물 150mL를 가했다. 수용액 층을 제거한 후 유기층을 MgSO4로 건조시켰다. 유기층을 농축한 후 잔류물을 실리카겔 쇼트 컬럼으로 정제하여 중간체 D-5 17.2g (수율: 94.0 %)을 얻었다.
Under an argon atmosphere, 19.5 g of intermediate D-4 and 300 mL of dichloromethane (dehydrated) were added to the flask, cooled to -78°C while stirring, and 90 mL of a 1M boron tribromide (BBr 3 ) dichloromethane solution was added. Stirring was continued for 3 hours while heating the reaction solution to room temperature. The reaction solution was ice-cooled and 150 mL of water was added. After removing the aqueous solution layer, the organic layer was dried with MgSO 4 . After concentrating the organic layer, the residue was purified using a silica gel short column to obtain 17.2g of intermediate D-5 (yield: 94.0%).
(6) 중간체 D의 합성(6) Synthesis of intermediate D
중간체 D-5 17.2g, N-methyl-2-pyrrolidinone (dehydrated) 300mL, K2CO3 24.2g을 플라스크에 가한 후 200 ℃에서 2 시간 동안 교반하였다. 반응 종료 후, 용액을 실온까지 냉각하고, Toluene 2L를 가한 후 분액 깔때기에 옮기고 물로 세척하였다. 이 용액을 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축한 후, toluene/methanol 혼합 용매에서 재결정하여 중간체 D 1.7g (수율: 10.8 %)을 얻었다.
17.2 g of intermediate D-5, 300 mL of N-methyl-2-pyrrolidinone (dehydrated), and 24.2 g of K2CO3 were added to the flask and stirred at 200°C for 2 hours. After completion of the reaction, the solution was cooled to room temperature, 2L of toluene was added, and the solution was transferred to a separatory funnel and washed with water. After drying this solution with MgSO 4 , origin impurities were removed through a silica gel short column, the solution was concentrated, and recrystallized in a toluene/methanol mixed solvent to obtain 1.7 g of intermediate D (yield: 10.8%).
화합물 H6의 합성Synthesis of compound H6
하기 반응식 6-2에 따라 화합물 H6를 합성하였다:Compound H6 was synthesized according to Scheme 6-2 below:
<반응식 6-2><Scheme 6-2>
중간체 A 대신 중간체 D를 사용하고, 10-(naphthalen-2-yl) anthracen-9-yl) boronic acid 대신에 (10-(4-(dibenzo [b, d] furan-2-yl) naphthalen-1-yl) anthracen-9-yl) boronic acid를 사용하였다는 점을 제외하고는, 상기 화합물 H1의 합성과 동일한 방법을 이용하여 화합물 H6 2.2g (수율: 61.7%)를 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.Use intermediate D instead of intermediate A, and (10-(4-(dibenzo [b, d] furan-2-yl)naphthalen-1 instead of 10-(naphthalen-2-yl)anthracen-9-yl)boronic acid. Compound H6 2.2g (yield: 61.7%) was obtained using the same method as the synthesis of compound H1, except that -yl) anthracen-9-yl) boronic acid was used. The produced compound was confirmed through MS/FAB.
계산값: 718.93, 측정값: 718.18
Calculated value: 718.93, Measured value: 718.18
합성예 7: 화합물 H7의 합성Synthesis Example 7: Synthesis of Compound H7
중간체 E의 합성Synthesis of intermediate E
하기 반응식 7-1에 따라 중간체 E를 합성하였다:Intermediate E was synthesized according to Scheme 7-1 below:
(1) 중간체 E-1의 합성(1) Synthesis of intermediate E-1
아르곤 분위기 하에서, (3,5-dimethoxynaphthalen-2-yl) boronic acid 22.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL, 2M sodium carbonate solution 150mL 를 플라스크에 투입하고 8 시간 동안 가열 환류 교반 하였다. 실온까지 냉각한 후 수용액 층을 제거하고 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 E-1 22.4g (수율 83.6 %)을 얻었다.
Under argon atmosphere, (3,5-dimethoxynaphthalen-2-yl) boronic acid 22.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL, 2M sodium carbonate solution 150mL was added to the flask and heated, refluxed, and stirred for 8 hours. After cooling to room temperature, the aqueous solution layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 22.4 g of intermediate E-1 (yield 83.6%).
(2) 중간체 E-2의 합성(2) Synthesis of intermediate E-2
아르곤 분위기 하에서 중간체 E-1 22.4g, 무수 THF 500mL를 플라스크에 투입하고 1.6M n-butyllithium의 hexane 용액 55mL를 첨가하고 반응 용액을 실온에서 4 시간 교반하였다. -78 ℃까지 냉각하고 trimethyl borate 28.2g의 THF 30mL 용액을 적하했다. 반응 용액을 실온까지 승온시키면서 8 시간 동안 교반하였다. 반응 용액에 10 % HCL 200mL를 더해 2 시간 동안 교반하였다. 반응 용액을 ether를 사용하여 추출하여 수층을 제거한 후 유기층을 포화 식염수로 세척 하였다. 유기층을 Mg2SO4에서 건조시킨 후 농축하고 잔류물을 hexane으로 세척하고 중간체 E-2 16.9g (수율: 65.2 %)을 얻었다.
Under an argon atmosphere, 22.4 g of intermediate E-1 and 500 mL of anhydrous THF were added to the flask, 55 mL of a 1.6 M n-butyllithium hexane solution was added, and the reaction solution was stirred at room temperature for 4 hours. It was cooled to -78°C, and 30 mL of THF solution containing 28.2 g of trimethyl borate was added dropwise. The reaction solution was stirred for 8 hours while raising the temperature to room temperature. 200 mL of 10% HCL was added to the reaction solution and stirred for 2 hours. The reaction solution was extracted using ether, the aqueous layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over Mg 2 SO 4 and concentrated, and the residue was washed with hexane to obtain 16.9 g of intermediate E-2 (yield: 65.2 %).
(3) 중간체 E-3의 합성(3) Synthesis of intermediate E-3
아르곤 분위기 하에서, 중간체 E-2 16.9g, 4-bromo-1-fluoro-2-iodobenzene 16.8g, Tetrakis (triphenylphosphine) palladium (0) 1.28g, toluene 180mL, 2M sodium carbonate solution 90mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후, 반응 용액을 toluene을 이용하여 추출하여 물층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 E-3 18.4g (수율: 78.3 %)를 얻었다.
Under argon atmosphere, 16.9g of intermediate E-2, 16.8g of 4-bromo-1-fluoro-2-iodobenzene, 1.28g of Tetrakis (triphenylphosphine) palladium (0), 180mL of toluene, and 90mL of 2M sodium carbonate solution were added to the flask and added to the flask. It was refluxed and stirred while heating for an hour. After cooling to room temperature, the reaction solution was extracted using toluene, the water layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 18.4 g of intermediate E-3 (yield: 78.3 %).
(4) 중간체 E-4의 합성(4) Synthesis of intermediate E-4
중간체 E-3 18.4g, dichloromethane (탈수) 250mL를 플라스크에 넣고 0℃로 냉각했다. BBr3 27.8g을 가한 후 실온에서 24 시간 동안 교반하였다. 반응 종료 후, 용액을 -78 ℃로 냉각하고 methanol에서 신중하게 불활성화하고, 충분한 양의 물로 불활성화했다. 용액을 분액 깔때기에 옮기고 dichloromethane으로 추출하고 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하여 얻어진 시료를 진공 건조하여 중간체 E-4 17.2g (수율 99.8 %)을 얻었다.
18.4 g of intermediate E-3 and 250 mL of dichloromethane (dehydrated) were added to the flask and cooled to 0°C. 27.8 g of BBr3 was added and stirred at room temperature for 24 hours. After completion of the reaction, the solution was cooled to -78 °C and carefully inactivated in methanol and inactivated with a sufficient amount of water. The solution was transferred to a separatory funnel, extracted with dichloromethane, dried with MgSO 4 , then impurities of origin were removed through a silica gel short column, and the sample obtained by concentrating the solution was vacuum dried to obtain 17.2 g of intermediate E-4 (yield 99.8%).
(5) 중간체 E의 합성(5) Synthesis of intermediate E
중간체 E-4 17.2g, N-methyl-2-pyrrolidinone (dehydrated) 300mL, K2CO3 24.5g을 플라스크에 가한 후 200 ℃에서 2 시간 동안 교반하였다. 반응 종료 후, 용액을 실온까지 냉각하고, Toluene 2L를 추가 분액 깔때기에 옮기고 물로 세척했다. 이 용액을 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하고, toluene / methanol 혼합 용매에서 재결정하여 중간체 E 10.1g (수율: 65.1 %)을 얻었다.
17.2 g of intermediate E-4, 300 mL of N-methyl-2-pyrrolidinone (dehydrated), and 24.5 g of K2CO3 were added to the flask and stirred at 200°C for 2 hours. After completion of the reaction, the solution was cooled to room temperature, 2L of Toluene was transferred to an additional separatory funnel, and the solution was washed with water. After drying this solution with MgSO 4 , origin impurities were removed through a silica gel short column, the solution was concentrated, and recrystallized in a toluene / methanol mixed solvent to obtain 10.1 g of intermediate E (yield: 65.1%).
화합물 H7의 합성Synthesis of compound H7
하기 반응식 7-2에 따라 화합물 H7을 합성하였다:Compound H7 was synthesized according to Scheme 7-2 below:
<반응식 7-2><Scheme 7-2>
(1) 중간체 H7-1의 합성(1) Synthesis of intermediate H7-1
중간체 A 대신 중간체 E를 사용하였다는 점을 제외하고는 중간체 H2-1의 합성과 동일한 방법을 이용하여 중간체 H7-1 6.0g (수율: 65.6%)을 얻었다. 6.0 g (yield: 65.6%) of Intermediate H7-1 was obtained using the same method as the synthesis of Intermediate H2-1, except that Intermediate E was used instead of Intermediate A.
(2) 중간체 H7-2의 합성(2) Synthesis of intermediate H7-2
중간체 H2-1 대신 중간체 H7-1를 사용하였다는 점을 제외하고는 중간체 H7-2의 합성과 동일한 방법을 이용하여 중간체 H7-2 6.1g (수율: 69.9%)을 얻었다.
6.1 g (yield: 69.9%) of Intermediate H7-2 was obtained using the same method as the synthesis of Intermediate H7-2, except that Intermediate H7-1 was used instead of Intermediate H2-1.
(3) 화합물 H7의 합성(3) Synthesis of compound H7
중간체 A 대신 중간체 H7-2를 사용하고, (10- (naphthalen-2-yl) anthracen-9-yl) boronic acid 대신 (10-phenylanthracen-9-yl) boronic acid를 사용하였다는 점을 제외하고는, 상기 화합물 H1의 합성과 동일한 방법을 이용하여 화합물 H7 4.9g (수율: 64.1%)를 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.Except that intermediate H7-2 was used instead of intermediate A, and (10-phenylanthracen-9-yl) boronic acid was used instead of (10- (naphthalen-2-yl) anthracen-9-yl) boronic acid. , 4.9g of compound H7 (yield: 64.1%) was obtained using the same method as the synthesis of compound H1. The produced compound was confirmed through MS/FAB.
계산값: 636.75, 측정값: 636.21
Calculated value: 636.75, Measured value: 636.21
합성예 8: 화합물 H8의 합성Synthesis Example 8: Synthesis of Compound H8
중간체 F의 합성Synthesis of Intermediate F
하기 반응식 8-1에 따라 중간체 F를 합성하였다:Intermediate F was synthesized according to Scheme 8-1 below:
<반응식 8-1>
<Scheme 8-1>
(1) 중간체 F-1의 합성(1) Synthesis of intermediate F-1
아르곤 분위기 하에서, (3,5-bis (methylthio) naphthalen-2-yl) boronic acid 25.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL, 2M sodium carbonate solution 150mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후 수용액 층을 제거하고 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토로 정제하여 중간체 F-1 24.8g (수율 83.3 %)을 얻었다.
Under argon atmosphere, (3,5-bis (methylthio) naphthalen-2-yl) boronic acid 25.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL, 2M 150 mL of sodium carbonate solution was added to the flask and stirred under reflux while heating for 8 hours. After cooling to room temperature, the aqueous solution layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 24.8 g of intermediate F-1 (83.3% yield).
(2) 중간체 F-2의 합성(2) Synthesis of intermediate F-2
아르곤 분위기 하에서 중간체 F-1 24.8g, 무수 THF 500mL를 플라스크에 투입하고 1.6M n-butyllithium의 hexane 용액 55mL를 첨가하고 반응 용액을 실온에서 4 시간 교반하였다. -78 ℃까지 냉각하고 trimethyl borate 27.9g의 THF 30mL 용액을 적하했다. 반응 용액을 실온까지 승온시키면서 8 시간 동안 교반하였다. 반응 용액에 10 % HCl 200mL를 더해 2 시간 동안 교반하였다. 반응 용액을 에테르를 사용하여 추출하여 수용액 층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 Mg2SO4에서 건조시킨 후 농축하고 잔류물을 hexane으로 세척하고 중간체 F-2 18.2g (수율 64.2 %)를 얻었다.
Under an argon atmosphere, 24.8 g of intermediate F-1 and 500 mL of anhydrous THF were added to the flask, 55 mL of a 1.6 M n-butyllithium hexane solution was added, and the reaction solution was stirred at room temperature for 4 hours. It was cooled to -78°C, and 30 mL of THF solution containing 27.9 g of trimethyl borate was added dropwise. The reaction solution was stirred for 8 hours while raising the temperature to room temperature. 200 mL of 10% HCl was added to the reaction solution and stirred for 2 hours. The reaction solution was extracted with ether, the aqueous layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over Mg 2 SO 4 and concentrated, and the residue was washed with hexane to obtain 18.2 g of intermediate F-2 (yield 64.2%).
(3) 중간체 F-3의 합성(3) Synthesis of intermediate F-3
아르곤 분위기 하에서 중간체 F-2 18.2g, 4-bromo-1-fluoro-2-iodobenzene 16.5g, Tetrakis (triphenylphosphine) palladium (0) 1.28g, toluene 180mL, 2M sodium carbonate solution 90mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후, 반응 용액을 toluene을 이용하여 추출하여 수용액 층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 F-3 19.0g (수율 76.8 %)을 얻었다.
Under argon atmosphere, 18.2g of intermediate F-2, 16.5g of 4-bromo-1-fluoro-2-iodobenzene, 1.28g of Tetrakis (triphenylphosphine) palladium (0), 180mL of toluene, and 90mL of 2M sodium carbonate solution were added to the flask and incubated for 8 hours. It was refluxed and stirred while heating. After cooling to room temperature, the reaction solution was extracted using toluene, the aqueous solution layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 19.0 g of intermediate F-3 (yield 76.8%).
(4) 중간체 F-4의 합성(4) Synthesis of intermediate F-4
중간체 F-3 19.0g, dichloromethane (탈수) 250mL를 플라스크에 넣고 0 ℃로 냉각하였다. BBr3 27.5g을 가한 후 실온에서 24 시간 동안 교반하였다. 반응 종료 후, 용액을 -78 ℃로 냉각하고 methanol에서 신중하게 불활성화하고, 충분한 양의 물로 불활성화했다. 용액을 분액 깔때기에 옮기고 dichloromethane으로 추출하고 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하여 얻어진 시료를 진공 건조하여 중간체 F-4 17.9g (수율: 99.8 %)을 얻었다.
19.0 g of intermediate F-3 and 250 mL of dichloromethane (dehydrated) were added to the flask and cooled to 0°C. 27.5 g of BBr3 was added and stirred at room temperature for 24 hours. After completion of the reaction, the solution was cooled to -78 °C and carefully inactivated in methanol and inactivated with a sufficient amount of water. The solution was transferred to a separatory funnel, extracted with dichloromethane, dried with MgSO 4 , then impurities of origin were removed through a silica gel short column, and the sample obtained by concentrating the solution was vacuum dried to obtain 17.9 g of intermediate F-4 (yield: 99.8%). .
(5) 중간체 F의 합성(5) Synthesis of intermediate F
중간체 F-4 10.8g, N-methyl-2-pyrrolidinone (dehydrated) 300mL, K2CO3 24.2g을 플라스크에 가한 후 200℃에서 2 시간 동안 교반하였다. 반응 종료 후, 용액을 실온까지 냉각하고, Toluene 2L를 가한 후 분액 깔때기에 옮기고 물로 세척했다. 이 용액을 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하고, toluene/methanol 혼합 용매에서 재결정하여 중간체 F 10.8g (수율: 66.1 %)을 얻었다.
10.8 g of intermediate F-4, 300 mL of N-methyl-2-pyrrolidinone (dehydrated), and 24.2 g of K2CO3 were added to the flask and stirred at 200°C for 2 hours. After completion of the reaction, the solution was cooled to room temperature, 2L of toluene was added, and the solution was transferred to a separatory funnel and washed with water. After drying this solution with MgSO 4 , origin impurities were removed through a silica gel short column, the solution was concentrated, and recrystallized in a toluene/methanol mixed solvent to obtain 10.8 g of intermediate F (yield: 66.1%).
화합물 H8의 합성Synthesis of compound H8
하기 반응식 8-2에 따라 화합물 H8을 합성하였다:Compound H8 was synthesized according to Scheme 8-2 below:
<반응식 8-2><Scheme 8-2>
(1) 중간체 H8-1의 합성(1) Synthesis of intermediate H8-1
중간체 A 대신 중간체 F를 사용하였다는 점을 제외하고는 중간체 H2-1의 합성과 동일한 방법을 이용하여 중간체 H8-1 6.4g (수율: 64.3%)을 얻었다.
6.4g of Intermediate H8-1 (yield: 64.3%) was obtained using the same method as the synthesis of Intermediate H2-1, except that Intermediate F was used instead of Intermediate A.
(2) 중간체 H8-2의 합성(2) Synthesis of intermediate H8-2
중간체 H2-1 대신 중간체 H7-1를 사용하고, 1-bromo-4-iodobenzene 대신 1-bromo-4-iodonaphthalene을 사용하였다는 점을 제외하고는 중간체 H7-2의 합성과 동일한 방법을 이용하여 중간체 H8-2 7.1g (수율: 71.2%)을 얻었다.
Intermediate H7-1 was used instead of Intermediate H2-1, and 1-bromo-4-iodonaphthalene was used instead of 1-bromo-4-iodobenzene, using the same method as the synthesis of Intermediate H7-2. 7.1g of H8-2 (yield: 71.2%) was obtained.
(3) 화합물 H8의 합성(3) Synthesis of compound H8
중간체 A 대신 중간체 H8-2를 사용하고, (10- (naphthalen-2-yl) anthracen-9-yl) boronic acid 대신 (10-phenylanthracen- 9-yl) boronic acid를 사용하였다는 점을 제외하고는, 상기 화합물 H1의 합성과 동일한 방법을 이용하여 화합물 H7 5.4g (수율: 63.6%)를 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.Except that intermediate H8-2 was used instead of intermediate A, and (10-phenylanthracen-9-yl) boronic acid was used instead of (10- (naphthalen-2-yl) anthracen-9-yl) boronic acid. , 5.4g of compound H7 (yield: 63.6%) was obtained using the same method as the synthesis of compound H1. The produced compound was confirmed through MS/FAB.
계산값: 718.93, 측정값: 718.18
Calculated value: 718.93, Measured value: 718.18
합성예 9: 화합물 H9의 합성Synthesis Example 9: Synthesis of Compound H9
중간체 G의 합성Synthesis of Intermediate G
하기 반응식 9-1에 따라 중간체 G를 합성하였다:Intermediate G was synthesized according to Scheme 9-1 below:
<반응식 9-1><Scheme 9-1>
(1) 중간체 G-1의 합성(1) Synthesis of intermediate G-1
아르곤 분위기 하에서, (1,6-bis (methylthio) naphthalen-2-yl) boronic acid 25.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL, 2M sodium carbonate solution 150mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후 수용액 층을 제거하고 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 G-1 25.4g (수율: 85.2 %)을 얻었다.
Under argon atmosphere, (1,6-bis (methylthio) naphthalen-2-yl) boronic acid 25.0g, 1-bromo-2-fluorobenzene 17.5g, tetrakistriphenylphosphine palladium (0) 2.32g, 1,2-dimethoxyethane 300mL, 2M 150 mL of sodium carbonate solution was added to the flask and stirred under reflux while heating for 8 hours. After cooling to room temperature, the aqueous solution layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO4, concentrated, and the residue was purified by silica gel column chromatography to obtain 25.4g of intermediate G-1 (yield: 85.2%).
(2) 중간체 G-2의 합성(2) Synthesis of intermediate G-2
아르곤 분위기 하에서, 중간체 G-1 25.4g, 무수 THF 500mL를 플라스크에 투입하고 1.6M n-butyllithium의 hexane 용액 55mL를 첨가하고 반응 용액을 실온에서 4 시간 동안 교반하였다. -78℃까지 냉각하고 trimethyl borate 28.2g의 THF 30mL 용액을 적하했다. 반응 용액을 실온까지 승온시키면서 8 시간 동안 교반하였다. 반응 용액에 10 % HCl 200mL를 더해 2 시간 동안 교반하였다. 반응 용액을 에테르를 사용하여 추출하여 수용액 층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 Mg2SO4에서 건조시킨 후 농축하고 잔류물을 hexane으로 세척하고 중간체 G-2 18.8g (수율: 64.8 %)를 얻었다.
Under an argon atmosphere, 25.4 g of intermediate G-1 and 500 mL of anhydrous THF were added to the flask, 55 mL of a 1.6 M n-butyllithium hexane solution was added, and the reaction solution was stirred at room temperature for 4 hours. It was cooled to -78°C, and 30 mL of a solution of 28.2 g of trimethyl borate in THF was added dropwise. The reaction solution was stirred for 8 hours while raising the temperature to room temperature. 200 mL of 10% HCl was added to the reaction solution and stirred for 2 hours. The reaction solution was extracted with ether, the aqueous layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over Mg2SO4, concentrated, and the residue was washed with hexane to obtain 18.8g of intermediate G-2 (yield: 64.8%).
(3) 중간체 G-3의 합성(3) Synthesis of intermediate G-3
아르곤 분위기 하에서 중간체 G-2 18.8g, 4-bromo-1-fluoro-2-iodobenzene 16.5g, Tetrakis (triphenylphosphine) palladium (0) 1.28g, toluene 180mL, 2M sodium carbonate solution 90mL를 플라스크에 투입하고 8 시간 동안 가열하면서 환류 교반하였다. 실온까지 냉각한 후, 반응 용액을 toluene을 이용하여 추출하여 수용액 층을 제거한 후 유기층을 포화 식염수로 세척하였다. 유기층을 MgSO4로 건조시킨 후 농축하고 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 중간체 G-3 19.4g (수율: 76.2 %)을 얻었다.
Under argon atmosphere, 18.8g of intermediate G-2, 16.5g of 4-bromo-1-fluoro-2-iodobenzene, 1.28g of Tetrakis (triphenylphosphine) palladium (0), 180mL of toluene, and 90mL of 2M sodium carbonate solution were added to the flask and incubated for 8 hours. It was refluxed and stirred while heating. After cooling to room temperature, the reaction solution was extracted using toluene, the aqueous solution layer was removed, and the organic layer was washed with saturated saline solution. The organic layer was dried over MgSO 4 and concentrated, and the residue was purified by silica gel column chromatography to obtain 19.4 g of intermediate G-3 (yield: 76.2 %).
(4) 중간체 G-4의 합성(4) Synthesis of intermediate G-4
중간체 G-3 19.4g, dichloromethane (탈수) 250mL를 플라스크에 넣고 0 ℃로 냉각하였다. BBr3 27.5g을 가한 후 실온에서 24 시간 동안 교반하였다. 반응 종료 후, 용액을 -78 ℃로 냉각하고 methanol에서 신중하게 불활성화하고, 충분한 양의 물로 불활성화했다. 용액을 분액 깔때기에 옮기고 dichloromethane으로 추출하고 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하여 얻어진 시료를 진공 건조하여 중간체 G-4 18.2g (수율: 99.5 %)을 얻었다.
19.4 g of intermediate G-3 and 250 mL of dichloromethane (dehydrated) were added to the flask and cooled to 0°C. 27.5 g of BBr3 was added and stirred at room temperature for 24 hours. After completion of the reaction, the solution was cooled to -78 °C and carefully inactivated in methanol and inactivated with a sufficient amount of water. The solution was transferred to a separatory funnel, extracted with dichloromethane, dried with MgSO 4 , then impurities of origin were removed through a silica gel short column, and the sample obtained by concentrating the solution was vacuum dried to obtain 18.2 g of intermediate G-4 (yield: 99.5%). .
(5) 중간체 G의 합성(5) Synthesis of intermediate G
중간체 G-4 18.2g, N-methyl-2-pyrrolidinone (dehydrated) 300mL, K2CO3 24.2g을 플라스크에 가한 후 200 ℃에서 2 시간 동안 교반하였다. 반응 종료 후, 용액을 실온까지 냉각하고, Toluene 2L를 추가한 후 분액 깔때기에 옮기고 물로 세척했다. 이 용액을 MgSO4로 건조한 후 실리카겔 쇼트 칼럼을 통해 원점 불순물을 제거하고, 용액을 농축하고, toluene/methanol 혼합 용매에서 재결정하여 중간체 G 11. 2g (수율: 67.3 %)를 얻었다.
18.2 g of intermediate G-4, 300 mL of N-methyl-2-pyrrolidinone (dehydrated), and 24.2 g of K2CO3 were added to the flask and stirred at 200°C for 2 hours. After completion of the reaction, the solution was cooled to room temperature, 2L of toluene was added, and the solution was transferred to a separatory funnel and washed with water. After drying this solution with MgSO4, origin impurities were removed through a silica gel short column, the solution was concentrated, and recrystallized in a toluene/methanol mixed solvent to obtain 11.2g of intermediate G (yield: 67.3%).
화합물 H9의 합성Synthesis of compound H9
하기 반응식 8-2에 따라 화합물 H9를 합성하였다:Compound H9 was synthesized according to Scheme 8-2 below:
<반응식 8-2><Scheme 8-2>
중간체 A 대신 중간체 G를 사용하고, 10-(naphthalen-2-yl) anthracen-9-yl) boronic acid 대신에 (10- (9 9-dimethyl-9H-fluoren-3-yl) anthracen-9-yl) boronic acid를 사용하였다는 점을 제외하고는, 상기 화합물 H1의 합성과 동일한 방법을 이용하여 화합물 H9 12.0g (수율: 62.6%)를 얻었다. 생성된 화합물을 MS/FAB을 통하여 확인하였다.Use intermediate G instead of intermediate A, and (10-(9-dimethyl-9H-fluoren-3-yl)anthracen-9-yl instead of 10-(naphthalen-2-yl)anthracen-9-yl)boronic acid. ) 12.0g of compound H9 (yield: 62.6%) was obtained using the same method as the synthesis of compound H1, except that boronic acid was used. The produced compound was confirmed through MS/FAB.
계산값: 708.94, 측정값: 708.19
Calculated value: 708.94, Measured value: 708.19
실시예 1Example 1
기판 및 애노드로서 코닝(corning) 15Ω/cm2 (1200Å) ITO 유리 기판을 50mm x 50mm x 0.7mm크기로 잘라서 이소프로필 알코올과 순수를 이용하여 각 5분 동안 초음파 세정한 후, 30분 동안 자외선을 조사하고 오존에 노출시켜 세정하고 진공증착장치에 이 유리기판을 설치하였다. As a substrate and anode, a corning 15Ω/cm 2 (1200Å) ITO glass substrate was cut into 50mm After irradiation and cleaning by exposure to ozone, this glass substrate was installed in a vacuum deposition apparatus.
상기 ITO 애노드 상부에 HT13을 진공 증착하여 500Å 두께의 정공 주입층을 형성하고, 상기 정공 주입층 상부에 HT3을 진공 증착하여 450Å 두께의 정공 수송층을 형성하였다. HT13 was vacuum deposited on top of the ITO anode to form a hole injection layer with a thickness of 500 Å, and HT3 was vacuum deposited on top of the hole injection layer to form a hole transport layer with a thickness of 450 Å.
상기 정공 수송층 상부에 화합물 H1(호스트) 및 FD1(도펀트)를 중량비 95 : 5로 공증착하여 30nm 두께의 발광층을 형성하였다. Compound H1 (host) and FD1 (dopant) were co-deposited on the top of the hole transport layer at a weight ratio of 95:5 to form a 30 nm thick light emitting layer.
상기 발광층 상부에 화합물 ET1을 증착하여 250Å 두께의 전자 수송층을 형성하고, 상기 전자 수송층 상부에 LiF를 증착하여 5Å 두께의 전자 주입층을 형성하고, 상기 전자 주입층 상부에 Al를 진공 증착하여 1500Å 두께의 캐소드를 형성하여, 유기 발광 소자를 제작하였다. Compound ET1 was deposited on top of the light emitting layer to form a 250Å thick electron transport layer, LiF was deposited on top of the electron transport layer to form a 5Å thick electron injection layer, and Al was vacuum deposited on top of the electron injection layer to form a 1500Å thick electron injection layer. An organic light-emitting device was manufactured by forming a cathode.
실시예 2 내지 9 및 비교예 1 내지 5Examples 2 to 9 and Comparative Examples 1 to 5
발광층 형성시 호스트로서 화합물 H1 대신 표 2에 기재된 화합물을 각각 사용하였다는 점을 제외하고는, 상기 실시예 1과 동일한 방법을 이용하여 유기 발광 소자를 제작하였다.
An organic light-emitting device was manufactured using the same method as Example 1, except that the compounds listed in Table 2 were used as the host instead of compound H1 when forming the light-emitting layer.
평가예 1Evaluation example 1
(구동 전압의 측정)(Measurement of driving voltage)
상기 실시예 1 내지 9 및 비교예 1 내지 5에서 제작된 유기 발광 소자의 효율을 10 mA/cm2의 전류 밀도에서 Kethley SMU 236을 이용하여 측정하고, 그 결과를 표 2에 나타내었다.
The efficiency of the organic light emitting devices manufactured in Examples 1 to 9 and Comparative Examples 1 to 5 was measured using Kethley SMU 236 at a current density of 10 mA/cm 2 , and the results are shown in Table 2.
(반감 수명의 측정)(Measurement of half-life)
상기 실시예 1 내지 9 및 비교예 1 내지 5에서 제작된 유기 발광 소자의 반감 수명을 50 mA/cm2의 전류 밀도에서 휘도계 PR650을 이용하여 측정하고, 그 결과를 표 2에 나타내었다. 반감 수명은, 유기 발광 소자 구동 후 휘도가 초기 휘도의 80%가 되는데 걸리는 시간을 측정한 것이다.The half lifespan of the organic light emitting devices manufactured in Examples 1 to 9 and Comparative Examples 1 to 5 was measured using a luminance meter PR650 at a current density of 50 mA/cm 2 , and the results are shown in Table 2. The half life is a measure of the time it takes for the luminance to reach 80% of the initial luminance after driving the organic light emitting device.
(cd/A)efficiency
(cd/A)
(hr)Half life (T80)
(hr)
상기 표 2로부터 실시예 1 내지 9의 유기 발광 소자의 효율 및 반감 수명은 비교예 1 내지 5의 유기 발광 소자의 효율 및 반감 수명에 비하여 우수함을 확인할 수 있다. From Table 2, it can be seen that the efficiency and half-life of the organic light-emitting devices of Examples 1 to 9 are superior to those of the organic light-emitting devices of Comparative Examples 1 to 5.
10: 유기 발광 소자
110: 제1전극
150: 유기층
190: 제2전극10: Organic light emitting device
110: first electrode
150: Organic layer
190: second electrode
Claims (20)
<화학식 1>
<화학식 2A>
<화학식 2B>
<화학식 2C>
<화학식 10>
상기 화학식 1, 2A 내지 2C 및 10 중,
A1은 상기 화학식 2A 내지 2C로 표시되는 그룹 중에서 선택되고, n1은 1 내지 3의 정수 중에서 선택되고,
X1은 O, S 및 C(R14)(R15) 중에서 선택되고,
B2 고리, B3 고리 및 B4 고리는 서로 축합되어 있고,
B1 고리 및 B4 고리는 서로 독립적으로, C6-C60 방향족 고리 및 C1-C60헤테로방향족 고리 중에서 선택되고,
B2 고리는 C7-C60방향족 고리 및 C1-C60 헤테로방향족 고리 중에서 선택되고,
B3 고리는 상기 화학식 10로 표시되되, X2는 O, S 및 C(R16)(R17) 중에서 선택되고,
L1, L2는 서로 독립적으로, 페닐렌기(phenylene), 펜탈레닐렌기(pentalenylene), 인데닐렌기(indenylene), 나프틸렌기(naphthylene), 아줄레닐렌기(azulenylene), 헵탈레닐렌기(heptalenylene), 인다세닐렌기(indacenylene), 아세나프틸렌기(acenaphthylene), 플루오레닐렌기(fluorenylene), 스파이로-플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페날레닐렌기(phenalenylene), 페난트레닐렌기(phenanthrenylene), 안트라세닐렌기(anthracenylene), 플루오란테닐렌기(fluoranthenylene), 트리페닐레닐렌기(triphenylenylene), 파이레닐렌기(pyrenylene), 크라이세닐렌기(chrysenylene), 나프타세닐렌기(naphthacenylene), 피세닐렌기(picenylene), 페릴레닐렌기(perylenylene), 펜타페닐렌기(pentaphenylene), 헥사세닐렌기(hexacenylene), 펜타세닐렌기(pentacenylene), 루비세닐렌기(rubicenylene), 코로네닐렌기(coronenylene) 및 오발레닐기렌기(ovalenylene); 및
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴기레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 이소인돌일기, 인돌일기, 인다졸일기, 푸리닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 카바졸일기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 트리아졸일기, 테트라졸일기, 옥사디아졸일기, 트리아지닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 티아디아졸일기, 이미다조피리디닐기, 이미다조피리미디닐기 및 -Si(Q31)(Q32)(Q33) 중에서 선택된 적어도 하나로 치환된, 페닐렌기, 펜탈레닐렌기, 인데닐렌기, 나프틸렌기, 아줄레닐렌기, 헵탈레닐렌기, 인다세닐렌기, 아세나프틸렌기, 플루오레닐렌기, 스파이로-플루오레닐렌기, 벤조플루오레닐렌기, 디벤조플루오레닐렌기, 페날레닐렌기, 페난트레닐렌기, 안트라세닐렌기, 플루오란테닐렌기, 트리페닐레닐렌기, 파이레닐렌기, 크라이세닐렌기, 나프타세닐렌기, 피세닐렌기, 페릴레닐렌기, 펜타페닐렌기, 헥사세닐렌기, 펜타세닐렌기, 루비세닐렌기, 코로네닐렌기 및 오발레닐렌기; 중에서 선택되고,
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택되고,
a1 및 a2는 서로 독립적으로, 0 내지 3의 정수 중에서 선택되고,
Ar1은 치환 또는 비치환된 C6-C60아릴기 및 치환 또는 비치환된 1가 비-방향족 축합다환 그룹 중에서 선택되고,
b1은 1 내지 5의 정수 중에서 선택되고,
R1 내지 R8, R11 내지 R13은 서로 독립적으로, 수소 및 중수소 중에서 선택되고,
R14 내지 R17는 서로 독립적으로, 치환 또는 비치환된 C1-C60알킬기 중에서 선택되고,
c11 내지 c13은 서로 독립적으로, 0 내지 4의 정수 중에서 선택되고,
*는 이웃한 원자와의 결합 사이트이고,
상기 치환된 C1-C60알킬기, 치환된 C6-C60아릴기 및 치환된 1가 비-방향족 축합다환 그룹의 치환기 중에서 선택된 적어도 하나는,
중수소(-D), -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기 및 C1-C60알콕시기;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹, 1가 비-방향족 헤테로축합다환 그룹, -Si(Q11)(Q12)(Q13), -N(Q11)(Q12), -B(Q11)(Q12), -C(=O)(Q11), -S(=O)2(Q11) 및 -P(=O)(Q11)(Q12) 중에서 선택된 적어도 하나로 치환된, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기 및 C1-C60알콕시기;
C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹 및 1가 비-방향족 헤테로축합다환 그룹;
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기, C1-C60알콕시기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹, 1가 비-방향족 헤테로축합다환 그룹, -Si(Q21)(Q22)(Q23), -N(Q21)(Q22), -B(Q21)(Q22), -C(=O)(Q21), -S(=O)2(Q21) 및 -P(=O)(Q21)(Q22) 중에서 선택된 적어도 하나로 치환된, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C6-C60아릴옥시기, C6-C60아릴티오기, C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹 및 1가 비-방향족 헤테로축합다환 그룹; 및
-Si(Q31)(Q32)(Q33), -N(Q31)(Q32), -B(Q31)(Q32), -C(=O)(Q31), -S(=O)2(Q31) 및 -P(=O)(Q31)(Q32);
중에서 선택되고,
상기 Q11 내지 Q13, Q21 내지 Q23 및 Q31 내지 Q33은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C60알킬기, C2-C60알케닐기, C2-C60알키닐기, C1-C60알콕시기, C3-C10시클로알킬기, C1-C10헤테로시클로알킬기, C3-C10시클로알케닐기, C1-C10헤테로시클로알케닐기, C6-C60아릴기, C1-C60알킬기로 치환된 C6-C60아릴기, C6-C60아릴기로 치환된 C6-C60아릴기, 터페닐기, C1-C60헤테로아릴기, C1-C60알킬기로 치환된 C1-C60헤테로아릴기, C6-C60아릴기로 치환된 C1-C60헤테로아릴기, 1가 비-방향족 축합다환 그룹 및 1가 비-방향족 헤테로축합다환 그룹 중에서 선택된다. Condensed ring compound represented by the following formula (1):
<Formula 1>
<Formula 2A>
<Formula 2B>
<Formula 2C>
<Formula 10>
In formulas 1, 2A to 2C and 10,
A 1 is selected from the group represented by Formulas 2A to 2C, n1 is selected from the integer of 1 to 3,
X 1 is selected from O, S and C(R 14 )(R 15 ),
The B 2 ring, B 3 ring and B 4 ring are condensed with each other,
B 1 ring and B 4 ring are independently selected from C 6 -C 60 aromatic ring and C 1 -C 60 heteroaromatic ring,
B 2 ring is selected from C 7 -C 60 aromatic ring and C 1 -C 60 heteroaromatic ring,
The B 3 ring is represented by Formula 10 above, where X 2 is selected from O, S and C(R 16 )(R 17 ),
L 1 and L 2 are independently of each other, phenylene, pentalenylene, indenylene, naphthylene, azulenylene, and heptalenylene. ), indacenylene, acenaphthylene, fluorenylene, spiro-fluorenylene, benzofluorenylene, dibenzofluorenylene, phenalenylene ( phenalenylene, phenanthrenylene, anthracenylene, fluoranthenylene, triphenylenylene, pyrenylene, chrysenylene, naphthacenyl naphthacenylene, picenylene, perylenylene, pentaphenylene, hexacenylene, pentacenylene, rubicenylene, corone coronenylene and ovalenylene; and
Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, pentalenyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group. group, acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group , pyrenyl group, chrysenyl group, naphthacenyl group, picenyl group, perylgyrenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group, ovalenyl group, pyrrolyl group, thiophenyl group, Furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindoleyl group, indole Diary group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group, naphthyridinyl group, quinoxalinyl group, quinazolinyl group, cynolinyl group, carbazolyl group, phenanthri Dinyl group, acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzooxazolyl group, triazolyl group, tetra Zolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, thiadiazolyl group, imidazopyridinyl group, imidazopyrimidinyl group, and -Si(Q 31 )(Q 32 )(Q 33 ) Substituted with at least one selected from phenylene group, pentalenylene group, indenylene group, naphthylene group, azulenylene group, hepthalenylene group, indacenylene group, acetate Naphthylene group, fluorenylene group, spiro-fluorenylene group, benzofluorenylene group, dibenzofluorenylene group, phenalenylene group, phenanthrenylene group, anthracenylene group, fluoranthenylene group, triphenyl lenylene group, pyrenylene group, chrysenylene group, naphthacenylene group, picenylene group, perylenylene group, pentaphenylene group, hexasenylene group, pentacenylene group, rubycenylene group, coronenylene group and ovalenylene group; is selected from,
Q 31 to Q 33 are independently selected from C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group, phenyl group, biphenyl group, terphenyl group and naphthyl group,
a1 and a2 are independently selected from integers from 0 to 3,
Ar 1 is selected from a substituted or unsubstituted C 6 -C 60 aryl group and a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group,
b1 is selected from an integer of 1 to 5,
R 1 to R 8 , R 11 to R 13 are independently selected from hydrogen and deuterium,
R 14 to R 17 are independently selected from substituted or unsubstituted C 1 -C 60 alkyl groups,
c11 to c13 are independently selected from integers from 0 to 4,
* is a binding site with a neighboring atom,
At least one selected from the group consisting of a substituted C 1 -C 60 alkyl group, a substituted C 6 -C 60 aryl group, and a substituted monovalent non-aromatic condensed polycyclic group,
Deuterium (-D), -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 - C 60 alkenyl group, C 2 -C 60 alkynyl group and C 1 -C 60 alkoxy group;
Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 3 -C 10 cycloalkyl group, C 1 -C 10 hetero Cycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group, monovalent non-aromatic condensed heteropolycyclic group, -Si(Q 11 )(Q 12 )(Q 13 ), -N(Q 11 )(Q 12 ), -B(Q 11 )(Q 12 ), -C(=O)(Q 11 ), -S(=O) 2 (Q 11 ), and -P(=O)(Q 11 )(Q 12 ). C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group, C 2 -C 60 alkynyl group and C 1 -C 60 alkoxy group substituted with at least one selected from among;
C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryl Oxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group and monovalent non-aromatic condensed heteropolycyclic group;
Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group , C 2 -C 60 alkynyl group, C 1 -C 60 alkoxy group, C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocyclo Alkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group, monovalent non-aromatic group -aromatic heterocondensed polycyclic group, -Si(Q 21 )(Q 22 )(Q 23 ), -N(Q 21 )(Q 22 ), -B(Q 21 )(Q 22 ), -C(=O) (Q 21 ), -S(=O) 2 (Q 21 ) and -P(=O)(Q 21 )(Q 22 ), C 3 -C 10 cycloalkyl group, C 1 -C substituted with at least one selected from 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 aryloxy group, C 6 -C 60 arylthio group, C 1 -C 60 heteroaryl group, monovalent non-aromatic condensed polycyclic group and monovalent non-aromatic condensed heteropolycyclic group; and
-Si(Q 31 )(Q 32 )(Q 33 ), -N(Q 31 )(Q 32 ), -B(Q 31 )(Q 32 ), -C(=O)(Q 31 ), -S (=O) 2 (Q 31 ) and -P(=O)(Q 31 )(Q 32 );
is selected from,
Q 11 to Q 13 , Q 21 to Q 23 and Q 31 to Q 33 are each independently selected from hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amine Dino group, hydrazino group, hydrazono group, C 1 -C 60 alkyl group, C 2 -C 60 alkenyl group, C 2 -C 60 alkynyl group, C 1 -C 60 alkoxy group, C 3 -C 10 cycloalkyl group, C 1 -C 10 heterocycloalkyl group, C 3 -C 10 cycloalkenyl group, C 1 -C 10 heterocycloalkenyl group, C 6 -C 60 aryl group, C 6 -C 60 substituted with a C 1 -C 60 alkyl group Aryl group, C 6 -C 60 aryl group substituted with C 6 -C 60 aryl group, terphenyl group, C 1 -C 60 heteroaryl group, C 1 -C 60 heteroaryl group substituted with C 1 -C 60 alkyl group, It is selected from a C 1 -C 60 heteroaryl group substituted with a C 6 -C 60 aryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group.
X2는 O 또는 S인, 축합환 화합물.According to paragraph 1,
X 2 is O or S, a condensed ring compound.
B1 고리 및 B4 고리는 벤젠이고,
B2 고리는 나프탈렌인, 축합환 화합물.According to paragraph 1,
B 1 ring and B 4 ring are benzene,
B 2 ring is naphthalene, condensed ring compound.
상기 L1, L2는 서로 독립적으로, 하기 화학식 3-1 내지 3-9, 3-25, 3-33 내지 3-41로 표시되는 그룹 중에서 선택되는, 축합환 화합물:
상기 화학식 3-1 내지 3-9, 3-25, 3-33 내지 3-41 중,
Y1은 C(Z3)(Z4)이고;
Z3 내지 Z4은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 파이레닐기, 크라이세닐기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 디벤조퓨라닐기, 디벤조티오페닐기, 트리아지닐기, 벤조이미다졸일기, 페난트롤리닐기 및 -Si(Q31)(Q32)(Q33) 중에서 선택되고,
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택되고,
d2는 1 또는 2이고,
d3는 1 내지 3의 정수 중에서 선택되고,
d4는 1 내지 4의 정수 중에서 선택되고,
d5는 1 내지 5의 정수 중에서 선택되고,
d6은 1 내지 6의 정수 중에서 선택되고,
d8은 1 내지 8의 정수 중에서 선택되고,
* 및 *'은 이웃한 원자와의 결합 사이트이다.According to paragraph 1,
Wherein L 1 and L 2 are each independently selected from the group represented by the following formulas 3-1 to 3-9, 3-25, 3-33 to 3-41:
In formulas 3-1 to 3-9, 3-25, 3-33 to 3-41,
Y 1 is C(Z 3 )(Z 4 );
Z 3 to Z 4 are each independently selected from hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group, phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group , anthracenyl group, pyrenyl group, chrysenyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, quinolinyl group, isoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group , dibenzofuranyl group, dibenzothiophenyl group, triazinyl group, benzoimidazolyl group, phenanthrolinyl group and -Si (Q 31 ) (Q 32 ) (Q 33 ),
Q 31 to Q 33 are independently selected from C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group, phenyl group, biphenyl group, terphenyl group and naphthyl group,
d2 is 1 or 2,
d3 is selected from an integer of 1 to 3,
d4 is selected from an integer of 1 to 4,
d5 is selected from an integer of 1 to 5,
d6 is selected from integers from 1 to 6,
d8 is selected from integers from 1 to 8,
* and *' are binding sites with neighboring atoms.
상기 L1, L2는 서로 독립적으로, 하기 화학식 4-1,4-3, 4-5, 4-7 내지 4-13, 4-17, 4-24 내지 4-35로 표시되는 그룹 중에서 선택되는, 축합환 화합물:
상기 화학식 4-1,4-3, 4-5, 4-7 내지 4-13, 4-17, 4-24 내지 4-35 중 * 및 *'은 이웃한 원자와의 결합 사이트이다.According to paragraph 1,
The L 1 and L 2 are independently selected from the group represented by the following formulas 4-1, 4-3, 4-5, 4-7 to 4-13, 4-17, 4-24 to 4-35. Condensed ring compounds, which are:
In the above formulas 4-1, 4-3, 4-5, 4-7 to 4-13, 4-17, 4-24 to 4-35, * and *' are bonding sites with neighboring atoms.
상기 a1 및 a2는 서로 독립적으로, 0 또는 1인, 축합환 화합물.According to paragraph 1,
wherein a1 and a2 are independently 0 or 1, a condensed ring compound.
상기 Ar1은
페닐기(phenyl), 비페닐기(biphenyl), 터페닐기(terphenyl), 펜탈레닐기(pentalenyl), 인데닐기(indenyl), 나프틸기(naphthyl), 아줄레닐기(azulenyl), 헵탈레닐기(heptalenyl), 인다세닐기(indacenyl), 아세나프틸기(acenaphthyl), 플루오레닐기(fluorenyl), 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기(phenalenyl), 페난트레닐기(phenanthrenyl), 안트라세닐기(anthracenyl), 플루오란테닐기(fluoranthenyl), 트리페닐레닐기, 파이레닐기(pyrenyl), 크라이세닐기(chrysenyl), 나프타세닐기(naphthacenyl), 피세닐기(picenyl), 페릴레닐기(perylenyl), 펜타페닐기(pentaphenyl), 헥사세닐기(hexacenyl), 펜타세닐기(pentacenyl), 루비세닐기(rubicenyl), 코로네닐기(coronenyl) 및 오발레닐기(ovalenyl); 및
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로펜테닐기, 시클로헥세닐기, 페닐기, 비페닐기, 터페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴기레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기, 오발레닐기, 피롤일기, 티오페닐기, 퓨라닐기, 이미다졸일기, 피라졸일기, 티아졸일기, 이소티아졸일기, 옥사졸일기, 이속사졸일기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 이소인돌일기, 인돌일기, 인다졸일기, 푸리닐기, 퀴놀리닐기, 이소퀴놀리닐기, 벤조퀴놀리닐기, 프탈라지닐기, 나프티리디닐기, 퀴녹살리닐기, 퀴나졸리닐기, 시놀리닐기, 카바졸일기, 페난트리디닐기, 아크리디닐기, 페난트롤리닐기, 페나지닐기, 벤조이미다졸일기, 벤조퓨라닐기, 벤조티오페닐기, 이소벤조티아졸일기, 벤조옥사졸일기, 이소벤조옥사졸일기, 트리아졸일기, 테트라졸일기, 옥사디아졸일기, 트리아지닐기, 디벤조퓨라닐기, 디벤조티오페닐기, 벤조카바졸일기, 디벤조카바졸일기, 티아디아졸일기, 이미다조피리디닐기, 이미다조피리미디닐기 및 -Si(Q31)(Q32)(Q33) 중에서 선택된 적어도 하나로 치환된, 페닐기, 비페닐기, 터페닐기, 펜탈레닐기, 인데닐기, 나프틸기, 아줄레닐기, 헵탈레닐기, 인다세닐기, 아세나프틸기, 플루오레닐기, 스파이로-플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페날레닐기, 페난트레닐기, 안트라세닐기, 플루오란테닐기, 트리페닐레닐기, 파이레닐기, 크라이세닐기, 나프타세닐기, 피세닐기, 페릴레닐기, 펜타페닐기, 헥사세닐기, 펜타세닐기, 루비세닐기, 코로네닐기 및 오발레닐기; 중에서 선택되고,
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택된, 축합환 화합물.According to paragraph 1,
The Ar 1 is
Phenyl, biphenyl, terphenyl, pentalenyl, indenyl, naphthyl, azulenyl, heptalenyl, Indacenyl, acenaphthyl, fluorenyl, spiro-fluorenyl, benzofluorenyl, dibenzofluorenyl, phenalenyl, phenanthrenyl ( phenanthrenyl, anthracenyl, fluoranthenyl, triphenylenyl, pyrenyl, chrysenyl, naphthacenyl, picenyl , perylenyl, pentaphenyl, hexacenyl, pentacenyl, rubicenyl, coronenyl and ovalenyl; and
Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group , cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclopentenyl group, cyclohexenyl group, phenyl group, biphenyl group, terphenyl group, pentalenyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group. group, acenaphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group , pyrenyl group, chrysenyl group, naphthacenyl group, picenyl group, perylgyrenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group, ovalenyl group, pyrrolyl group, thiophenyl group, Furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindoleyl group, indole Diary group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, phthalazinyl group, naphthyridinyl group, quinoxalinyl group, quinazolinyl group, cynolinyl group, carbazolyl group, phenanthri Dinyl group, acridinyl group, phenanthrolinyl group, phenazinyl group, benzoimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzooxazolyl group, triazolyl group, tetra Zolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, thiadiazolyl group, imidazopyridinyl group, imidazopyrimidinyl group, and -Si(Q 31 )(Q 32 )(Q 33 ) Substituted with at least one selected from phenyl group, biphenyl group, terphenyl group, pentalenyl group, indenyl group, naphthyl group, azulenyl group, hepthalenyl group, indacenyl group , acenaphthyl group, fluorenyl group, spiro-fluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenalenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pi Renyl group, chrysenyl group, naphthacenyl group, picenyl group, perylenyl group, pentaphenyl group, hexacenyl group, pentacenyl group, rubisenyl group, coronenyl group and ovalenyl group; is selected from,
Q 31 to Q 33 are each independently selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, and a naphthyl group.
상기 Ar1은 하기 화학식 5-1 내지 5-19, 5-21 내지 5-24로 표시되는 그룹 중에서 선택된, 축합환 화합물:
상기 화학식 5-1 내지 5-19, 5-21 내지 5-24 중,
Y31 및 Y32는 서로 독립적으로, C(Z33)(Z34)이고;
Z33 내지 Z34은 서로 독립적으로, 수소, 중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기, 히드라조노기, C1-C20알킬기, C1-C20알콕시기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 플루오레닐기, 스파이로-비플루오레닐기, 벤조플루오레닐기, 디벤조플루오레닐기, 페난트레닐기, 안트라세닐기, 파이레닐기, 크라이세닐기, 피리디닐기, 피라지닐기, 피리미디닐기, 피리다지닐기, 퀴놀리닐기, 이소퀴놀리닐기, 퀴녹살리닐기, 퀴나졸리닐기, 카바졸일기, 디벤조푸라닐기, 디벤조티오페닐기, 벤조이미다졸일기, 페난트롤리닐기, 트리아지닐기, -N(Q31)(Q32) 및 -Si(Q31)(Q32)(Q33) 중에서 선택되고,
상기 Q31 내지 Q33은 서로 독립적으로, C1-C10알킬기, C1-C10알콕시기, 페닐기, 비페닐기, 터페닐기 및 나프틸기 중에서 선택되고,
e2는 1 또는 2이고,
e3는 1 내지 3의 정수 중에서 선택되고,
e4는 1 내지 4의 정수 중에서 선택되고,
e5는 1 내지 5의 정수 중에서 선택되고,
e6은 1 내지 6의 정수 중에서 선택되고,
e8은 1 내지 8의 정수 중에서 선택되고,
*은 이웃한 원자와의 결합 사이트이다.According to paragraph 1,
Ar 1 is a condensed ring compound selected from the group represented by the following formulas 5-1 to 5-19 and 5-21 to 5-24:
In formulas 5-1 to 5-19 and 5-21 to 5-24,
Y 31 and Y 32 are independently C(Z 33 )(Z 34 );
Z 33 to Z 34 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group, hydrazono group, C 1 -C 20 alkyl group, C 1 -C 20 alkoxy group, phenyl group, biphenyl group, terphenyl group, naphthyl group, fluorenyl group, spiro-bifluorenyl group, benzofluorenyl group, dibenzofluorenyl group, phenanthrenyl group , anthracenyl group, pyrenyl group, chrysenyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, quinolinyl group, isoquinolinyl group, quinoxalinyl group, quinazolinyl group, carbazolyl group , dibenzofuranyl group, dibenzothiophenyl group, benzoimidazolyl group, phenanthrolinyl group, triazinyl group, -N (Q 31 ) (Q 32 ) and -Si (Q 31 ) (Q 32 ) (Q 33 ). selected,
Q 31 to Q 33 are independently selected from C 1 -C 10 alkyl group, C 1 -C 10 alkoxy group, phenyl group, biphenyl group, terphenyl group and naphthyl group,
e2 is 1 or 2,
e3 is selected from an integer of 1 to 3,
e4 is selected from integers 1 to 4,
e5 is selected from integers 1 to 5,
e6 is selected from integers from 1 to 6,
e8 is selected from integers from 1 to 8,
* is a bonding site with a neighboring atom.
상기 Ar1은 하기 화학식 6-1 내지 6-4, 6-8 내지 6-10, 6-13, 6-15, 6-16 내지 6-18, 6-21 내지 6-23, 6-28, 6-29, 6-32 내지 6-41로 표시되는 그룹 중에서 선택된, 축합환 화합물:
상기 화학식 6-1 내지 6-4, 6-8 내지 6-10, 6-13, 6-15, 6-16 내지 6-18, 6-21 내지 6-23, 6-28, 6-29, 6-32 내지 6-41 중 *는 이웃한 원자와의 결합 사이트이다.According to paragraph 1,
Ar 1 is represented by the following formulas 6-1 to 6-4, 6-8 to 6-10, 6-13, 6-15, 6-16 to 6-18, 6-21 to 6-23, 6-28, Condensed ring compounds selected from the group represented by 6-29, 6-32 to 6-41:
The formulas 6-1 to 6-4, 6-8 to 6-10, 6-13, 6-15, 6-16 to 6-18, 6-21 to 6-23, 6-28, 6-29, In 6-32 to 6-41, * is a bonding site with a neighboring atom.
R14 내지 R17는 서로 독립적으로, 치환 또는 비치환된 C1-C20알킬기 중에서 선택되는, 축합환 화합물.According to paragraph 1,
R 14 to R 17 are each independently selected from a substituted or unsubstituted C 1 -C 20 alkyl group.
R14 내지 R17는 서로 독립적으로,
C1-C20알킬기; 및
중수소, -F, -Cl, -Br, -I, 히드록실기, 시아노기, 니트로기, 아미디노기, 히드라지노기 및 히드라조노기 중 적어도 하나로 치환된, C1-C20알킬기;
중에서 선택되는, 축합환 화합물.According to paragraph 1,
R 14 to R 17 are independently of each other,
C 1 -C 20 alkyl group; and
C 1 -C 20 alkyl group substituted with at least one of deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amidino group, hydrazino group and hydrazono group;
A condensed ring compound selected from among.
하기 화학식 1-1 내지 1-42 중 하나로 표시되는, 축합환 화합물:
<화학식 1-1>
<화학식 1-2>
<화학식 1-3>
<화학식 1-4>
<화학식 1-5>
<화학식 1-6>
<화학식 1-7>
<화학식 1-8>
<화학식 1-9>
<화학식 1-10>
<화학식 1-11>
<화학식 1-12>
<화학식 1-13>
<화학식 1-14>
<화학식 1-15>
<화학식 1-16>
<화학식 1-17>
<화학식 1-18>
<화학식 1-19>
<화학식 1-20>
<화학식 1-21>
<화학식 1-22>
<화학식 1-23>
<화학식 1-24>
<화학식 1-25>
<화학식 1-26>
<화학식 1-27>
<화학식 1-28>
<화학식 1-29>
<화학식 1-30>
<화학식 1-31>
<화학식 1-32>
<화학식 1-33>
<화학식 1-34>
<화학식 1-35>
<화학식 1-36>
<화학식 1-37>
<화학식 1-38>
<화학식 1-39>
<화학식 1-40>
<화학식 1-41>
<화학식 1-42>
상기 화학식 1-1 내지 1-42 중, X1, X2, L1, L2, a1, a2, Ar1, b1, R1 내지 R8, R11 내지 R13 및 c11 내지 c13에 대한 설명은 제1항에 기재된 바와 동일하다.According to paragraph 1,
A condensed ring compound represented by one of the following formulas 1-1 to 1-42:
<Formula 1-1>
<Formula 1-2>
<Formula 1-3>
<Formula 1-4>
<Formula 1-5>
<Formula 1-6>
<Formula 1-7>
<Formula 1-8>
<Formula 1-9>
<Formula 1-10>
<Formula 1-11>
<Formula 1-12>
<Formula 1-13>
<Formula 1-14>
<Formula 1-15>
<Formula 1-16>
<Formula 1-17>
<Formula 1-18>
<Formula 1-19>
<Formula 1-20>
<Formula 1-21>
<Formula 1-22>
<Formula 1-23>
<Formula 1-24>
<Formula 1-25>
<Formula 1-26>
<Formula 1-27>
<Formula 1-28>
<Formula 1-29>
<Formula 1-30>
<Formula 1-31>
<Formula 1-32>
<Formula 1-33>
<Formula 1-34>
<Formula 1-35>
<Formula 1-36>
<Formula 1-37>
<Formula 1-38>
<Formula 1-39>
<Formula 1-40>
<Formula 1-41>
<Formula 1-42>
In Formulas 1-1 to 1-42 , description of X 1 , is the same as described in paragraph 1.
하기 화학식 1-1(1) 내지 1-42(1) 중 하나로 표시되는, 축합환 화합물:
<화학식 1-1(1)>
<화학식 1-2(1)>
<화학식 1-3(1)>
<화학식 1-4(1)>
<화학식 1-5(1)>
<화학식 1-6(1)>
<화학식 1-7(1)>
<화학식 1-8(1)>
<화학식 1-9(1)>
<화학식 1-10(1)>
<화학식 1-11(1)>
<화학식 1-12(1)>
<화학식 1-13(1)>
<화학식 1-14(1)>
<화학식 1-15(1)>
<화학식 1-16(1)>
<화학식 1-17(1)>
<화학식 1-18(1)>
<화학식 1-18(1)>
<화학식 1-19(1)>
<화학식 1-20(1)>
<화학식 1-21(1)>
<화학식 1-22(1)>
<화학식 1-23(1)>
<화학식 1-24(1)>
<화학식 1-25(1)>
<화학식 1-26(1)>
<화학식 1-27(1)>
<화학식 1-28(1)>
<화학식 1-29(1)>
<화학식 1-30(1)>
<화학식 1-31(1)>
<화학식 1-32(1)>
<화학식 1-33(1)>
<화학식 1-34(1)>
<화학식 1-35(1)>
<화학식 1-36(1)>
<화학식 1-37(1)>
<화학식 1-38(1)>
<화학식 1-39(1)>
<화학식 1-40(1)>
<화학식 1-41(1)>
<화학식 1-42(1)>
상기 화학식 1-1(1) 내지 1-42(1) 중 X1, X2, L1, L2, a1, a2, Ar1 및 b1에 대한 설명은 제1항에 기재된 바와 동일하다.According to paragraph 1,
A condensed ring compound represented by one of the following formulas 1-1(1) to 1-42(1):
<Formula 1-1(1)>
<Formula 1-2(1)>
<Formula 1-3(1)>
<Formula 1-4(1)>
<Formula 1-5(1)>
<Formula 1-6(1)>
<Formula 1-7(1)>
<Formula 1-8(1)>
<Formula 1-9(1)>
<Formula 1-10(1)>
<Formula 1-11(1)>
<Formula 1-12(1)>
<Formula 1-13(1)>
<Formula 1-14(1)>
<Formula 1-15(1)>
<Formula 1-16(1)>
<Formula 1-17(1)>
<Formula 1-18(1)>
<Formula 1-18(1)>
<Formula 1-19(1)>
<Formula 1-20(1)>
<Formula 1-21(1)>
<Formula 1-22(1)>
<Formula 1-23(1)>
<Formula 1-24(1)>
<Formula 1-25(1)>
<Formula 1-26(1)>
<Formula 1-27(1)>
<Formula 1-28(1)>
<Formula 1-29(1)>
<Formula 1-30(1)>
<Formula 1-31(1)>
<Formula 1-32(1)>
<Formula 1-33(1)>
<Formula 1-34(1)>
<Formula 1-35(1)>
<Formula 1-36(1)>
<Formula 1-37(1)>
<Formula 1-38(1)>
<Formula 1-39(1)>
<Formula 1-40(1)>
<Formula 1-41(1)>
<Formula 1-42(1)>
The descriptions of X 1 ,
X2는 O 및 S 중에서 선택되고,
L1 및 L2은 서로 독립적으로, 하기 화학식 4-1 내지 4-3, 4-5, 4-7 내지 4-13, 4-17, 4-24 내지 4-35로 표시되는 그룹 중에서 선택되고,
a1 및 a2는 서로 독립적으로, 0 또는 1이고,
상기 Ar1은 하기 화학식 6-1 내지 6-4, 6-8 내지 6-10, 6-13, 6-15, 6-16 내지 6-18, 6-21 내지 6-23, 6-28, 6-29, 6-32 내지 6-41로 표시되는 그룹 중에서 선택되고,
b1은 1 또는 2인, 축합환 화합물:
상기 화학식 4-1 내지 4-3, 4-5, 4-7 내지 4-13, 4-17, 4-24 내지 4-35 및 6-1 내지 6-4, 6-8 내지 6-10, 6-13, 6-15, 6-16 내지 6-18, 6-21 내지 6-23, 6-28, 6-29, 6-32 내지 6-41 중 * 및 *'는 이웃한 원자와의 결합 사이트이다.According to clause 15,
X 2 is selected from O and S,
L 1 and L 2 are independently selected from the group represented by the following formulas 4-1 to 4-3, 4-5, 4-7 to 4-13, 4-17, 4-24 to 4-35, and ,
a1 and a2 are independently 0 or 1,
Ar 1 is represented by the following formulas 6-1 to 6-4, 6-8 to 6-10, 6-13, 6-15, 6-16 to 6-18, 6-21 to 6-23, 6-28, selected from the group represented by 6-29, 6-32 to 6-41,
b1 is 1 or 2, a condensed ring compound:
The formulas 4-1 to 4-3, 4-5, 4-7 to 4-13, 4-17, 4-24 to 4-35 and 6-1 to 6-4, 6-8 to 6-10, Among 6-13, 6-15, 6-16 to 6-18, 6-21 to 6-23, 6-28, 6-29, 6-32 to 6-41, * and *' refer to neighboring atoms. It is a binding site.
상기 제1전극이 애노드이고,
상기 제2전극이 캐소드이고,
상기 유기층이, i) 상기 제1전극과 상기 발광층 사이에 개재되며, 정공 주입층, 정공 수송층, 버퍼층 및 전자 저지층 중 적어도 하나를 포함한 정공 수송 영역 및 ii) 상기 발광층과 상기 제2전극 사이에 개재되며, 정공 저지층, 전자 수송층 및 전자 주입층 중 적어도 하나를 포함한 전자 수송 영역을 포함한, 유기 발광 소자.According to clause 17,
The first electrode is an anode,
The second electrode is a cathode,
The organic layer includes i) a hole transport region interposed between the first electrode and the light-emitting layer and including at least one of a hole injection layer, a hole transport layer, a buffer layer, and an electron blocking layer, and ii) between the light-emitting layer and the second electrode. An organic light-emitting device comprising an electron transport region including at least one of a hole blocking layer, an electron transport layer, and an electron injection layer.
상기 발광층에 상기 축합환 화합물이 포함되어 있는, 유기 발광 소자. According to clause 17,
An organic light-emitting device wherein the light-emitting layer contains the condensed cyclic compound.
상기 발광층은 형광 도펀트를 더 포함한, 유기 발광 소자. According to clause 17,
An organic light-emitting device wherein the light-emitting layer further includes a fluorescent dopant.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160006995A KR102611207B1 (en) | 2016-01-20 | 2016-01-20 | Condensed-cyclic compound and organic light emitting device comprising the same |
US15/399,414 US11276827B2 (en) | 2016-01-05 | 2017-01-05 | Condensed cyclic compound and an organic light-emitting device including the same |
US15/399,255 US10553800B2 (en) | 2016-01-05 | 2017-01-05 | Condensed cyclic compound and an organic light-emitting device including the same |
US15/399,155 US10580999B2 (en) | 2016-01-05 | 2017-01-05 | Condensed cyclic compound and an organic light-emitting device including the same |
US15/399,349 US11107999B2 (en) | 2016-01-05 | 2017-01-05 | Condensed cyclic compound and an organic light-emitting device including the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160006995A KR102611207B1 (en) | 2016-01-20 | 2016-01-20 | Condensed-cyclic compound and organic light emitting device comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170087562A KR20170087562A (en) | 2017-07-31 |
KR102611207B1 true KR102611207B1 (en) | 2023-12-08 |
Family
ID=59419011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160006995A KR102611207B1 (en) | 2016-01-05 | 2016-01-20 | Condensed-cyclic compound and organic light emitting device comprising the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102611207B1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2145936A3 (en) * | 2008-07-14 | 2010-03-17 | Gracel Display Inc. | Fluorene and pyrene derivatives and organic electroluminescent device using the same |
KR101219492B1 (en) * | 2009-12-11 | 2013-01-28 | 삼성디스플레이 주식회사 | Compound Containing 5-Membered Heterocycle And Organic Electronic Element Using The Same, Terminal Thereof |
-
2016
- 2016-01-20 KR KR1020160006995A patent/KR102611207B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20170087562A (en) | 2017-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102608414B1 (en) | Condensed compound and organic light emitting device comprising the same | |
KR102595922B1 (en) | Carbazole-based compound and organic light emitting device comprising the same | |
KR102615642B1 (en) | Organic light emitting device | |
KR102600472B1 (en) | Condensed cyclic compound and organic light emitting device comprising the same | |
KR102536246B1 (en) | Heterocyclic compound and organic light emitting device comprising the same | |
KR102633852B1 (en) | Carbazole-based compound and organic light emitting device comprising the same | |
KR20170065711A (en) | Condensed-cyclic compound and organic light emitting device comprising the same | |
CN111718269A (en) | Amine compound and organic light-emitting element including same | |
KR20240017382A (en) | Condensed compound and organic light emitting diode comprising the same | |
KR20210156921A (en) | Heterocyclic compound and organic light-emitting device including the same | |
KR102606280B1 (en) | Polycyclic compound and organic light emitting device comprising the same | |
KR102625861B1 (en) | Heterocyclic compound and organic light emitting device comprising the same | |
KR102628848B1 (en) | Condensed compound and organic light-emitting device including the same | |
KR102633851B1 (en) | Diamine-based compound and organic light emitting device comprising the same | |
KR102364221B1 (en) | Condensed-cyclic compound and organic light emitting device comprising the same | |
KR102544984B1 (en) | Compound and Organic light emitting device comprising same | |
JP2018048109A (en) | Condensed cyclic compound and organic light-emitting device including the same | |
KR102630639B1 (en) | Organic light-emitting device including diamine compound and diamine compound | |
KR102602194B1 (en) | Condensed-cyclic compound and organic light-emitting device comprising the same | |
KR102628850B1 (en) | Condensed cyclic compound and organic light emitting device comprising the same | |
KR102388728B1 (en) | Condensed-cyclic compound and organic light emitting device comprising the same | |
KR102304719B1 (en) | Condensed-cyclic compound and organic light emitting diode comprising the same | |
KR102536247B1 (en) | Heterocyclic compound and organic light-emitting device comprising the same | |
KR20210145895A (en) | A heterocyclic compound and organic light-emitting device comprising the same | |
KR102512719B1 (en) | Condensed-cyclic compound and organic light emitting device comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |